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process.
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8. Science is the biggest luxury product of humanity.
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7Flavoenzymes are highly diverse enzymes that harness the
power of their flavin cofactor to catalyse redox reactions.
The fungal, FAD-dependent enzyme vanillyl alcohol ox-
idase (VAO) has been studied in this thesis through dif-
ferent computational and experimental approaches. This
oxidative enzyme, which covalently binds its cofactor via
a histidine residue, is active with a wide range of para-
substituted phenols. Several of these substrates are con-
verted into high-value chemicals, e.g. coniferyl alcohol,
vanillin and chiral alcohols.
Interest in oxidative enzymes is booming and several
are being prepared for industrial applications or are al-
ready used at large scale. Examples are glucose oxidase,
used as a biosensor in blood glucose meters for diabetic
patients; hexose oxidase, used in the baking industries
to improve dough properties, and laccases, which are on
their way for applications in the pulp and paper indus-
try. Each application of a new enzyme faces different
challenges. Baeyer-Villiger monooxygenases for example
are promising biocatalysts for the pharmaceutical indus-
try, but many of them are operationally unstable or suffer
from substrate or product inhibition. Research to over-
come these obstacles is ongoing and requires the inte-
gration of protein engineering with process design. Such
integrative approaches profit from the advances made in
both fields and are likely to reduce the time needed by in-
dividual enzymes to grow into their new role as industrial
biocatalysts.
VAO belongs to the VAO/PCMH family, whose mem-
bers all share the same FAD-binding fold. Within that
family, VAO is part of the subgroup of 4-phenol oxidizing
enzymes. VAO is the only fungal member of that group
and its physiological role in fungi is unclear. Using the
sequence and three-dimensional structure of VAO from
Penicillium simplicissimum, we have identified novel, pu-
tative fungal VAOs. We found that these fungal VAOs likely
8originated from a bacterial ancestor and were transferred
to fungi by horizontal gene transfer. Based on the se-
quences of these novel fungal VAOs we have defined sev-
eral motifs that should help to resolve misannotations in
sequence databases.
In the reaction cycle of VAO, reoxidation of reduced
FAD by dioxygen is a crucial step. After product forma-
tion, flavin reoxidation results in the release of hydro-
gen peroxide. VAOs that were heterologously produced
in the methylotrophic yeast Komagataella phaffii con-
tain a highly stable, non-covalently bound anionic FAD
semiquinone. In VAO, this redox state of FAD is atypical
and its stability is baffling. We think that enzymes pro-
duced in this eukaryotic expression system fell victim to
oxidative stress: substrate binding uncouples dioxygen re-
duction from product formation, and thus results in atyp-
ical single electron flavin redox cycling. In other words, in
these enzymes the normally quick decay of the p-quinone
methide intermediate is impaired by an increased energy
barrier to the product, resulting in the reaction falling back
to the p-quinone methide intermediate.
In any enzymatic reaction, substrates have to "find"
the active site before catalysis can happen. Because most
enzymes are not diffusion limited, this step is often ne-
glected. It is nevertheless of fundamental interest to un-
derstand the inner workings of enzymes. The identifi-
cation of diffusion (or migration) paths based on crystal
structures remains challenging due to the rigidity of these
tightly packed structures. In VAO, we have identified one
path for phenolic ligands and one for dioxygen and hy-
drogen peroxide to enter and leave the active site. After
the substrate has reached the active site, two concierge
residues close off the reaction center. Interestingly, in our
simulations only the protonated forms of phenolic sub-
strates are able to enter the enzyme.
9A VAO-catalysed reaction that is of relevance for the
food industry is the synthesis of natural vanillin from nat-
ural p-creosol. VAO catalyses this reaction via the inter-
mediate formation of vanillyl alcohol. However, in the first
reaction step, a covalent p-creosol-FAD adduct is formed,
significantly inhibiting this reaction. We have used quan-
tum chemical modelling to study this process in more de-
tail. The productive reaction to vanillyl alcohol competes
with adduct formation due to the lower energy barrier of
the reaction pathway to the adduct. An aspartate residue
in the active site is crucial in adduct formation, and its
flexibility is the cause for adduct formationwith p-creosol.
Bulkier substrates prevent the attack of this aspartate on
FAD by steric hindrance.
Oxidative enzymes, such as VAO, are moving into the
spotlight of different industries. One strategy to identify
enzymes for industrial applications is to mine genomes.
Genome mining of VAO-like sequences is hampered by
misannotations present in sequence databases. Opening
up sequence databases to editing by users would help to
resolve misannotations.
Recent experimental and computational research has fur-
ther advanced the understanding of VAO’s reactivity. We
have demonstrated that computational tools can success-
fully be used to study processes out of the reach of experi-
mental techniques. It is crucial to integrate different com-
putational methodologies into one, easy to use, computa-
tional enzymology toolbox. Such a toolbox should lower
the barrier between the fields of computational and ex-
perimental enzymology. Collaborations that successfully
connect industry and academia, as well as computational
and experimental enzymologists, will decide the future of
industrial applications of enzymes.

Samenvatting
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Enzymen maken het leven mogelijk - maar hoe doen ze
dit? Enzymen versnellen (katalyseren) een chemische re-
actie door een omgeving te vormen waarin deze reactie
sneller kan verlopen. Dit betekent ook dat de energiebar-
rière, die moet worden overwonnen voor elke chemis-
che reactie, wordt verlaagd. De omgeving in het enzym
waarin de reactie kan plaatsvinden wordt het actieve cen-
trum genoemd. De interacties in het actieve centrum zijn
vaak geoptimaliseerd voor een specifiek enzym-substraat
molecuul paar (door natuurlijke selectie tijdens de evolu-
tie), wat enzymen geeft met verschillende specialisaties
(substraatspecificiteiten). De bouwstenen waarmee en-
zymen worden gebouwd (aminozuren) bepalen welk type
reactie een enzym kan katalyseren.
Sommige enzymen gebruiken cofactoren om reacties
te katalyseren die met enkel aminozuren niet mogelijk
zijn. Vitaminen zijn meestal de voorlopers voor deze co-
factoren. Flavoenzymen, bijvoorbeeld het enzym vanillyl
alcohol oxidase (VAO) dat is onderzocht in dit proefschrift,
gebruikt een flavine cofactor om er redoxreacties mee te
katalyseren. VAO is oorspronkelijk uit een schimmel geeï-
soleerd en bindt zijn flavine-adenine-dinucleotide cova-
lent via een histidine-aminozuur in het actieve centrum.
VAO converteert uitsluitend para-gesubstitueerde, feno-
lische substraten. Veel van deze substraten worden in
waardevolle chemicaliën zoals coniferylalcohol, vanilline
en chirale alcoholen omgezet. We hebben dit enzym ex-
perimenteel in het lab en met de computer bestudeerd.
De belangstelling voor oxidatieve enzymen zoals VAO
is in de afgelopen jaren enorm toegenomen en veel van
deze enzymen worden gebruikt of voorbereid voor in-
dustriële toepassingen. Enkele voorbeelden zijn glucose-
oxidase, hexose-oxidase, laccasen of Baeyer-Villiger-
monooxygenasen. Glucoseoxidase is een enzym dat de
bloedsuikerspiegel voor diabetici kan meten, hexose oxi-
dase wordt in de bakkersindustrie gebruikt om de eigen-
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schappen van het deeg te verbeteren en laccasen worden
ontwikkeld voor toepassingen in de pulp- en papierindus-
trie. Elk enzymheeft temakenmet verschillende uitdagin-
gen en deze uitdagingen zijn afhankelijk van de gewenste
toepassing.
VAOs die werden geproduceerd in de gist Komagataella
phaffii bevatten allemaal een hoogst ongebruikelijke en
stabiele vorm van de flavine cofactor: een niet-covalent
gebonden, anionische semichinon. We vermoeden dat
deze enzymen het slachtoffer zijn geworden van oxi-
datieve stress. Door het substraat te binden, worden de
normaal gekoppelde reacties die zuurstof verminderen en
product vormen ontkoppeld, en de reacie eindigt zonder
product te vormen.
In een enzymatische reactie moeten de substraten al-
tijd het actieve centrum van het enzym "vinden" voordat
een reactie kan plaatsvinden. De migratiepaden in enzy-
men kunnen worden geïdentificeerd door berekeningen
die de bewegingen van een enzym simuleren. In VAO ont-
dektenwe demigratiepaden van verschillendemoleculen.
Twee concierge aminozuren sluiten het pad naar de ac-
tieve centrum af zodra een substraat het heeft bereikt. In-
teressant is dat alleen geprotoneerde substraten in in het
actieve centrum worden toegelaten.
De synthese van natuurlijke vanilline uit natuurlijke
creosoot, gekatalyseerd door VAO, is belangrijk voor de
voedingsindustrie. VAO katalyseert deze reactie met het
tussenproduct vanillylalcohol. In de eerste reactiestap
wordt helaas een stabiel, covalent adduct gevormd tussen
het substraat en de cofactor, wat deze reactie sterk ver-
traagt. We hebben deze reactie in detail bestudeerd
met kwantummechanische berekeningen en vonden dat
de productieve reactie (waarin vanillyl alcohol wordt
gevormd) concurreert met adductvorming.
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Oxidatieve enzymen, waaronder VAO, komen steeds
meer in de schijnwerpers van verschillende industrieën.
We hebben aangetoond dat computergestuurd onderzoek
met succes kan worden gebruikt om processen te on-
derzoeken die buiten het bereik van experimentele tech-
nieken liggen. Met het oog op de toekomst van de in-
dustriële toepassingen van enzymen moet samenwerking
tussen de industrie en de academischewereldworden ver-
sterkt en ook de samenwerking tussen de experimentele
en computationele enzymologie moet worden uitgebreid.

Zusammenfassung
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Enzyme ermöglichen Leben - aber wie machen sie das?
Enzyme beschleunigen (katalysieren) eine chemische
Reaktion dadurch, dass sie eine Umgebung formen in der
diese Reaktion schneller ablaufen kann. Das bedeutet
auch, dass die Energiebarriere, welche für jede chemische
Reaktion überwunden werden muss, gesenkt wird. Die
Umgebung im Enzym, in welchem die Reaktion beschleu-
nigt stattfinden kann, wird das aktive Zentrum genannt.
Die Interaktionen im aktiven Zentrum sind oft für ein
Enzym-Molekül-Paar optimiert (durch natürliche Selek-
tion während der Evolution), wodurch Enzyme mit ver-
schiedenen Spezialisierungen (Substratspezifitäten) ent-
standen sind. Die Bausteine, aus welchen Enzyme gebaut
werden (sogenannte Aminosäuren), bestimmen, welche
Art von Reaktion ein Enzym katalysieren kann - und limi-
tieren damit die Enzyme in ihrem Reaktionspektrum.
Einige Enzyme benutzen sogenannte Kofaktoren um
Reaktionen, welche mit Aminosäuren alleine nicht mach-
bar sind, zu katalysieren. Vitamine sind meist die
Vorstufen der Kofaktoren von Enzymen. Flavoen-
zyme, wie das Enzym Vanillyl Alkohol Oxidase (VAO)
welches in dieser Doktorarbeit untersucht wurde, be-
nutzen einen Flavin-Kofaktor um Redoxreaktionen zu
katalysieren. Dieser Flavin-Kofaktor wird aus Riboflavin
(Vitamin B2) hergestellt. VAO ist pilzlichenUrsprungs und
bindet seinen Flavin-Kofaktor kovalent durch eine His-
tidin Aminosäure im aktiven Zentrum. VAO setzt auss-
chliesslich para-substituierte, phenolische Substrate um.
Viele dieser Substrate werden in wertvolle Chemikalien
wie z. B. Coniferylalkohol, Vanillin und chirale Alkohole
umgewandelt. Wir haben dieses Enzym experimentell
und mit Computermodellen untersucht.
Das Interesse an oxidativen Enzymen wie VAO ist über
die letzten Jahre hinweg massiv gewachsen. Viele solche
Enzyme werden für industrielle Anwendungen benutzt
oder auf diese vorbereitet. Beispiele beinhalten Glukose-
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Oxidase, Hexose-Oxidase, Laccasen oder Baeyer-Villiger
Monooxygenasen. Glukose-Oxidase ist ein wichtiges En-
zym, welches in den Blutzuckermessgeräten von Dia-
betikern den Blutzuckerpegel misst, Hexose-Oxidase wird
in der Backindustrie gebraucht um die Eigenschaften des
Teigs zu verbessern und Laccasen sind auf dem Weg zu
Anwendungen in der Zellstoff- und Papierindustrie. Jedes
Enzym muss sich anderen Herausforderungen stellen,
wobei sich diese je nach der gewünschten Anwendung
drastisch unterscheiden.
VAOs, welche in der Hefe Komagataella phaf-
fii hergestellt wurden, enthalten alle eine äusserst
ungewöhnliche und stabile Form des Flavin-Kofaktors:
ein nicht-kovalent gebundenes, anionisches Semichinon.
Wir vermuten, dass diese Enzyme oxidativem Stress zum
Opfer gefallen sind. Durch das Binden des Substrats wer-
den die normalerweise gekoppelten Reaktionen, welche
Sauerstoff reduzieren und Produkt formen, entkoppelt.
Dies führt zu einer atypischen Reaktion, in der kein
Produkt geformt wird.
In einer enzymatischen Reaktionmüssen die Substrate
das aktive Zentrum des Enzyms immer "finden" bevor
eine Reaktion stattfinden kann. Die Migrationsbahnen in
Enzymen können mit Berechnungen, welche die Bewe-
gungen eines Enzyms simulieren, identifiziert werden. So
haben wir in VAO die Migrationsbahnen von verschiede-
nen Molekülen entdeckt. Zwei Pförtner-Aminosäuren
schliessen den Weg zum aktive Zentrum ab, sobald ein
Substrat dieses erreicht hat. Interessanterweise werden
nur protonierte Substrate in das aktive Zentrum hinein-
gelassen.
Die Synthese von natürlichemVanillin aus natürlichem
p-Creosol wird von VAO katalysiert und ist für die Lebens-
mittelindustrie von Bedeutung. VAO katalysiert diese
Reaktion mit dem Zwischenprodukt Vanillyl Alkohol. Im
21
ersten Reaktionschritt wird jedoch ein stabiles, kova-
lentes Addukt zwischen dem Substrat und dem Kofaktor
geformt, was diese Reaktion stark verlangsamt. Wir haben
diese Reaktion mit quantenmechanischen Berechnungen
detailliert untersucht und herausgefunden, dass die pro-
duktive Reaktion, bei welcher Vanillyl Alkohol geformt
wird, mit der Adduktbildung konkurriert.
Oxidative Enzyme, unter anderem auch VAO, befinden
sich zunehmend imFokus verschiedener Industriezweige.
Wir haben veranschaulicht, dass computergestützte
Forschung erfolgreich genutzt werden kann um Abläufe
ausserhalb der Reichweite experimenteller Techniken
zu untersuchen. Um die Zukunft von industriellen
Anwendungen von Enzymen zu sichern, muss die Zusam-
menarbeit zwischen der industriellen und akademischen
Welt gestärkt, sowie die Zusammenarbeit zwischen der
experimentellen und computergestützten Enzymologie
ausgebaut werden.

Abbreviations
4PO the 4-phenol oxidising subgroup of the VAO/PCMH flavoprotein family
CAZy Carbohydrate-Active Enzymes database
EC x.x.x.x Enzyme Commission number
EUGO Eugenol oxidase
FAD Flavin adenine dinucleotide (oxidised)
FADH2 Flavin adenine dinucleotide (reduced)
FMN Flavin mononucleotide
INDOX Industrial oxidoreductases
MC Monte Carlo (the technique, not the place)
MD Molecular dynamics
NAD+ Nicotinamide adenine dinucleotide (oxidised)
NADH Nicotinamide adenine dinucleotide (reduced)
NADP+ Nicotinamide adenine dinucleotide phosphate (oxidised)
NADPH Nicotinamide adenine dinucleotide phosphate (reduced)
PCMH p-cresol methylhydroxylase
PDB Protein data bank
PELE Protein energy landscape exploration
QCC Quantum chemical cluster
QCM Quantum chemical modelling
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QM Quantummechanics
QM/MM Quantummechanical/molecular mechanics
SDS-PAGE Sodium dodecyl sulfate - polyacrylamide gel electrophoresis
VAO Vanillyl alcohol oxidase
Amino acid residues (three-letter/one-letter abbreviation). A number after the abbreviated amino acid
residue indicates its position in the protein sequence.
Ala/A Alanine
Arg/R Arginine
Asn/N Asparagine
Asp/D Aspartate
Cys/C Cysteine
Glu/E Glutamate
Gln/Q Glutamine
Gly/G Glycine
His/H Histidine
Ile/I Isoleucine
Leu/L Leucine
Lys/K Lysine
Met/M Methionine
Phe/F Phenylalanine
Pro/P Proline
Ser/S Serine
Thr/T Threonine
Trp/W Tryptophan
Tyr/Y Tyrosine
Val/V Valine
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From Oxygen to Flavoenzyme Oxidases
A short history of oxygen. Oxygen is the thirdmost abun-
dant chemical element in our universe, preceeded only by
hydrogen and helium. It is produced in stars through he-
lium burning, in the so-called Carbon-Nitrogen-Oxygen
cycle [1, 2]. On Earth, oxygen is present in numerous
chemical substances, for example water, carbon dioxide,
amino acids, and as dioxygen in air. The atmosphere that
we breathe today contains approximately 21% dioxygen,
which has not always been the case. Dioxygen concentra-
tions were very low during the first half of Earth’s existence
(Figure 1). For that time, it is generally estimated that
dioxygen concentrations in the atmosphere were as low
as 0.001% of modern oxygen concentrations [3]. But be-
tween 2.4 and 2.1 billion years ago, the concentrations of
dioxygen in the atmosphere increased permanently. This
’Great Oxidation Event’ (GOE) led to our modern atmo-
sphere and was caused by photosynthetic organisms, see
Figure 1.
Cyanobacteria, as well as plants and algae, are able to
do photosynthesis. Plants and algae obtained the ability
Figure 1: The organisms causing
the ’Great Oxidation Event’ were
cyanobacteria, the earliest organ-
isms capable of oxygenic photo-
synthesis [3]. Photosynthesis uses
water as an initial electron donor
to produce sugar from carbon-
dioxide and forms dioxygen as a
byproduct.
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The term "powerhouse of the cell"
was coined by Philip Siekevitz in
1957 [7].
Cofactor: a substance (other than
the substrate) whose presence is
essential for the activity of an en-
zyme [8]. Without its cofactor
bound, the enzyme is inactive and
is called an apoenzyme. With its
cofactor bound, covalently or non-
covalently, the enzyme is active
and is called a holoenzyme.
to perform photosynthesis through endosymbiosis of an
ancestor ofmodern cyanobacteria [4, 5, 6]. This endosym-
biontic cyanobacterium is called a chloroplast, the power-
plant of plants and algae. Other bacteria use up dioxygen
as a substrate in a process called oxidative phosphoryla-
tion. Oxidative phosphorylation is one of many oxidation
reactions wich are essential for living organisms. One bac-
terium capable of oxidative phosphorylationwas acquired
by eukaryotes through endosymbiosis leading to modern
eukaryotes like fungi and animals. This form of endosym-
biosis resulted in mitochondria, the "powerhouses of the
cell".
An oxidation reaction has historically been defined as
a reaction where dioxygen is consumed. Since the 19th
century, the term oxidation is used more broadly and de-
scribes a reaction in which electrons are transferred from
one molecule to another, e.g: 2H2 +O2 → 2H2O. In this
reaction, hydrogen gas is oxidised (by donating two elec-
trons) and oxygen is reduced (by accepting the electrons).
Because one reaction partner is reduced and one is oxi-
dised, oxidation reactions are also called redox reactions.
Redox reactions can also be catalysed by enzymes. How-
ever, because the amino acids that form an enzyme are
only able to do acid-base and covalent catalysis, addi-
tional molecules are needed as electron source: cofac-
tors. The cofactor can be organic or inorganic (e.g. cop-
per, iron, vanadium). Examples of organic cofactors are
nicotinamide adenine dinucleotide (NADH or NAD+, de-
pending on its oxidation state), nicotinamide adenine din-
ucleotide phosphate (NADPH or NADP+, depending on
its oxidation state) and flavin adenine dinucleotide (FAD),
flavin mononucleotide (FMN) or riboflavin, see Figure 2.
Enzymes and their cofactors. Cofactors are sometimes
also called coenzymes or cosubstrates or prosthetic
groups. While there are clear biochemical definitions for
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Figure 2: Structures of the flavin
cofactors. Riboflavin in black,
FMN in black and blue and FAD in
black, blue and red.
these terms, they are sometimes used as synonyms, de-
pending on the field of research [9, 10, 11, 12]. Here, the
definition from the Oxford dictionary will be used, see
margin note.
The cofactor FAD is bright yellow in solution (when ox-
idised) and enzymes which bind it (or FMN) are flavoen-
zymes. In FAD’s chemical structure, the respective phos-
phate group of the flavin mononucleotide moiety (in
blue in Figure 2) is connected to that of the adenosine
monophosphate (in red in Figure 2). FAD is a redox cofac-
tor and can exist in five different redox states, which have
different colours: fully oxidised (FAD, yellow), anionic
semiquinone (FAD•–, red), neutral semiquinone (FADH•,
blue), hydroquinone (FADH2, colourless) or the deproto-
nated, reduced FAD (FADH–, colourless). Switching be-
tween these five states can be reversible. Although gen-
erally the oxidation state of FAD is mentioned, it is only
its isoalloxazine ring that is reduced or oxidised (in black,
together with the ribityl chain, in Figure 2). The different
redox states of FAD are depicted in Figure 3, but are also
valid for other flavins. Flavoenzymes use and modulate
the unique and versatile properties of FAD to catalyse a
wide range of chemical reactions.
Flavoenzymes are critical to redox reactions essential
for life on Earth. The most important part of the flavin co-
factor is its isoalloxazine ring, which forms the "catalytic
heart of a flavoenzyme" [13]. In some cases, modified ver-
sions of the isoalloxazine ring are used. Examples of such
modifications are depicted in Figure 4 on page 31.
The covalent modifications of the flavins fine-tune
their reactivity by affecting their redox properties. The
protein environment of the cofactor also helps to tune
these redox properties, which leads to different reactivi-
ties in various flavoenzymes with the same cofactor. Most
flavoenzymes distinguish strictly between FAD and FMN,
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Figure 3: The five redox states
of FAD. FAD can switch between
these different states by accept-
ing two protons and two elec-
trons in its fully oxidised form to
become fully reduced, colourless
FADH2. It can also switch from its
fully oxidised state to the anionic
semiquinone radical by gaining
one electron, changing its colour
to red (FADH•–), or become the
neutral semiquinone through the
gain of one electron and one pro-
ton, changing its colour to blue
(FAD•). From the semiquinone
state, FAD• becomes the hydro-
quinone (FADH2) through the ac-
ceptance of one proton and one
electron, while FAD•– becomes
the deprotonated, reduced flavin
(FADH–), which is colourless.
using only one of the two, while others are more flexi-
ble and are able to use either. Examples of flavoenzymes
that accept only FAD in vivo are vanillyl alohol oxidase
and berberine bridge enzyme [14, 15]. A flavoenzyme that
was recently found to be indiscriminating between FAD
and FMN is proline dehydrogenase [16]. An example of
a flavoenzyme that binds FMN is old yellow enzyme [17].
A flavoprotein that binds riboflavin is riboflavin-binding
protein, which is present in the eggwhite of chicken eggs
[18]. Riboflavin (also known as vitamin B2) is essential to
organisms because it is the precursor of FAD and FMN.
Flavoenzymes can be classified into five groups, based
on the swiftness of their reaction with dioxygen and the
reaction they catalyse. Firstly, there are oxidases, which
react rapidly with dioxygen to produce oxidised flavopro-
tein and hydrogen peroxide. Secondly, there are dehydro-
genases, which react very slowly with dioxygen. Thirdly,
there are monooxygenases, which break the bond link-
ing the two oxygens in dioxygen and introduce one oxy-
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Figure 4:Modified flavins.
A: Covalently bound FAD in vanil-
lyl alcohol oxidase.
B: Hydroperoxy flavin.
C: Prenylated flavin, as observed
in UbiD [19].
Spins in dioxygen and FAD. Spin
configuration of dioxygen and
FAD and the mechanism of reac-
tion to avoid a "spin-forbidden"
reaction [28]. Square brackets
mark the "caged radical pair".
FADH–(↑↓)+O2→ (↑↑)
[FADH• ↑↑O–2]→
[FADH• ↑↓O–2]→
FADHOO–
+H+
–––––––––– FADHOOH→
FAD+H2O2
gen atom into their substrates. The other oxygen atom is
reduced to water. Fourthly, there are reductases, which
mainly pass electrons from NAD(P)H to their substrate.
And, last but not least, there are disulfide oxidoreductases,
which contain active-site thiols and use a dithiol sub-
strate and NAD+ (or NADH in the case of peroxidases that
are members of this family). They form disulfide prod-
ucts and NADH or a reduced dithiol product and NAD(P)+
[13]. These five groups illustrate that flavoenzymes catal-
ysemarkedly diverse reactions. They are therefore present
in many different biological pathways and are of interest
for industrial applications [13, 20, 21, 22, 23]. They are
colourful and versatile enzymes, due to their cofactor, and
can be yellow, red, blue, green, purple or even pink [24].
For the remainder of this introduction, the focus will be
on flavoenzyme oxidases using FAD as cofactor. Flavoen-
zyme oxidases with an FAD cofactor can be found in dif-
ferent protein families, metabolic pathways and industrial
reactions [25, 26, 27]. They are particularly interesting due
to their ability to tame oxygen. Despite the essential role
dioxygen plays in life, it remains a difficult and dangerous
molecule.
The troublewith oxygen. Thedifficultywith dioxygen lies
in its electron spin configuration. Dioxygen is dominantly
present in its triplet spin state, leaving two unpaired elec-
trons of parallel spin available for a reaction. In flavoen-
zyme oxidases, reduced flavin needs to be oxidised for the
reaction cycle to begin anew with oxidised flavin. How-
ever, the spin state of reduced flavin is singlet, meaning
no unpaired electrons are present and the spins of the two
paired electrons are antiparallel (see the reaction shown
in the margin note). The reaction cannot proceed under
these conditions because bonds can only be formed be-
tween electrons of antiparallel spin (Hund’s rule) and the
spin of each electron needs to be conserved. Therefore,
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"All things are poison and nothing
is without poison; only the dose
makes a thing not a poison."
Paracelsus, ca. 1538
the spin state of dioxygen needs to be changed first for it
to undergo a reaction with flavin. Reduced flavin transfers
an electron to dioxygen, resulting in a "caged radical pair"
[28]. The "caged radical pair" is a highly unstable state and
the spin of one electron in triple state will invert so that
the electrons are in a singlet spin state (still in the "caged
radical pair"). Now a reaction can occur between the two
electrons in singlet spin states and a highly unstable in-
termediate, flavin hydroperoxide (FADHOOH), is formed.
Flavin hydroperoxide then dissociates heterolytically into
oxidised flavin and hydrogen peroxide. Hydrogen perox-
ide is formed because dioxygen keeps both bonding elec-
trons and hydrogens and is thus reduced.
The trouble with dioxygen is the formation of radical
intermediates during reactions. These radicals need to
be carefully contained within the enzyme lest they dam-
age the enzyme or organism. Some enzymes are better
at containing radicals, leaving them functional for more
reaction cycles (also called turnovers). Additionally, the
formation of hydrogen peroxide by oxidases can be risky
as this molecule can be toxic to organisms and detri-
mental to enzyme activity. Therefore, enzymes that ex-
cessively produce hydrogen peroxide aremostly located in
a specialised organelle in the cell called the peroxisome.
Regulation of hydrogen peroxide concentrations can be
achieved through coexpression of catalase enzymes [29].
Hydrogen peroxide also has important functions as a sig-
nalling molecule. Low levels of hydrogen peroxide are re-
quired in growth regulation, whereas increasing hydrogen
peroxide concentrations can initiate expression of antiox-
idative genes [30].
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Figure 5: Some of the substrates of
VAO.
Vanillyl Alcohol Oxidase
Vanillyl alcohol oxidase (VAO) is a flavoenzyme oxidase
that was first isolated from the fungus Penicillium sim-
plicissimum in 1992 [31]. The fungus was discovered in
paper-mill waste-water in an attempt to identify organ-
isms able to grow using veratryl alcohol as their sole car-
bon source [32]. Veratryl alcohol is a naturally occuring,
aromatic compound and a product of lignin degradation,
where it stabilises lignin peroxidases [33]. Interestingly, P.
simplicissimum is not ligninolytic, but able to use inter-
mediates of lignin degradation as sole carbon source. In
P. simplicissimum, the degradation pathways of veratryl
alcohol produce protocatechuate as a ring-fission inter-
mediate [32]. Growth of the fungus with different lignin
degradation intermediates revealed that veratryl alcohol
and 4-(methoxymethyl)phenol induce expression of a yel-
low enzyme: VAO [31].
Expression of VAO is not induced by vanillyl alco-
hol in P. simplicissimum. However, in another fungus,
Byssochlamys fulva, the expression of a homologous VAO
is induced by vanillyl alcohol [34]. In P. simplicissimum, 4-
(methoxymethyl)phenol is the onlymolecule identified so
far that induces expression of VAO and is also a substrate,
therefore it could possibly be the natural substrate of VAO
[35].
Substrate screening with VAO revealed that it is active
with an extensive range of substrates and catalyses differ-
ent types of reactions with them. Benzylic alcohols and
benzylic amines are oxidised, 4-allylphenols are hydroxy-
lated, 4-alkylphenols are hydroxylated or dehydrogenated
and 4-(methoxymethyl)phenol is demethylated [36, 37].
Looking at these substrates (see Figure 5), it becomes
clear that they have one thing in common: all are para-
substituted phenols. Therefore, there must be a mecha-
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Figure 6: Oligomerisation state of
VAO. Octameric VAO at the top,
the square indicates the location
of the dimer (middle). In the
dimer, the square shows the loca-
tion of the active site and selected
residues (as depicted at the bot-
tom). FAD is shown in yellow and
amino acid residues are coloured
in blue.
nism in place in VAO which requires this property of its
substrates.
There are several other interesting properties of VAO
that need to be mentioned. The amino acid sequence of
VAO consists of 560 amino acids, which makes it a size-
able enzyme. But the enzyme is even bigger once it has
folded into its three-dimensional structure. In vitro, the
quaternary structure of active VAO is homodimeric or ho-
mooctameric [38], Figure 6). VAO’s quaternary structure
can also be called a tetramer of dimers. In vitro, octameri-
sation is FAD and salt dependent, with the fraction of oc-
tameric VAO increasing with increasing salt concentra-
tions [14, 38]. Both forms have comparable activity [38].
Monomeric VAO is not observed in vitro. Ewing et al.
could show that a surface loop is essential for octameri-
sation of VAO [39].
Each subunit in VAO consists of two domains, the FAD-
binding and the cap domain. The active site is located
at the interface of these two domains, meaning that the
dimer contains two and the octamer eight active sites. As
their names indicate, the FAD-binding domain is where
the cofactor binds and the cap domain closes over the ac-
tive site like a cap. In the active site, the isoalloxazine
ring of FAD is covalently bound to His422 via a 8α-(N3-
histidyl) bond. Ironically, this histidine is located in the
cap domain in VAO, not the FAD-binding domain [40].
The phosphate-ribityl chain of FAD and the adenosine
monophosphate however are bound in the FAD-binding
domain through non covalent interactions [40].
The post-translational, covalent inclusion of FAD in the
binding pocket is conditional to the proper folding of the
enzyme after expression of the polypeptide. Once fold-
ing has occurred, VAO oligomerises to the dimer. FAD will
then migrate into the apoprotein and be encased. Bind-
ing only occurs if the FADbinding cavern has already been
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A word about redox potentials.
Every member of a redox couple,
such as FAD and VAO’s substrate,
has its own redox potential, which
is a measure of their tendency to
lose or gain electrons. The part-
ner in the redox couple with the
more negative redox potential will
be reduced. In VAO, this is FAD.
With an increasing difference in
redox potentials between the re-
dox partners, the energy changes
involved also increase. No redox
reaction can take place anymore
if this change in energy becomes
too significant. Increasing the
redox potential of FAD therefore
means that the redox potentials
between FAD and the substrate
approach each other, making the
redox reaction more energetically
favourable. Therefore, VAO with
a covalently bound FAD can react
with substrates with higher redox
potentials than VAO with a non-
covalently bound FAD.
Crystal structures are structure
models of proteins. Proteins are
crystallised and the obtained crys-
tal is shot with an X-ray beam. Be-
fore the crystal is destroyed, the
electrons in the crystal diffract the
X-ray beam. These diffraction pat-
terns are linked to the location of
electrons in the crystal and give
the necessary information to de-
termine a protein structure. The
better defined the crystal, the bet-
ter the diffraction pattern and the
higher the certainty about the po-
sition of the electrons and thus the
higher the resolution of the crystal
structure. High resolution protein
structures have resolutions below
1.0 Å. Crystal structures can be ob-
tained in cellulo and it is also pos-
sible to perform time-resolved ex-
periments to study dynamic pro-
cesses [47, 48].
formed [14, 41, 42]. Although the FAD is not yet covalently
bound in the holoenzyme at this stage, it already promotes
octamerisation. FAD is covalently bound to His422 in an
autocatalyic process for which the reduced form of FAD is
required [41, 43]. Once FAD is covalently bound it is reox-
idised by dioxygen. It was found that this covalent bind-
ing of FAD increases the redox potential of FAD [43, 44].
This increase of the redox potential (from -65 mV in non-
covalent VAO to 55 mV in covalent VAO [43, 44]) increases
the oxidative power of FAD.
Several other residues in the active site have been
shown to be of importance for catalysis in VAO (see Fig-
ure 6) [39, 41, 42, 43, 44, 45, 46]. An aspartate is of great
importance during catalysis and the covalent inclusion of
FAD in VAO. This Asp170 additionally increases the re-
dox potential of FAD and has been proposed to act as ac-
tive site base, activating a water molecule involved in sub-
strate conversion [40, 43]. The position of Asp170 and
a threonine (Thr457) in the active site has been shown
to be responsible for the enantioselective hydroxylation
of 4-alkylphenols, elegantly demonstrated by inversion of
enantioselectivity of a variant [46]. Two tyrosines (Tyr108
and Tyr503) are of special interest in VAO. Based on the
crystal structures available, it was suggested that these
two tyrosines are involved in deprotonation of the para-
substituted phenolic substrates, creating the phenolate
inside the actives site [40]. This hypothesis was put to the
test recently by Ewing et al., but the detailed mechanism
of this deprotonation remains elusive [49].
During the different stages of VAO catalysis, FAD is
switching between its oxidised and reduced state. The
reaction cycle of VAO is therefore split into two half-
reactions, the reductive and the oxidative one. In the re-
ductive half-reaction, FAD gets reduced upon substrate
binding through hydride transfer. This generates the
quinone methide intermediate of the substrate, which
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Figure 7: Reaction mech-
anism of VAO with 4-
(methoxymethyl)phenol.
then continues to react. Depending on the type of sub-
strate, different reactions occur with this intermediate.
Figure 7 illustrates the reaction mechanism of VAO with
4-(methoxymethyl)phenol, VAO’s proposed physiological
substrate [35].
It is in the family. VAO is part of a larger family of
structurally related flavoenyzmes, called the VAO/PCMH
family. Whereas these enzymes are highly diverse in
function, they all share the same two-domain structure.
Of these two domains, the FAD-binding domain is the
most conserved and more variation is observed in the
substrate-binding domain (corresponding to the cap do-
main in VAO). A handful of the characterised enzymes
in this family share similar catalytic features with VAO.
Amongst them are p-cresol methylhydroxylase (PCMH)
and eugenol oxidase (EUGO), the two closest relatives of
VAO for which three-dimensional structure models are
available. Other close relatives for which less experi-
mental data is available are eugenol dehydrogenase (also
called eugenol hydroxylase) and a decarboxylase [50, 51,
52, 53, 54]. Within the well characterised members of this
subgroup of the VAO/PCMH family, the requirement for
para-substituted substrates is prevalent, as is the cova-
lently bound cofactor. Nevertheless, their substrate scope
differs, as does their oligomerisation state. Unlike VAO,
which forms homooctamers, EUGO exclusively forms ho-
modimers, and PCMH dimers of heterodimers, consisting
of two FAD-subunits as well as two cytochrome c subunits
[40, 55, 56]. PCMH requires this cytochrome c subunit to
reoxidise FAD, a feat that both VAO and EUGO can achieve
through dioxygen [31, 55]. The difference in substrate
scope of these enzymes (see Figure 8) is most likely due to
the variation of active site residues involved in catalysis.
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Figure 8: Name-giving substrates
of VAO, EUGO and PCMH. It is
of importance to know that these
substrates are not always the ones
that are convertedmost efficiently,
nor are they necessarily the physi-
ological substrate.
Induction or conditional expres-
sion of a gene in an organism
When expression of a gene is in-
duced in the organism it originates
from, this is homologous expres-
sion. If the gene is expressed in
another organism, e.g. Escherichia
coli, this is heterologous expres-
sion and E. coli is the host organ-
ism. Several substances can be
used to induce expression in the
host organism, depending on the
promoter placed before the gene of
interest.
Wet lab vs dry lab
Since the dawn of science, experiments have been at the
core of scientific research. The earliest scientist called
themselves philosophers, a constant reminder of which
is the "Philosophiae Doctor" (Doctor of Philosophy, PhD).
One could argue that the techniques and tools used at that
time were crude compared to today’s standards, but eu-
reka moments nevertheless came to some of them - albeit
in their bathtub. Archimedes is also the supposed inven-
tor of what is believed to be the very first computer, the
Antikythera mechanism [57, 58, 59].
Wet lab
Since the times of Archimedes, the wet lab has changed
drastically. It is a place where the object of research is
no longer observed by the human eye, but through ma-
chines with detectors that far exceed that organ. Advances
in microbiology in the past century have lead to biotech-
nology being a widely used tool in the life sciences. It is
now possible to take genes from any organism and place
them into another organism to study their function in
detail. These genes can be expressed to produce pro-
teins and enzymes of interest to scientists or industries.
The produced proteins can then be studied through tech-
niques likemass spectrometry, electronmicroscopy, NMR
or crystallography. Cofactors bound to the enzyme can
be identified through fluorescence and absorption spec-
troscopy. Stopped-flow instruments can be used to study
the firstmilliseconds of an enzyme reaction. Studies at the
single molecule level are also possible through the use of
advanced microscopy techniques as well as microfluidic
systems [60, 61].
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A sequence alignment is created
when gaps are inserted in se-
quences to create overlap in sim-
ilar regions. The three words (or
very short sequences) "GUDRN",
"GDRUN" and "GUDRUN" can be
aligned to give the following mul-
tiple sequence alignment:
G U D R - N
G - D R U N
G U D R U N
BLAST stands for: Basic Local
Alignment Search Tool. It starts
with a short part of the sequence
(a word) to align it to a subject se-
quence. This initial alignment is
then extended and saved and a re-
port is calculated if the extended
alignment is better than the initial
one. Typical elements of the re-
port are the score and the E value.
The score is higher if the quality of
the alignment is better and if se-
quences are more similar. The E
value gives an indication of how
probable it is to get the alignment
by chance. The lower the E value,
the more similar the sequences
are, and the lower the chance that
this similiarity is accidental.
Homology. Homologous enzymes
share a common ancestor butmay
have dissimilar function. Heterol-
ogous enzymes do not share a
common ancestor but may have
similar function. There is no per-
centage of homology or heterology
as these terms are binary and refer
to the fact that there was a com-
mon ancestor or not.
Many properties of enzymes and their mechanisms
can be solved using these andmore elaborate techniques.
Nevertheless there are currently limitations to the resolu-
tion that can be achieved in such experiments. Whereas
fantastic advances have been achieved to experimentally
study proteins and enzymes in almost atomistic detail, it
is not yet possible to follow an enzyme reaction in atom-
istic and sub-atomistic detail [62, 63, 64, 65]. This is a
requirement of studying a chemical reaction, where elec-
trons are exchanged betweenmolecules.
Here, we climb out of the bathtub and into the com-
puter.
Dry lab
The first modern day computers were men and women
whose job it was to compute routine calculations [66].
With time, modern, machine based computers were de-
veloped and we are now on the advent of artificial in-
telligence. Although discussions whether the Turing test
has been passed already are still ongoing, it will surely
not take much longer for computers to challenge our per-
ception of them further. Unlike these "smart" comput-
ers, other modern day supercomputers are functioning
more like the first human computers. They assist scien-
tists in rapidly calculating the solutions to complex prob-
lems. Several such problems that are relevant for this the-
sis will be described in more detail below.
To compare sequences of related proteins, bioinfor-
matic studies are needed. Bioinformatics relies heav-
ily on the use of supercomputers. Behind every assem-
bly and annotation of full genomes, the search of se-
quence databases or the building of multiple sequence
alignments is a supercomputer. When one is look-
ing for sequences similar to a query sequence with
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Figure 9: A selective overview
of the timescales of biochemi-
cal events and the in silico ap-
proaches that can be used to study
them. Protein translation and pro-
tein folding can in theory be stud-
ied by using Quantum Chemical
Modelling (QCM), but such a cal-
culation would take years to fin-
ish with the most advanced com-
puters available today. On the
other hand, QCM can be used to
study electron transfers and en-
zyme reactions by only modelling
a small part of the enzyme. To
study "slower" processes, such as
ligand binding to an enzyme, be-
comes computationally expensive
and approximations need to be
made or combinations of tech-
niques need to be used. Every
technique thus has its limitations,
making each suited to answer dif-
ferent research questions.
the BLAST webserver (https://blast.ncbi.nlm.nih.
gov/Blast.cgi), a supercomputer is remotely accessed.
It will search all the different databases and perform pair-
wise alignments of the query against other sequences.
When one builds a multiple sequence alignment us-
ing clustalomega (http://www.ebi.ac.uk/Tools/msa/
clustalo/), which can align up to 4’000 sequences, a dif-
ferent supercomputer is accessed remotely and performs
all the calculations necessary to align these sequences.
From such an alignment, a homology model of a pro-
tein can be built (using e.g. SWISS-MODEL https://
swissmodel.expasy.org/). All these tools are very easy
to use and biochemical research without them has be-
come unimaginable. Homology models link bioinformat-
ics to structural bioinformatics. In this field, different
methods of computer modelling of proteins are available
today, which will be discussed in more detail below.
There are three main methods of structural bioinfor-
matics that are relevant to the work presented in this the-
sis: Quantum Chemical Modelling, Molecular Dynamics
and Monte Carlo. All three can be applied to answer dif-
ferent research questions, but the time it takes to obtain
results may vary significantly depending on the method
used. Figure 9 illustrates the most common use of the dif-
ferent methods and the biochemical events that can be
studied with them.
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The very basic steps of a classi-
cal Molecular Dynamics simula-
tion are:
1. Compute the forces on all the
atoms in the protein (deter-
mine the potential energy of all
the atoms).
2. Solve the equation of motion
for all the atoms in the protein
(prepare to move the atoms
in agreement with the interac-
tions they have with one an-
other).
3. Move the atoms.
4. Do step 1., 2. and 3. a few
times and then save all the po-
sitions of all the atoms in the
protein.
5. Go back to step 1.
To follow these instructions for
one atom is trivial, however an
average amino acid in a protein
consists of 20 atoms and an aver-
age protein consists of 400 amino
acids. Therefore, the calculation of
protein movements can become
challenging, especially for larger
proteins.
Proteins have four structure levels. The primary struc-
ture, a linear sequence varying in length of the 20 natu-
ral amino acid residues (also called residues). The pri-
mary structure organises itself (folds) into α-helices and
β-sheets, forming the secondary structure. The tertiary
structure is formed when the secondary structure ele-
ments fold into one fully organised structure. And finally,
the quaternary structure results from tertiary structure el-
ements interacting together. Each of the tertiary structure
elements in this quaternary structuremay be called a sub-
unit. As can be seen from Figure 9, protein folding (the
process of a primary structure organising itself into a ter-
tiary structure) is one of the slower biochemical processes.
With Molecular Dynamics, Newton’s equations of mo-
tion of all the atoms in a protein are solved to model
the movements of the protein. With Monte Carlo ap-
proaches, the different configurations of a system are gen-
erated and sampled to calculate properties of the system.
With Quantum Chemical Modelling, transition states are
hunted down and their energies are calculated. The de-
tailed description of these techniques goes beyond the
purpose of this introduction, but an overview will be pro-
vided.
Molecular Dynamics Proteins aremoving structures and
their movements are essential to their function. But the
crystal structure of a protein is fixed and only little to no
information on the movements of the protein is available
from it. To study the functional movemenents of proteins,
Molecular Dynamics simulations (MD) can be used. In
MD simulations, atoms and bonds are considered as balls
and strings. The string represents different properties of
a covalent bond between atoms, such as the length of a
bond, the bond angle and the bond dihedral angle. Cova-
lent bonds between different amino acids determine the
structure of a protein. Additionally, there are non-covalent
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A typical Monte Carlo simula-
tions follows these steps:
1. Generate a starting configura-
tion of the system.
2. Select one particle in the sys-
tem at random.
3. Move that particle to a new,
random position (conforma-
tion).
4. Accept the new position of the
particle (or not).
5. Calculate the desired property
of the system.
6. Continue with step 2.
Perform your own Monte Carlo
simulation:
1. Place 10 coins on this page.
You are not allowed to place
a coin on top of another one.
Depending on what coins you
use, space will become quite
limited.
2. Now take one coin away at ran-
dom and . . .
3. . . . put it in a new place.
4. It is not allowed to place a coin
on top of another coin. If the
coin is placed on top of an-
other one, move the coin again
(reject this conformation).
5. Measure all the distances be-
tween the coins and calculate
the average distance between
them.
6. Continue with step 2.
Are you sure you did everything
at random? If you expand this
idea and use it to find the highest
mountain in the world, it becomes
clear that there is no point in sam-
pling in the Netherlands.
interactions without whom a protein could never form
any kind of secondary structure: the van der Waals in-
teractions and Coulomb interactions. In MD simulations,
the sum of all these interactions is calculated, producing a
"movie" of the continuous movements of proteins.
Monte Carlo In Monte Carlo simulations (MC), random
sampling is used to explore the properties of a system. The
challenge is to sample in the correct region and to sam-
ple truly at random. Using MC simulations, it is possible
to model the movements of a protein as a molecule dif-
fuses through it. These slower movements are computa-
tionally too expensive to calculate with classical MD sim-
ulations (see Figure 9). The longer a process takes (fs to
s), the longer its simulation takes. Faster computers do
help to partly overcome this issue, allowing simulations of
processes in the μs timescale. However, for now, approxi-
mations need to be made to model longer processes. One
such approximation is described below.
Protein Energy Landscape Exploration (PELE) is a MC
based approach [67]. PELE can be used to simulate a sub-
stratemigrating into an enzyme’s active site. The substrate
can be placed at a random position on the surface of the
protein or close to a hypothetical entrance to the active
site. PELE then proceeds as follows:
1. Calculate the initial energy of the system.
2. Perturb both the ligand (rotation + translation + inter-
nal degrees of freedom-rotamers) and the protein (by
applying normal modes to the backbone).
3. Model side chains by a hierarchical tree scheme using
experimental side chain rotamer libraries. Then, re-
lieve steric clashes, perform clustering and minimisa-
tion.
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Computationally expensive sim-
ulations. Every computer works
by using Central Proccessing Units
(CPUs, also called nodes) to fol-
low instructions of a program. My
personal computer runs with a
core i5 microprocessor. This cur-
rently means that I have four cores
(the basic computation unit of the
CPU) available that programs can
give commands to. It also means
that a program that needs to get
many things done quickly can use
more than one core to get the
job done. On a supercomputer,
I can get access to more cores so
that programs can run even faster.
To calculate all the possible inter-
actions between all the atoms of
an enzyme will take at least four
times longer onmy personal com-
puter (with four cores) than on
16 cores of a supercomputer. Of
course a supercomputer does not
only have 16 cores, but thousands
of cores. Using 64 cores for 1 h
costs approximately 2 €. A simu-
lation that runs for 48 h therefore
costs approximately 96 €, but one
running for 1 month costs 1488 €.
The more cores you want to use,
the more expensive the cost per
hour becomes. Cloud computing
is also an option, with one hour of
128 cores being sold today for ca.
5$ [68].
Atomic units and energies The
atomic unit of length, the Bohr ra-
dius, a0 corresponds to 0.53 Å. 1
Å correspons to 10–10 m. Ener-
gies aremeasured in hartrees, with
1 hartree corresponding to 627.509
kcal/mol.
4. Minimise the full system with a truncated Newton
method.
5. Calculate the final energy of the system.
6. Accept or reject by using a Metropolis criterion.
7. Go back to step 1.
The random movements of the substrate introduced by
the MC step allows the fast, non-continuous exploration
of conformations.
The continuous exploration of conformations through
MD is computationally expensive and usually only a
handful of simulations are produced. By using PELE, hun-
dreds of simulations can be calculated and a statistical
analysis of themost usedmigration path of a substrate can
be performed.
Modelling enzymatic reactions with Quantum Mechanics.
To computationally model enzymatic reactions, electrons
have to be taken into account. Purely MD techniques
cannot work with units smaller than atoms and there-
fore require the addition of quantum mechanics (QM).
Oversimplified, all QM methods need to approximate
the Schrödinger equation. An exact solution of the
Schrödinger equation is currently impossible for any sys-
tem bigger than one electron and therefore also the sys-
tems used in this thesis. One approximation to the
Schrödinger equation is the Born-Oppenheimer approx-
imation, which considers the nuclei as static, given that
they are much heavier and slower than electrons. Other
approximations concern the molecular orbitals (using
Hartree-Fock theory), using different pre-defined sets of
one-electron functions (known as basis functions or sets).
Hybrid quantum mechanical/molecular mechanics
(QM/MM) approaches model the active site of an en-
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Figure 10: Transition States (TS)
and Energy Landscapes. When a
substrate is converted to a prod-
uct by an enzyme, an energy bar-
rier needs to be crossed. The
height of the energy barrier de-
termines the speed (rate) of the
reaction. A rate of 1 (or 1000)
substrate conversion(s) per sec-
ond corresponds to an energy bar-
rier of approximately 13.4 (or 17.4)
kcal/mol. It is important to note
that the representation above is
only a two dimensional represen-
tation of a three dimensional en-
ergy landscape. Different con-
formations of the enzyme with
substrate or product bound can
have the same energy and are
the reason the energy landscape
is three-dimensional. Conforma-
tions need to be carefully analysed
in addition to the calculated ener-
gies.
zyme with QM, and the remainder of the enzyme with
MD (or MC). The challenge of QM/MM approaches is
to properly deal with the interface of these two regions.
Purely Quantum Chemical Modelling (QCM) approaches
do not have this problem because they only take the ac-
tive site residues of an enzyme into account. In the so-
called quantum chemical cluster (QCC or all-QM) ap-
proach used in this thesis [69], the protein environment
surrounding the active site is approximated using a polar-
izable homogeneous medium with a dielectric constant.
The QCC approach used in this thesis employs Density
Function Theory (DFT) and the Becke, 3-parameter, Lee-
Yang-Parr (B3LYP) hybrid density functional method. The
B3LYP functional (a function of a function) is used by the
majority of studies of enzyme catalysis.
The general approach for the QCC calculations in this
thesis was as follows:
1. Build a medium sized model of approximately 100 to
200 atoms.
2. Use a small basis set (31G(d,p)) for geometry optimisa-
tion of the model and scan for transition states in gas
phase (see Figure 10).
3. Identify stationary points (such as a transition state)
along the reaction coordinate.
4. Calculate the single point energies of the stationary
points, including dispersion forces (by using a larger
basis set, e.g. 6-311+G(2d,2p)), the zero-point energy
(by using frequency calculations and the solvent cor-
rection) and by using the solvation model based on
density (SMD) with a dielectric constant of = 4.
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5. Calculate the final energy of each stationary point (en-
ergies of the large basis set corrected for the zero-point
energy and solvation).
6. Express the final energies of the stationary points rela-
tive to the starting structure.
7. Build a larger model once the free energy landscape of
the reaction coordinate of interest has been explored
with the medium sized model.
There are two main arguments for first exploring the
free energy landscape of a reaction with a medium sized
model before starting calculations with a big model.
Firstly, and most practically, the calculations are faster
with a medium sized model. As a rough estimate, the fol-
lowing applies: if a calculation with 100 atoms takes 2 h, a
calculation with 200 (or 300) atoms will not take twice (or
three times) as long but approximately N3 times as long.
This is because the B3LYP functional does not scale lin-
early, but to the power of three. Secondly, the free energy
landscape becomes more complex with increasing model
size: the risk of exploring the "wrong" part of the free en-
ergy landscape increases. Therefore, it becomes more dif-
ficult to find the globalminimumormaximum, and to dis-
tinguish these two points from local minima or maxima.
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There are generous margins on
each page to enable the reader to
add own comments and thoughts.
Thesis outline
In this thesis, four different approaches are used to shed
light on VAO from different perspectives. These ap-
proacheswere chosen to answer the followingmajor ques-
tions: can expression in a eukaryotic host (instead of a
bacterial one) improve the expression of VAO? How many
VAO homologs exist in the current databases and what
properties do they have? Where do VAOs come from? How
do substrates enter the active site, and how do products
exit it? Why is there an adduct formed for the p-creosol to
vanillin reaction in VAO?
Chapter 1 has introduced basic knowledge of the tech-
niques used in this thesis. Chapter 2 sets the stage to pro-
vide the reader with more background on oxidative en-
zymes and their properties and applications. In Chap-
ter 3, we have explored the origins of VAO using a bioin-
formatic approach. In Chapter 4 we attempted to ob-
serve the effect of sequence variation on function of VAO-
like enzymes. This chapter also illustrates one of the pit-
falls that can be encountered when attempting this type
of work. In Chapter 5, a MC approach was used to simu-
late the migration of ligands in and out of VAO. In Chap-
ter 6, an all-QM approach was used to model the reaction
mechanism of VAO. Chapter 7 provides a general discus-
sion of the results obtained in this thesis. The existing,
original articles that form the basis of all these chapters
are referenced at the beginning of each chapter.
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Challenges in bulk chemical
oxidation catalysis: it is desirable
to use dioxygen directly, e.g. from
air. But because dioxygen in air
is a diradical triplet, it has two
unpaired electrons that can react
in a radical like fashion (marked
in black in the chemical structure
below).
Radical reactions are notoriously
difficult to control because they
proceed via propagation and are
difficult to terminate. Addition-
ally, chemoselective oxidations
can usually only be achieved by
using protective groups, which
need to be removed again later.
Enzymes are chemoselective by
nature, meaning they selectively
oxidise only one functional group:
Enzymes can also be stereose-
lective, meaning they produce
stereoisomers. There are two
types of stereoisomers, enan-
tiomers (mirror images of each
other, just like your hands) and
diastereomers.
Enantiomers:
Diastereomers:
Abstract
Oxidation reactions with dioxygen and hydrogen perox-
ides are difficult to control in the artificial environment of
man-made chemistry. This makes oxizymes, i.e. oxida-
tive enzymes that use dioxygen or hydrogen peroxide as
co-substrates, very valuable targets for the chemical and
pharmaceutical industries. Additionally, growing aware-
ness of sustainability issues in society has encouraged the
use of oxizymes in these industries.
Some oxizymes generate hydrogen peroxide as a by-
product. Hydrogen peroxide has antimicrobial effects and
is therefore of interest for the food industries as well as
other industries where microorganisms pose a danger to
the consumer or patient. Hydrogen peroxide can also be
used as a bleaching agent and thus applications of ox-
izymes in the textile industries as well as the pulp and pa-
per industries are common practice.
Oxizymes have recently been found to play an im-
portant role as auxiliary enzymes in the degradation of
biomass. In this role, they support carbohydrate active
enzymes in the degradation of cellulose and chitin, or
assist in the deconstruction of lignin-derived polymers.
They are therefore of importance for the biofuels industry,
which aims to create biofuels from renewable plant mate-
rials to replace petroleum-based fuels.
Oxizymes have many more properties that make them
useful for industrial applications. This review summa-
rizes the technological advancements, which have made
the use of enzymes in industry possible, as well as show-
cases different types of oxizymes currently used in differ-
ent industries. Also, the challenges oxizymes face before
their industrial applications can be fully developed, are
discussed.
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Classification of Oxizymes
In the history of life, first the production of dioxygen and
then the consumption of dioxygen to gain energy have
been key evolutionary events. While there are specialised
organisms that are able to grow without dioxygen or for
which dioxygen is toxic, the majority of organisms pro-
duce or use dioxygen to harvest energy. There are remark-
able and highly specialised enzyme-cascades devoted to
this process. However, there are also many oxizymes
that catalyse reactions not involved in energy harvesting.
These reactions are highly specific and diverse, as are the
enzymes that catalyse them. Oxizymes are classified by
the types of reactions they catalyse, as well as by their co-
factors.
Figure 11: Schematic overview il-
lustrating the properties of differ-
ent oxizymes. The enzymes are
grouped based on whether they
react with dioxygen or hydrogen
peroxide and whether they incor-
porate oxygen atoms into their
substrates or not.
Oxizymes belong to the big enzyme class of oxidore-
ductases (EC 1.x.x.x). For the purpose of this review,
we define oxizymes as enzymes using dioxygen or hy-
drogen peroxide (see Figure 11). The enzyme classes
discussed here will be oxidases (EC 1.x.3.x), peroxidases
(EC 1.11.1.x), peroxygenases (EC 1.11.2.1), monooxyge-
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Enzyme Commission numbers
(EC numbers) classify enzymes by
the chemical reactions they catal-
yse. Other than oxidoreductases,
there are transferases (EC 2.x.x.x),
hydrolases (EC 3.x.x.x), lyases (EC
4.x.x.x), isomerases (EC 5.x.x.x)
and ligases (EC 6.x.x.x).
Besides flavins, NADH and heme
can be cofactors of enzymes.
nases (EC 1.13.12.x, 1.14.13- 18.x) and dioxygenases (EC
1.13.11.x, 1.14.11.x, 1.14.12.x).
These enzymes can carry one or more different cofac-
tors, e.g. flavin, heme, nicotinamide, or metal ions. One
enzyme can carry several and different cofactors at the
same time. A tightly bound cofactor is called a prosthetic
group, whereas a dissociable cofactor is called a coen-
zyme. The latter needs to be regenerated in large-scale ap-
plications because the stochiometric use is too expensive
[70, 71].
Oxidases catalyse the transfer of electrons from their
substrate or the prosthetic group to dioxygen. No oxy-
gen atom (except fromwater) is incorporated into the sub-
strate, and dioxygen generally is reduced to hydrogen per-
oxide. Oxidases can contain iron, copper or flavin as co-
factors [72]. Examples of the industrial application of ox-
idases are the use of hexose oxidase in the food indus-
tries and the use of monoamine oxidase to create chiral
amines, which will be discussed in more detail.
Monooxygenases catalyse the incorporation of one oxy-
gen atom into their substrate while the other oxygen
atom is reduced to yield water. Monooxygenases can
catalyze a plethora of reactions ranging from hydroxy-
lations and epoxidations to dehydrogenations and cy-
clisations, and are classified according to the cofactor
they carry. There are single center monooxygenases con-
taining iron (e.g. cytochrome P450 monooxygenases),
copper (e.g. lytic polysaccharide monooxygenases), or
flavin (e.g. Baeyer- Villiger monooxygenases) as cofac-
tors, multi-centermonooxygenases containing several co-
factors, as well as cofactor-free monooxygenases [73].
Many monooxygenases use a flavin for dioxygen activa-
tion. They can be classified in eight different groups, de-
pending on fold and function [74].
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Anaerobic organisms can live
without dioxygen, while the term
anoxic describes environments
without any electron acceptor
(e.g. dioxygen, nitrate or sulfate).
Hypoxic environments are low in
dioxygen. For obligate anaerobic
organisms the presence of dioxy-
gen is toxic. Facultative anaerobes
are able to survive with or without
dioxygen, but obligate anoxic
organisms are poisoned in oxic
environments. Electron transport
chains are highly specialised
enzyme-cascades in aerobic or-
ganisms that use dioxygen as the
final electron acceptor. In anaero-
bic organisms, electron transport
chains use different final electron
acceptors, e.g. sulfur. Highly
specialised enzyme-cascades in
plants harvest light and convert
it into chemical energy (i.e. high-
energy electrons), by splitting
water and creating dioxygen
during photosynthesis.
Dioxygenases catalyse the incorporation of two atoms
of oxygen into their substrate. They can contain dif-
ferent types of (metal ion) cofactors. Non-heme iron
dioxygenases that are active with aromatic compounds
can be organised into two groups. The first group con-
tains a high-spin ferrous site (extradiol enzymes) involved
in the activation of dioxygen [75, 76], while the second
group contains a high-spin ferric site (intradiol enzymes)
that activates substrates [77, 78]. Rieske non-heme iron
dioxygenases have an additional 2Fe-2S (Rieske) center
in their active sites and catalyse the stereospecific ad-
dition of dioxygen to aromatic hydrocarbons [79]. α-
Ketoglutarate dependent dioxygenases constitute another
important group of non-heme iron dioxygenases [80].
They are active on a wide range of compounds and have
high potential for industrial applications [81].
Peroxidases catalyse the transfer of two electrons from
their substrate to hydrogen peroxide and water is pro-
duced. Some peroxidases can also transfer electrons to
organic hydroperoxides. There are metal free and metal
containing peroxidases. Metal free peroxidases havemetal
free cofactors like flavin, while metal containing peroxi-
dases carry metal containing cofactors like heme. Most of
the heme enzymes contain a so-called protoheme (ferric
protoporphyrin IX) as cofactor in their active site. Other
metal containing peroxidases are non-heme peroxidases
and contain manganese, vanadium or selenium instead
of iron. The reaction catalysed by protoheme peroxidases
involves the activation of dioxygen by heme through two
highly oxidised iron intermediates called Compound I and
II.
Peroxygenases catalyse the incorporation of an oxygen
atom from hydrogen peroxide into their substrate. Many
peroxygenases also have weak peroxidase activity. A new
class of peroxygenases has been discovered in 2004 [82]
and more research is ongoing to better understand the
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EC 1.11.2.1:
1.: Oxidoreductase
11.: Acting on peroxide as accep-
tor
2.: With H2O2 as acceptor, one
oxygen atom of which is incorpo-
rated into the product
1. With NAD(+) or NADP(+) as ac-
ceptor
Just as we have experimental
toolboxes for biotechnology, we
need computational toolboxes for
biotechnology!
mechanistic properties of these so-called unspecific per-
oxygenases (UPOs; EC 1.11.2.1). They are known so
far to catalyse the oxidation of aromatic and heterocyclic
compounds, the epoxidation of alkenes, the hydroxyla-
tion of aliphatic compounds and dealkylation reactions.
The biggest issues hampering the development of indus-
trial applications of UPOs are the current lack of success-
ful large-scale expression [83] as well as heme inactivation
by hydrogen peroxide.
The ExplorEnz database (http://www.
enzyme-database.org/) contains several hundred
different oxizymes. Out of them, a selection was made
for distinct enzymes, which are used in industry or are
candidates for future industrial applications.
Industrial Interest in Oxizymes
Historically, glucose oxidase, for use by the baking indus-
try to improve flour and dough properties, was one of the
first oxizymes to attract industrial interest. Since then,
many other oxizymes have been found to be suitable for
industrial applications.
The development of genetic engineering, toolboxes for
protein expression and high throughput screening have
made it possible to produce sufficient quantities of an en-
zyme with desired properties in a convenient host organ-
ism on an industrial scale. In parallel, technologies for
genome and metagenome sequencing have been devel-
oped. This has opened up a completely new perspec-
tive on the natural diversity of enzymes and the poten-
tial of their unknown characteristics. In addition to these
developments, considerable efforts have been made and
are still under way to solve elusive sequence-structure-
function relationships of proteins in general and of en-
zymes more specifically. An overview of the technolo-
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gies developed for protein engineering to advance indus-
trial biocatalysis has been presented by Bornscheuer and
coworkers [84]. The technologies described there can also
be applied to enzymes used in other industries beyond the
chemical and pharmaceutical industries. A more detailed
review on engineered enzymes for chemical production
has been composed by Luetz and colleagues [85].
While there are several areas where oxizymes are ap-
plied, the main industries involved are the chemical and
pharmaceutical industries, the food and food additives
industries, the textile, pulp and paper industries as well
as the biorefinery and biofuels industries. These indus-
tries are interested in oxizymes for completely different
reasons. The chemical and pharmaceutical industries are
mostly interested in oxizymes due to their formidable abil-
ity to selectively oxidise their substrates. Other industries
aremore interested in oxizymes for their ability to produce
hydrogen peroxide or replace the effect of chemicals on a
final product.
Chemical and Pharmaceutical Industries
Oxizymes are of exceptional interest for the chemical and
pharmaceutical industry because of their sophisticated
properties and as candidates for applications in the syn-
thesis of building blocks of chiral and non-chiral drugs
and chemicals. The chemical introduction of oxygen
atoms into organic substrates remains difficult due to,
amongst other reasons, the use of strong oxidants incom-
patible with the substrate, and unwanted side products
formed through chemical side reactions. The enantiose-
lectivity ofmany oxizymes is an alternative for the difficult
chemical synthesis of chiralmolecules. In otherwords, ox-
izymes are highly selective in the oxidation of their sub-
strates, which chemical oxidations are not. Most of man-
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PRODUCTIVELY:
Prevent waste
Renewable materials
Omit derivatisation steps
Degradable chemical products
Use safe synthetic methods
Catalytic reagents
Temperature, pressure ambient
In-Process Monitoring
Very few auxiliary substances
E-factor,maximise feed in product
Low toxicity of chemical products
Yes it’s safe
IMPROVEMENTS:
Inherently non-hazardous and
safe
Minimise material diversity
Prevention instead of treatment
Renewable material and energy
inputs
Output-led design
Very simple
Efficient use of mass, energy,
space & time
Meet the need
Easy to separate by design
Networks for exchange of local
mass & energy
Test the life cycle of the design
Sustainability throughout product
life cycle
made oxidations are very complex, use non-renewable re-
sources or use and create toxic by-products and/or prod-
ucts. The chemical and pharmaceutical industries have
coined the term “industrial biocatalysis” in the last 20
years and the field has exploded since. Research in in-
dustrial biocatalysis has gained a considerable amount of
momentum around the turn of the millennium. Several
reviews have been published at that time predicting this
development [86, 87, 88, 89]. The motivation behind this
accelerated and boosted investment in industrial and aca-
demic research in industrial biocatalysis, andmore specif-
ically the industrial applications of oxizymes, is highly di-
verse. From the industries’ viewpoint, the use of biocata-
lysts may simplify the complicated chemical synthesis of
oxygen containing compounds. In academic research, the
interests are more fundamental. The discovery of novel
enzymes and catalytic mechanisms as well as new reac-
tions, which are impossible to achieve by chemicalmeans,
may be of greater interest. For society, the main driving
force behind the funding of research into biocatalytic pro-
cesses appears to be a desire for sustainable processes.
These very different motivations and targets of the three
stakeholders are not easily met.
The desire for more sustainable processes has lead to
the formulation of the 24 principles of green chemistry
and green engineering. These principles can be sum-
marised with two acronyms, “PRODUCTIVELY” and “IM-
PROVEMENTS” [90, 91]. The evaluation of the “green-
ness” of a process is not always straightforward and the
use of an enzyme does not necessarily make a process
green [92]. Ecological and economical assessments of bio-
catalytic processes are mostly performed in industry and
are not published. A few rare examples exist for academic
research into that field [93, 94]. However, the development
of industrial biocatalysts would most likely benefit from
more such analyses already at an earlier stage of research
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EC 1.4.3.3:
1.: Oxidoreductase
4.: Acting on the CH-NH2 group of
donors
3.: With oxygen as acceptor
Figure 12: MAO-N catalysed
reaction in the process for the
production of a boceprevir in-
termediate developed by Merck
and Codexis. 6,6-Dimethyl-3-
azabicyclo[3.1.0]hexane is con-
verted into a secondary amine.
After Li et al. [98]
to avoid “running into dead-ends” and to accelerate the
development and application of usable industrial biocat-
alysts.
A well-known example of an industrial oxidative bio-
catalyst is D-amino oxidase (DAO; EC 1.4.3.3). DAO’s
most relevant industrial application is the production of
7-aminocephalosporanic acid from cephalosporin C. 7-
Aminocephalosporanic acid is a key raw material for the
production of many cephalosporin antibiotics [95]. Other
applications of DAO include the production of pure L-
amino acids and the detection and analytical determina-
tion of D- amino acids and analogues [96].
Another example of a “pharmaceutical” industrial ox-
idative biocatalyst is monoamine oxidase. This enzyme,
originally isolated from human liver mitochondria [97], is
widely applied to help in the chemo-enzymatic deracemi-
sation of amines. This enzyme is briefly discussed below.
Monoamine oxidase from Aspergillus niger (MAO-N;
EC 1.4.3.4) is a flavoenzyme. The first publications of
MAO-N date from 1995. MAO-N lacks a cysteine, which
is responsible for covalent linkage of the flavin cofactor in
its mammalian homologues, MAO-A and MAO-B. While
human MAO-B is a drug target for antidepressants and
neuroprotective drugs, the human MAO-A gene has been
popularised and nicknamed “warrior gene” [99]. MAO-
N has attracted attention for a different reason: it can be
used to produce chiral amines. MAO-N has been evolved
to produce enantiomerically pure cyclic tertiary amines
[100, 101]. The crystal structure of MAO-N was pub-
lished in 2008 and the structure-function relationships of
themutants obtained by directed evolution were analysed
[102].
Merck and Codexis recently patented and published a
process to produce a secondary amine as an intermedi-
ate of boceprevir using an optimised version of MAO-N
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EC 1.14.13.:
1.: Oxidoreductase
14.: Acting on paired donors
with incorporation or reduction of
molecular oxygen. The oxygen in-
corporated need not be derived
from O2
13.: With NADH or NADPH as one
donor, and incorporation of one
atom of oxygen
[98, 103] (Figure 12). They also analysed the variant en-
zymes they obtained with the help of the crystal structure
(Figure 13). As is illustrated by these examples, MAO-N is
a valuable tool to develop enantiomerically pure amines,
which are of high value for organic synthesis or as inter-
mediates for the synthesis of pharmaceuticals.
Figure 13: Solvent accessible sur-
face representation of the MAO-N
structure with its non-covalently
bound flavin cofactor (pdb code
2VVM). Residues proposed to
form a hydrophobic cavity from
the surface to the substrate-
binding site are shown as fine
lines. Close to this hydrophobic
cavity are mutations found to
enable the enzyme to catalyse the
oxidation of secondary amines
(N336S and A385S) and two ad-
ditional mutations which enable
the quadruple mutant to catalyse
the oxidation of tertiary amines
(T384N and I246M) [102]. The
figure was created using PyMOL,
after [102].
Other Oxizymes, which are in the Early Stages of
Research into their Industrial Applicability
Baeyer-Villiger monooxygenases (BVMOs; EC 1.14.13.x)
are flavin-dependent monooxygenases that catalyse the
oxidation of carbonyl compounds into esters or lactones.
BVMOs could be especially useful for the production of
enantiopure chemicals [104]. Baeyer-Villiger monooxyge-
nases have attracted considerable academic interest for
their envisaged industrial applications. The increased
number of BVMOs available for biochemical studies as
well as the elucidation of 3D structures has helped to il-
lustrate and rationally explain the ability of BVMOs to
catalyse reactions with many different substrates. De-
spite their ability to catalyse highly specific oxygenation
58 OXIZYMES FOR BIOTECHNOLOGY
A recent publication has identified
fungal BVMOs which appear to be
less inhibited by higher substrate
loadings (up to 30mM) [108].
EC 1.14.14.x:
1.: Oxidoreductase
14.: Acting on paired donors,
with incorporation or reduction of
molecular oxygen. The oxygen in-
corporated need not be derived
from O2
14.: With reduced flavin or flavo-
protein as one donor and incorpo-
ration of one atom of oxygen
reactions, the industrial use of BVMOs still faces chal-
lenges. Some of these challenges are the development of
cost-effective technical approaches, enzyme stability, im-
proved efficiency of the enzyme and organic solvent tol-
erance [105, 106, 107]. Technologies and tools used to ad-
dress and overcome the obstacles BVMOs face for their
industrial application are, among others, genome min-
ing [109, 110] and directed evolution [111, 112]. The is-
sue of cofactor regeneration has been addressed by fu-
sion engineering, creating a BVMO fused to a NADPH-
regenerating phosphite dehydrogenase [113]. Scaling up
of processes using BVMOs has been performed using dif-
ferent approaches [114]. Several patent applications filed
by Codexis and other companies illustrate that these chal-
lenges can be overcome, e.g. [115, 116].
CytochromeP450monooxygenases (E.C. 1.14.14.x) have
previously received much attention from the pharmaceu-
tical industries for their key role in drug metabolism. The
cytochrome P450 superfamily is enormous and growing,
which makes it difficult to keep nomenclature uniform.
The cytochrome P450 homepage aims at establishing a
uniform and evolutionary accurate nomenclature system
[117]. In August 2013, a total of 21,039 cytochrome P450
sequences were included on the website. An overview of
some of the thousands of reactions these enzymes catal-
yse was assembled by Bernhardt and Urlacher [118]. Cy-
tochrome P450s are heme dependent enzymes and have
recently attracted the spotlight for their ability to catalyse
the regio- and stereospecific oxidation of non-activated
hydrocarbons. The focus on these and other properties
of cytochrome P450monooxygenases has led to engineer-
ing efforts using rational design and other techniques to
allow an industrial application of a thus tailored enzyme
[119]. An overview of cytochrome P450 monooxygenases
with perspectives for their synthetic application has been
composed by Urlacher and coworkers [118, 120]. Exam-
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EC 1.1.3.4:
1.: Oxidoreductase
1.: Acting on the CH-OH group of
donors
3.: With oxygen as acceptor
EC 1.11.1.7:
1.: Oxidoreductase
11.: Acting on a peroxide as accep-
tor
1.: Peroxidases
EC 1.10.3.2:
1.: Oxidoreductase
10.: Acting on diphenols or related
substances as donors
3.: With oxygen as acceptor
ples of patents and patent applications that are using cy-
tochrome P450 monooxygenases include e.g. the produc-
tion of erythromycins [121] and 11-beta-hydroxy steroids
[122].
In summary, oxizymes employed in the chemical and
pharmaceutical industries are used for the regio- and
stereoselective oxidations they catalyse.
Biosensors and Analytical Chemistry
Another well established area of application for oxizymes
is their use as biosensors and in analytical chemistry. Glu-
cose oxidase (GOX; EC 1.1.3.4) is used as a biosensor to
monitor glucose levels in the blood of diabetic patients.
Lactate oxidase (EC 1.1.3.2) is researched for applications
as a biosensor reporting L-lactate concentrations in blood
and sweat of athletes. A patent application for a lac-
tate sensor using a lactate oxidase has been filed in 2013
by the Japanese company Arkray Inc [123]. Another ox-
izyme, which already has a widespread medical applica-
tion, is horseradish peroxidase (EC 1.11.1.7). Antibody-
horseradish peroxidase conjugates are widely used in the
immunohistochemical detection of antigens in tissues to
allow specific staining of the tissues targeted by the anti-
body.
Polyaniline is a conductive polymer used in sensors
and electrochromic devices. It changes colour depending
on its oxidation state and is one of the most studied con-
ductive polymers of the last 50 years. Laccase (EC 1.10.3.2)
has been used to synthesise polyaniline, more precisely to
catalyse the polymerisation of aniline [124].
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Generally Recognised As Safe: is a
designation by the American Food
and Drug Administration (FDA)
used to label food additives or or-
ganisms involved in the food pro-
duction process (e.g.the yeast Sac-
charomyces cerevisiae that is in-
volved in the production of bread
and beer).
Food and Food Additives Industries
The food and food additives industries use oxizymes like
GOX to prolong the shelf life of foods by removing residual
glucose and dioxygen. In the same reaction GOX also pro-
duces hydrogen peroxide, a good bactericide, which can
later be removed by a catalase. Depending on the desired
effect of the enzyme on the foodstuffs, different demands
are made on the enzyme. For antimicrobial effects, the
production of hydrogen peroxide by oxidases is key. In
this case, substrate specificity should be broad to allow
production of sufficient amounts of hydrogen peroxide.
For the more targeted degradation of specific chemicals
in foodstuffs, narrow substrate specificity is preferable.
In any case, processing stability of the enzyme is of
importance because the processing conditions of food-
stuffs are defined by food safety regulations. Also, the non-
toxicity of the enzyme in the final product needs to be
guaranteed because the complete removal of the enzyme
from the final product is often not possible or wanted.
The non-toxicity of an enzyme can be assessed through
toxicology studies and a GRAS status can be awarded to
the enzyme itself and the production organism used. Al-
though the enzyme and its productsmay be non-toxic, the
use of enzymes from pathogenic or toxic organisms is not
desired.
Hexose oxidase (HOX; EC 1.1.3.5) from Chondrus cris-
pus, is produced by Danisco/DuPont. HOX is a flavo-
protein that binds its flavin cofactor covalently and be-
longs to the VAO/PCMH family. Discovered in 1973, HOX
was found to have much broader substrate specificity
than GOX. GOX was the first bio-replacement of chemi-
cal bread improvers like potassium bromate, prompted by
consumers desire for “clean label” products [125]. GOX
binds its flavin cofactor non-covalently and belongs to the
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Disulfide bonds can be crucial
for enzyme stability. Two cys-
teine residues are required to form
a disulfide bond. Intramolecular
disulfide bonds are formed within
one chain (subunit) of the pro-
tein while intermolecular ones are
formed between different chains
(subunits) of the protein.
Figure 14: HOX catalysed oxi-
dation of glucose to gluconolac-
tone with the concomitant reduc-
tion of dioxygen to hydrogen per-
oxide and the subsequent non-
enzymatic hydrolysis of glucono-
lactone to gluconic acid. Unlike
GOX,HOX catalyses this type of re-
action for a variety of hexose sug-
ars.
glucose-methanol-choline (GMC) family. GOX is used to
catalyse the conversion of glucose and dioxygen into glu-
conolactone and hydrogen peroxide. The hydrogen per-
oxide formed then acts by oxidizing the thiol groups in the
gluten proteins forming intra- and intermolecular disul-
fide bonds, which leads to increased dough strength [125].
HOX was seen as a more suitable enzyme for that task
due to its broader substrate specificity. HOX catalyses the
conversion of severalmono- and oligosaccharides into the
corresponding lactones, with concomitant formation of
hydrogen peroxide (Figure 14) [125].
In 1995, a method of using HOX as dough improving
agent was patented [126]. Initially, the production of suf-
ficient amounts of HOX protein was limiting [127, 128].
HOX is now heterologously expressed in Hansenula poly-
morpha on a commercial scale, after toxicology studies
were performed to confirm the safety of the procedure
[129]. HOX is currently used in POWERBake®, a product
which is marketed for improving the baking process.
Besides its properties useful for application in the
food industries, HOX was also found to have antifouling
properties through the production of hydrogen peroxide.
These properties were patented as early as 1999 [130], but
only published in 2010 [131]. The most recent published
patent on HOX has a priority date from 2000, and uses
HOX in a process to prevent the Maillard reaction in food-
stuffs [132]. Products coming from these patents are not
on the market yet.
The HOX example illustrates the disparity in focus be-
tween academic research and industrial research. While
academia likes to emphasize an enzyme’s potential for in-
dustrial applications, this is contrary to the behaviour of
industry and wording of scientific publications from in-
dustry, where the mention of industrial applications is
secondary and naturally understood. Industry first re-
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Patent A government authority or
licence conferring a right or title
for a set period, especially the sole
right to exclude others from mak-
ing, using, or selling an invention.
A prioritity date is the date of the
filing of the first patent covering an
application. Subsequent applica-
tions (and patents) can be related
to each other through identical
priority dates. A patent family can
contain patents filed in different
countries. Human genes, animals
and plants cannot be patented be-
cause they are a product of nature.
Trade mark A symbol, word, or
words legally registered ® or es-
tablished by use TM as represent-
ing a company or product.
quires not only a patent, but also a strategy for the use of
a patent or several patents to protect their efforts to de-
velop the enzyme and provide a viable and economically
sustainable path for the long-termuse of the enzyme. This
includes using the same enzyme for asmany different and
diverse applications as possible.
A peroxidase (MsP1, EC 1.11.1.19) from Marasmius
scorodonius is produced through expression in Aspergillus
niger by DSM. It is used to degrade beta-carotene in whey,
thus whitening the whey. This property was patented in
2004. Subsequent scientific publications described the
enzyme in more detail [133, 134, 135]. The peroxidase is
present in the product “Maxibright”, which is protected by
a trademark from 2009. MsP1 was declared GRAS in 2012,
after an application for this status byDSM [136]. MsP1 has
beenmentioned for its potential for industrial application
in second generation biofuels in 2009 [135], due to its in-
duction by lignin and possible contribution to the modifi-
cation of lignified biopolymers.
Textile Industries and the Pulp and Paper Indus-
tries
The textile industries and the pulp and paper industries
use oxizymes like peroxidases and laccases for dye transfer
inhibition as well as dye degradation. A broad substrate
specificity of the enzyme for several dyes and dye classes
as well as stability under processing conditions constitute
desired properties. Specificity of the enzyme for one dye
only makes sense if that dye is used as the major com-
pound in the targeted process.
Peroxidase from Coprinus cinereus (CiP, EC 1.11.1.7) is
a heme enzyme produced by Novozymes through expres-
sion in Aspergillus oryzae or Aspergillus niger. The reac-
tion catalysed by CiP involves the activation of dioxygen
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by heme through two highly oxidised iron intermediates
called Compound I and Compound II. Compound I is
oxidised by two electron equivalents and compound II
is oxidised by one electron equivalent. Compound II is
therefore the reduced form of Compound I. The reac-
tion scheme below illustrates how CiP oxidises dyes (from
[137]).
CiP + H2O2 CpPI + H2O (2.1)
CpPI + dyered CpPII + dyeox (2.2)
CpPII + dyered CiP + dyeox + H2O (2.3)
CiP was first used in combination with a laccase in
the dye transfer inhibition (DTI) technology. The first
publication of the enzyme dates from 1988, and the first
patent has a priority date of 1989 [138, 139]. CiP was
patented for use in the DTI technology, however all these
patents appear to have lapsed and the trademark for
“Guardzyme”, a CiP containing DTI product, has lapsed as
well. “Guardzyme” is aimed to work at low temperatures
to oxidise and therefore decolourise dyes that dissolve into
the washing mix.
CiP has been described in several scientific publica-
tions, at least four years after patenting [137, 140, 141, 142,
143, 144, 145]. CiP was considered the first member of a
novel family of secretory fungal peroxidases. Compared
to horseradish peroxidase it has broader substrate speci-
ficity. The issue of its low thermostability (irreversible un-
folding after 1 min at 67 °C) [144] could be addressed by
directed evolution, which resulted in a 100-fold increase
in thermostability [137]. The first 3D structure of CiP be-
came available in 1994 [146], which lead to the rational en-
gineering of a thermostable enzyme in 2010 [147]. Inter-
estingly, the mutations found by the random and rational
approaches to increase thermostability are not the same,
see Figure 15 for an illustration.
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Figure 15: Solvent accessible sur-
face representation of the CiP
structure with its bound heme
cofactor (pdb code 1H3J). The
positions of mutations found to
increase thermostability by [137]
(wild type residues Ile49, Val53,
Thr121, Met166, Glu239, Met242,
Tyr272), located close to the heme)
are shown in black and [147] (wild
type residues Ser323 and Glu328,
located at the protein surface) are
shown in grey. While the mu-
tations close to the heme group
were identified through directed
evolution experiments creating a
library of thousands of mutants,
the residues at the protein surface
were identified using an in silico
approach to screen a knowledge-
based library of eight mutants.
The figure was created using Py-
MOL.
A recent patent application uses the CiP peroxidase to
modify the colour of textiles [148]. It remains to be seen
how the use of CiP in the textile industry develops further.
Novozymes also has patented CiP to produce paper or pa-
perboard from mechanical pulp [149]. CiP illustrates the
power of protein engineering tools and the willingness of
industry to invest in the development of improved enzyme
variants.
Other peroxidases that have attracted attention from
industry are dye-decolorising peroxidases (EC 1.11.1.19;
DyPs). These peroxidases, as is indicated by their name,
oxidise dyes and other substrates, effectively decoloris-
ing them. DyPs cannot directly react with bulky sub-
strates, but have evolved a long-range electron transfer
pathway, which transfers electrons to the heme cofactor.
A surface tryptophan has been shown to play an essen-
tial role in this mechanism [150, 151]. Other peroxidases
that also operate via a long-range electron transfer mech-
anism are lignin peroxidases (EC 1.11.1.14), cytochrome
C peroxidases (EC 1.11.1.5) and versatile peroxidases (EC
1.11.1.16) [152, 153, 154].
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Dichlorodiphenyltrichloroethane
(DDT):
Laccases (EC 1.10.3.2) are high redox potential multi-
copper oxidases. Multi-copper oxidases vary in their
copper binding sites but can be identified based on
the conserved amino acids involved in copper binding
[155]. A bioinformatics analysis of the domains and do-
main organisation of multi-copper oxidases has been per-
formed by Nakamura and coworkers [156]. Laccases typ-
ically transfer four electrons to dioxygen, which is re-
duced to water while the substrate is oxidised. They
have attracted interest from industry for several reasons.
Laccases can oxidise phenolic and non-phenolic lignin-
related compounds as well as highly recalcitrant environ-
mental pollutants like dichlorodiphenyltrichloroethane
(DDT). Novozymes has patented a process using laccase
from Myceliophthora thermophila to treat pulp for in-
creased paper wet strength [157]. Several other properties
of laccases, which could lead to different applications in
the pulp and paper industries were summarised by Virk et
al. [158].
Laccases can act on bulky substrates like lignin by us-
ing chemical mediators as redox shuttles. The mediator
can oxidise the lignin polymer, which leads to debranch-
ing and degradation, and is in turn reduced again in the
enzyme’s active site. This action explains why many wood
degrading fungi have laccases; they are needed to unlock
lignin via the action of their mediators. Different media-
tors are used to achieve the desired functionality of differ-
ent laccases, also for synthetic applications [159].
Direct reactions of laccases with phenolic substrates
create radical intermediates, which lead to the formation
of polymers. A medical application of this property of lac-
cases has been imagined for the coating of catheters. The
zwitterionic coating currently used to prevent biofilm for-
mation in the catheter is polydimethylsiloxane. A pro-
cess to coat catheters using laccases has been described
by Blanco and coworkers [160]. Laccases have also been
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EC 1.14.18.1:
1.: Oxidoreductase
14.: Acting on paired donors
with incorporation or reduction of
molecular oxygen. The oxygen in-
corporated need not be derived
from O2
18.: With another compound as
one donor, and incorporation of
one atom of oxygen
Carbohydrate-active enzymes
Database (CAZy): contains fami-
lies of structurally-related catalytic
and carbohydrate-binding do-
mains of enzymes. It contains
glycoside hydrolases, glycosyl
transferases, polysaccaride lyases,
carbohydrate esterases and redox
enzymes with auxiliary activities
(AA). Vanillyl alcohol oxidase has
been classified in the AA4 family.
studied for their application in the creation of bioactive
hydrogel dressings [161]. A review on the potential ap-
plications of laccases in polymerisation and grafting re-
actions has been composed by Kudanga and cowork-
ers [162]. Other enzymes that have been explored for
their potential to create bio-polymers are tyrosinases (EC
1.14.18.1) and peroxidases [163].
Much effort has been directed to the discovery of new
(mostly fungal) laccases and the improvement of their
temperature and pH stability properties [164]. Improved
robustness of laccases is of crucial importance, given the
demanding process conditions of the textile and pulp and
paper industries.
The use of different protein engineering techniques to
increase stability of peroxidases and laccases will certainly
lead to an increase in industrial applications of these en-
zymes.
Biorefinery and Biofuels Industries
In the biorefinery and biofuels industries, the use
of cellulolytic and chitinolytic enzymes is well es-
tablished [165]. These enzymes are classified as
carbohydrate-active enzymes. Several oxizymes
have recently been classified into a new class of
carbohydrate-active enzymes (CAZymes, http:
//www.cazy.org/Auxiliary-Activities.html)
with auxiliary activities [166]. Examples of these re-
classified enzymes are laccases, gluco-oligosaccharide
oxidases, vanillyl alcohol oxidases and lytic polysaccha-
ride monooxygenases. Some of these enzyme groups
are currently being investigated in more detail for
their impact on the efficiency of enzyme cocktails for
second-generation biofuels.
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LPMOs have recently been found
to be hydrogen peroxide depen-
dent, and not dioxygen depen-
dent, as previously thought [167].
These results are highly valuable
and likely to encourage further,
detailed investigation of the reac-
tion pathways of LPMO, similar to
a recent study [168].
World Economic Forum
Lytic polysaccharide monooxygenases (LPMOs; no EC
number assigned yet) are monooxygenases that carry a
single metal ion, mostly copper, as a cofactor. Their ad-
dition to enzyme cocktails for the creation of second-
generation biofuels boosts enzymatic cellulose conver-
sion. They have been grouped into three families of
CAZymes with auxiliary activities, AA9, AA10 and AA11
[166, 169, 170]. AA9 and AA10 LPMOs have been mainly
identified in fungal or bacterial genomes, respectively.
The AA9 enzymes have been proposed to act directly on
cellulose and thus make the cellulose more accessible to
other CAZymes [171]. AA10 LPMOs are able to cleave crys-
talline cellulose, a property that cellulases do not possess.
To elucidate how these LPMOs catalyse this reaction, sev-
eral studies have been performed, using different compu-
tational and experimental techniques [172, 173].
While the biofuels industries are interested in creating
biofuels from renewable plant materials, the biorefinery
industries are aiming at the valorisation of thesematerials
not only into biofuels but also into value-adding chemi-
cals, especially from lignin. Efforts are under way to de-
velop new enzymes and technologies to enable these ad-
vancements. A review summarising these developments
has been recently published [174]. Despite the established
saying in the pulp industry that “one can make anything
out of lignin except money” [174], there appears to be
readiness to invest intomore research from academia and
industry to further explore the possibilities of lignin val-
orisation.
As noted in the WEF report on “The future of industrial
biorefineries” from 2010, “there are some indications that
lignin could be used as a value-adding component of slow-
release fertilizers and as a starting compound for vanillin
fermentation“ [175]. Vanillin is a high-value chemical,
which is of great value for the food and food additives
industries because of its vanilla flavour [176]. World-
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wide demand for vanilla flavour is nowadays mostly cov-
ered by chemically synthesised vanillin or vanillin pro-
duced from petrochemical rawmaterials. The production
of vanillin from wood would therefore allow covering the
consumers demand for natural vanillin from renewable
sources. Other vanillin production routes start from fer-
ulic acid (Givaudan, [177]) or could be developed to in-
volve the use of oxizymes such as vanillyl alcohol oxidase
(VAO; EC 1.1.3.38) [178, 45]. VAO binds its flavin cofactor
covalently and is the foundingmember of the VAO/PCMH
family [179, 31]. Oxizymes and the processes using them
to produce these types of high-value chemicals would be
more connected to the chemical industries and the de-
mands on these enzymes are therefore different from the
demands on enzymes for the biofuels industries.
Other oxizymes that are attracting more attention due
to their ability to degrade lignin are versatile peroxidases
[152], lignin peroxidase [180] and manganese peroxidase
(EC 1.11.1.13) [181]. For a more complete overview of en-
zymes involved in the degradation of (ligno)cellulose, we
refer the reader to a review by Bornscheuer and colleagues
[182].
Use of Whole-Cells as Biocatalystst ("Designer
Bugs") and Different Industrial Expression Sys-
tems
As mentioned previously, industries use oxizymes for dif-
ferent reasons and have different scopes of applications
for the enzymes. Depending on the desired product(s)
from an enzymatic reaction, it is also possible to use so-
called "designer bugs" instead of purified enzymes. These
"designer bugs" are modified microorganisms, which
have optimised enzyme pathways for the manufacturing
of a desired product or entire groups of products. Within
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Membrane-bound enzymes (and
proteins) are infamous for being
extremely difficult to work with in
vitro. This is mainly due to their
strong binding to membranes
(making isolation difficult) as
well as their membrane span-
ning or membrane associated
domains. Because the insides
of membranes are hydrophobic
environments, membrane span-
ning and membrane associated
domains contain hydrophobic
residues that interact with the
membrane. If these residues are
exposed to hydrophilic solvents,
e.g. water, the protein structure
can become highly unstable.
Komagataella pastoris has been
renamed to Komagataella phaffii,
[190], a fact which was missed in
the original publication of this ar-
ticle.
the industries that use oxizymes, there is a range of com-
panies which have focussedmore on the use of either "de-
signer bugs" or purified enzymes [87].
There are two main reasons to use a whole-cell ap-
proach instead of purified enzyme(s) [183]. Firstly, a
whole-cell approach may be more economical compared
to the use of purified enzyme(s). This holds true as long as
a negative impact of other cell products is not a problem.
The use of purified enzyme(s) is not always possible due to
stability issues. Especially formembrane-bound enzymes,
purification of an active form is challenging [184]. If entire
cascades of enzymatic reactions are desired, it also makes
more sense to use whole cells. Secondly, in addition to the
costs of the purified enzyme, the costs of cofactors are also
a good reason to use a whole-cell process. In whole-cell
processes the cofactors are regenerated by the cells at low
cost [185]. Some examples of the use of whole-cell biocat-
alysts are the production of (S)-styrene oxide using styrene
monooxygenase (EC 1.14.14.11) [186] and the preparative
scale production of enantiopure compounds by BVMOs
[187, 188]. An analysis of the use of whole-cell biocata-
lysts in the fine chemicals industries has been performed
by Straathoff and colleagues [189].
The expression of oxizymes on an industrial scale re-
mains challenging because many oxizymes are fungal en-
zymes. The expression of fungal enzymes is often dif-
ficult to achieve in bacterial expression systems like Es-
cherichia coli. Alternative eukaryotic expression systems
are yeast systems, Komagataella pastoris (formerly known
as Pichia pastoris), Hansenula polymorpha or different
fungal systems, mostly Aspergillus strains like Aspergillus
niger or Aspergillus oryzae. Depending on the company
and patent situation, customised expression platforms are
developed to allow large-scale expression of the desired
enzymes.
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In conclusion, the examplesmentioned above illustrate
the different strategies used by different industries to de-
velop oxizymes for industrial applications. While some
industries rely on a naturally occurring version of the en-
zyme, other industries invest considerable efforts to tailor
the enzyme for a specific application.
Challenges Oxizymes Face in their Industrial Ap-
plicability
Chemical and Pharmaceutical Industries: an “Uphill Bat-
tle Against Entrenched Chemical Processes” and High De-
mands There remains a significant gap between the po-
tential and predicted applications of oxizymes and their
actual applications. While academic research is more and
more focussing on potential applications of oxizymes, and
although these potential applications are emphasised re-
peatedly in publications, there is a notable discrepancy in
the numbers of these predicted applications and the ac-
tual industrial applications one can find. This may in part
be due to the limited public access to information about
the details of industrial processes.
Other reasons for this discrepancy are diverse and de-
pend on many factors, however a few common denomi-
nators can be found. Many industries are open to the use
of enzymes and actively researching the potential of en-
zymes for their processes. Nevertheless, the cost of adapt-
ing an existing process to be compatible with the use of
an enzyme must not be underestimated. Another impor-
tant factor is the cost of the enzyme. The production of
enzymes is becoming cheaper and immobilisation by sta-
bilising the enzyme can allow several recycling steps of the
enzyme. However, the level of research and development
needed to identify a suitable enzyme through genome
mining or to tailor an existing enzyme to an application
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is substantial. Depending on the industry, this investment
can be supported and justified by the high value product
that is generated in the process. As a consequence, the
investment into research and development for enzymes
that cannot be used for the creation of high value prod-
ucts cannot be supported [88]. The arguments mentioned
do not only hold true for the replacement of chemical pro-
cesses by enzymatic processes, but also for the replace-
ment of an enzyme in an existing enzymatic process. Once
an enzyme is used in a process, there is low motivation to
find a more suitable enzyme or to adapt the used enzyme
further. Like in evolution, the creation of perfection is not
economically feasible.
Yet it seems that industry wants perfect enzymes for
their processes. “A candidate biocatalyst for an industrial
process must be suited to the conditions required for the
process such as high substrate and product tolerance, resis-
tance to pH, temperature and constituents of the reaction
matrix. It must also possess high productivity and selec-
tivity, which maximises production of the desired product
and minimises formation of side-products. However, these
characteristics alone are not sufficient for a successful scale-
up of the process. The downstream processing also needs to
minimise losses, remove side-products and still be environ-
mentally tenable.” [87].
The above criteria only make an enzyme a candidate
biocatalyst. The efforts that are most likely required to in-
corporate the candidate biocatalyst into a modified ver-
sion of an existing process are the next hurdle. These
high demands of industry on a biocatalyst and the imped-
iments that almost inevitably follow during the develop-
ment of biocatalytic industrial-scale processes are difficult
to fulfil and overcome. Academic research can be of help
for the development of industrial enzymes, especially in
those cases where industry shares its goals for the enzyme
with academia.
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Different research strategies should therefore be
adapted depending on the enzyme and the envisaged
applications of the enzyme. In light of the fact that also
for enzymes, “it takes 20 years to become an overnight
success” [86], academia should not be expected to provide
ready-made enzymes for “potential industrial applica-
tions”. It is more desirable to allow academia to explore
the unknown biotransformation territories while using
focussed industry-academia collaborations to identify
novel enzymes wanted by industry and improve enzymes
where industry requires them [86].
Other Industries The food and food additives indus-
tries, the textile industries and the pulp and paper indus-
tries as well as the biorefinery and biofuels industries do
have different demands for oxizymes than the chemical
and pharmaceutical industries. While specificity is de-
sired by the chemical and pharmaceutical industries, the
opposite seems to hold true for most applications in these
other industries. The main focus is on oxizymes that have
broad substrate specificity. This enables them to have
maximal impact on the product. In the food and food
additives industries, the production of hydrogen peroxide
is desired to conserve foodstuffs. In the textile industries
and the pulp and paper industries, the decolourisation of
different types of dye iswanted. And in the biorefinery and
biofuels industries, the auxiliary activities of the enzyme
should be as broad as possible to achieve maximal posi-
tive impact on the performance of the enzyme cocktails
used to create biofuels. The specificity of the enzyme for
only one substrate is only desired in rare cases. Stability
under processing conditions is of highest importance and
can nowadays be addressed by protein engineering tech-
niques.
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A recent review by participants
of the INDOX project summarises
the current state of oxidoreduc-
tases in industrial applications
[191].
Conclusions and Outlook
The industrial use of oxizymes is increasing since the
turn of the millennium. However, the pace at which
oxizymes are incorporated into industrial applications is
slower than expected. Reasons for this slower pace vary
from industry to industry, but the most likely common
denominator is the economical cost of research and de-
velopment needed to identify and customise an enzyme
suitable for an industrial process as well as the design
of such a process itself. The use of computational tools
to minimise screening efforts may contribute to lower-
ing the cost of enzyme customisation. Another issue ob-
structing the development of industrial (oxidative) en-
zymes is miscommunication between academic research
and industrial demands. There are a number of interna-
tional projects built on and encouraging collaborations
between academia and different industries, some on-
going or about to start and some already finished, e.g.
PEROXYCATS, OXYGREEN, BIOTRAINS, BIONEXGEN, IN-
DOX, OXEPI, OXYPOL and ROBOX. Such targeted collab-
orations may help to alleviate the confusion of students
and young researchers in the field of industrial oxizymes
when faced with the huge number of potential industrial
applications of these enzymes compared to the numbers
of actual applications.
Undoubtedly, the industrial use of oxizymes holds great
promise. In the interest of reaching sustainability goals set
by society, combined efforts to increase targeted collabo-
rations between industry and academia are desirable. Ex-
isting collaborations as well as new collaborations require
more time to help more oxizymes reach maturity for in-
dustrial applications.
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Abstract
Vanillyl alcohol oxidase (VAO) is a fungal flavoenzyme that
converts a wide range of para-substituted phenols. The
products of these conversions, e.g. vanillin, coniferyl al-
cohol and chiral aryl alcohols, are of interest for several
industries. VAO is the only known fungalmember of the 4-
phenol oxidising (4PO) subgroup of the VAO/PCMHflavo-
protein family. While the enzyme has been biochemically
characterised in great detail, little is known about its phys-
iological role and distribution in fungi.
We have identified and analysed novel, fungal candidate
VAOs and found them to be mostly present in Pezizomy-
cotina and Agaricomycotina. The VAOs group into three
clades, of which two clades do not have any characterised
member. Interestingly, bacterial relatives of VAO do not
form a single outgroup, but rather split up into two sepa-
rate clades.
We have analysed the distribution of candidate VAOs in
fungi, as well as their genomic environment. VAOs are
present in low frequency in species of varying degrees of
relatedness and in regions of low synteny. These findings
suggest that fungal VAOsmay have originated from bacte-
rial ancestors, obtained by fungi through horizontal gene
transfer.
Because the overall conservation of fungal VAOs varies
between 60 and 30% sequence identity, we argue for a
more reliable functional prediction using critical amino
acid residues. We have defined a sequence motif P-x-x-x-
x-S-x-G-[RK]-N-x-G-Y-G-[GS] that specifically recognizes
4PO enzymes of the VAO/PCMH family, as well as addi-
tional motifs that can help to further narrow down puta-
tive functions. We also provide an overview of fingerprint
residues that are specific to VAOs.
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Catalase-peroxidases (EC
1.11.1.21), peroxidases (EC
1.11.1.7) and catalases (EC
1.11.1.6) are all oxidoreductases
acting on a peroxide as acceptor
and are peroxidases (1.11.1.x).
However, catalases exclusively
convert hydrogen peroxide to
water and dioxygen, whereas
peroxidases convert hydrogen
peroxide and a phenolic donor
molecule to water and an acti-
vated phenolic donor molecule.
Catalase-peroxidases are en-
zymes which can catalyse both
types of reactions and use the
same heme active site do to so.
The sequences of catalases and
catalase-peroxidase differ signif-
icantly, making a bioinformatic
separation possible as well.
Introduction
Vanillyl alcohol oxidase (VAO, EC 1.1.3.38) is a covalent
flavoenzyme first isolated from the ascomycetous fungus
Penicillium simplicissimum [31]. VAO is active with a wide
range of para-substituted phenols [36, 37]. Several VAO
reactions produce high-quality aromatic compounds, e.g.
vanillin and coniferyl alcohol (see Figure 16A for an
overview). These molecules are of interest for the food,
flavour and fragrance industry, exemplified by several
patents, e.g. from Mane [192], Rhodia [193] and Unilever
[194]. VAO can also produce chiral aryl alcohols. For in-
stance, the VAO-mediated conversion of 4-ethylphenol re-
sults in the formation of (R)-1-(4-hydroxyphenyl)ethanol
with an enantiomeric excess of 94% [195]. Interestingly,
an engineered variant of VAO was shown to be capable of
producing the (S)-isomer of 1-(4-hydroxyphenyl)ethanol
with an enantiomeric excess of 80% [46]. It has been pro-
posed that the methyl ether 4-(methoxymethyl)phenol is
the physiological substrate of VAO, as it is the only known
substrate that induces expression of the vao gene in P.
simplicissimum [31]. However, little is known about the
origin of 4-(methoxymethyl)phenol and the physiological
role of VAO. Subcellular localisation studies showed that
theP. simplicissimum enzyme (PsVAO), together with a co-
inducible catalase-peroxidase, is distributed throughout
the cytosol and peroxisomes [29].
PsVAO is the prototype of a large flavoprotein family,
the VAO/PMCH family, together with p-cresol methylhy-
droxylase (PpPCMH, from Pseudomonas putida NCIMB
9866, recommended name: 4-methylphenol dehydroge-
nase (hydroxylating), EC 1.17.99.1). The FAD-binding do-
mains of all enzymes within this family share a com-
mon fold [179]. Within the VAO/PMCH family, VAO and
PCMH belong to the 4-phenol oxidising (4PO) subgroup
[196]. All 4PO enzymes contain a Tyr-Tyr-Arg triad, which
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Figure 16: Different reactions
catalysed by PsVAO (A) and active
site of PsVAO (B).
A: p-Creosol (4-methylphenol)
is converted via vanillyl alcohol
(4-hydroxy-3-methoxybenzyl
alcohol) to vanillin (4-hydroxy-
3-methoxybenzaldehyde).
Coniferyl alcohol (4-hydroxy-
3-methoxycinnamyl alcohol)
is produced from eugenol
(2-methoxy-4-allylphenol). 4-
Ethylphenol is converted to
(R)-1-(4-hydroxyphenyl)ethanol.
The proposed physiological sub-
strate 4-(methoxymethyl)phenol
is oxidatively demethylated to
4-hydroxybenzaldehyde.
B: Active site of PsVAO (PDBID
1VAO). The FAD cofactor is
coloured in yellow and critical
amino acid residues are shown in
dark grey. See Table 1 for more
information about these critical
amino acid residues.
is crucially involved in substrate binding, and therefore
is the cause of the selectivity of these enzymes for para-
substituted phenols [49]. VAO is the only known fungal
member of this subgroup, whereas all other known mem-
bers are bacterial enzymes [51, 52, 55, 56, 196, 197, 198].
Among the 4PO enzymes, PsVAO is characterised in
greatest biochemical detail [199]. It has been established
that the covalent binding of the FAD cofactor of PsVAO is
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crucial for the redox properties of this enzyme, as it signif-
icantly increases its redox potential [44]. This increase in
redox potential speeds up the rate of reduction of the FAD
by the substrate, and thus increases the overall reaction
rate [44]. The same effect has been observed in PpPCMH
[200, 201]. PsVAO has most properties in common with
eugenol oxidase from the actinobacterium Rhodoccocus
jostii RHA1 (RjEUGO) [55, 202]. Both enzymes contain
a 8α-(N3-histidyl)-FAD as prosthetic group, use oxygen
as electron acceptor, and share a considerable overlap
in substrate specificity. A main difference, however, is
that PsVAO is as a homo-octamer [31], while RjEUGO is
a homo-dimer [55]. A recent protein engineering study
showed that an extra surface loop in PsVAO determines
this difference in oligomerisation behavior [39]. Another
remarkable difference between PsVAO and RjEUGO con-
cerns the reactivity with alkylphenols. PsVAO converts a
wide range of alkylphenols to the corresponding alcohols
or alkenes [37], whereas RjEUGO shows almost no activity
with these compounds [55].
Because of the conservation of the FAD-binding do-
main, all 4PO enzymes share at least 25% sequence iden-
tity. To reliably identify novel VAOs, their fungal origin
can be used, as well as conservation of known critical
amino acid residues (see Table 3.1 and Figure 16B). Cur-
rently, no clear sequence motifs specific to VAO are de-
fined [203, 204]. Little is known about the occurrence
of VAO in fungi, besides that it is produced in P. simpli-
cissimum, Byssochlamys fulva and Fusariummonoliforme
[31, 34, 205]. In B. fulva, expression of vao is induced by
vanillyl alcohol [34]. In F.monoliforme, vao expressionwas
observed with veratryl alcohol and anisyl alcohol, and to
a lesser extent with vanillyl alcohol [205]. In P. simplicis-
simum, vanillyl alcohol and eugenol are not inducing ex-
pression of vao, but 4-(methoxymethyl)phenol, anisyl al-
cohol and veratryl alcohol are [35].
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Table 3.1: Function of critical amino acid residues in
PsVAO.
Residue(s) Function
Tyr108, Tyr503, Arg504
substrate binding,
substrate deprotonation [40, 49]
His61
autocatalytic formation of
covalent bond of FAD to His422 [41]
His422 covalent bond to FAD [40]
Ile414
no function known in VAO but the corresponding
Tyr residue in PCMH is covalently binding FAD [56]
Asp170
autocatalytic formation of covalent bond of FAD to His422;
catalytic base; stereoselectivity of VAO [40, 195, 43]
Thr457 stereoselectivity of VAO [195, 43]
Loop 219-240 essential for octamerisation [39]
Tyr51, Tyr 408
tyrosines suggested to be involved in
dioxygen migration to the re side of the active site [199]
Asp192, Met195,
Glu464, His466, (Tyr503)
access of phenolic ligand to si
side of active site [199]
Here, we aim to shed light on the occurrence of VAO
in fungi. VAO has recently been added to the CAZy
(Carbohydrate-Active Enzymes) database, as a separate
family of auxiliary activities (AA4) involved in lignin break-
down [166]. We have used this criterion to mine fungal
genomes in the Mycocosm database for putative VAOs.
Results
We have identified candidate VAOs in the Mycocosm
database and performed a phylogenetic analysis of them.
Wehave used the bacterial 4POs as outgroup for the analy-
sis of these fungal sequences. Wemapped the distribution
of VAO homologs in different fungi. We analysed the phy-
logenetic tree obtained, as well as conservation of critical
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amino acid residues and cellular localisation of putative
VAOs. We analysed the genomic environments of these
putative VAOs. We also proposemotifs for the future iden-
tification of fungal VAOs, as well as bacterial 4POs.
Fungal distribution of VAO homologs Different classes
of fungi possess sequences homologous to the sequence
of PsVAO, which are annotated as AA4 in the Myco-
cosm database. In Basidiomycota only Agaricomycotina
were found to contain putative VAOs (11). In Ascomy-
cota, only Pezizomycotina contain putative VAOs: doth-
ideomycetes (29), leotiomycetes (6), sordariomycetes (19),
eurotiomycetes (25) and orbiliomycetes (3), see also Fig-
ure 17. Gene duplications appear to have occurred in al-
most all fungal classes containing VAO homologs. As can
be seen in Figure 17, in Agaricomycotina only three organ-
ismshavemultiple copies of vao genes, while in Pezizomy-
cotina, 19 organisms have multiple copies of vao genes.
Most striking is Aspergillus sydowii, which contains seven
putative VAOs.
The fungi found to carry a vao gene are living in very
diverse environments, e.g. Jaapia argillacea in the north-
ern hemisphere and Aspergillus glaucus in the artic re-
gions, while Eurotium rubrum is the most common fun-
gal species isolated from the Dead Sea. Other fungi e.g
Gloeophyllum trabeum, Dacryopinax primogenitus and
Glonium stellatum are wood decayers. This observation
does not enable us to draw a conclusion on the native
functions of VAOs or fungal 4POs, other than that they are
likely involved in a metabolic pathway used by all these
fungi.
The prevalence of VAO sequences in fungal genomes
does not follow fungal taxonomy. While several fungal
clades do not appear to contain any species with a VAO,
there are no clades in which all species contain a VAO.
The presence of a VAO in a species also does not appear
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Figure 17: Species-tree showing
the occurrence of putative VAO
sequences in different fungi. The
branch lengths are indicative of
evolutionary distances.
A) Overview of all fungal classes,
with the number behind the class
indicating how many putative
VAOs were found in that class.
No number means there is no
putative VAO present.
B) Details on the fungal classes
that were found to contain puta-
tive VAOs. The number behind
the organism indicates how many
putative VAOs were found in that
organism. Note that especially the
branch lengths for closely related
species are not accurate.
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to be related to life style or biotope as they can be found
in some saprobic, plant pathogenic and animal/human
pathogenic fungi, but are also frequently absent in other
fungi with these life styles. The same applies to the num-
ber of vao copies, which differs for species with a VAO
between one and seven and again cannot be linked to
biotope or life style.
Three different subgroups/clades of fungal VAOs Here
we will describe the phylogenetic tree of PsVAO homo-
logues in more detail (see Figure 18). This tree was cre-
ated using the bacterial 4POs (RjEUGO and PpPCMH)
and the novel fungal VAOs. All sequences were between
502 and 632 amino acids long. Please note that RjEUGO
is more closely related to PsVAO than the other bacte-
rial 4POs, forming its own clade (marked in green in
Figure 18). ART40635, WP_068805427, WP_061561479,
AAM21269 and WP_056693180 are bacterial sequences
that were added to expand the outgroup. Interestingly,
these bacterial sequences do not form one outgroup in
the tree but two distinct clades. They separate the fun-
gal VAOs into one clademore closely related to PCMH and
one clade more closely related to EUGO.
Three main clades can be identified, with 4POs con-
taining a cytochrome c subunit sequence rooting the en-
tire tree (marked in grey in Figure 18). The blue clade
(see Figure 18) contains sequences, which are markedly
different from PsVAO in at least three aspects: i) they do
not contain the octamerisation loop [39], nor do they con-
tain Tyr51, a proposed gatekeeper for oxygen access to the
active site [199]; ii) they do not share the three residues
Arg312, Arg398, Glu410 which are conserved in most of
the other homologs; iii) some of these sequences contain a
short loop between positions 321 and 322, which is absent
in all other sequences studied here. Please note that all
residues are numbered according to the PsVAO number-
ing. The clade containing PsVAO is marked in red in Fig-
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ure 18 (VAO clade). All sequences in this clade contain the
octamerisation loop, or at least a 2-4 residues shorter vari-
ant thereof. Members of the VAO clade all contain Tyr51,
Arg312, Arg398 and Glu410 (except the sequence from
Beauveria bassania (Beaba1), which contains an aspartate
at position 312). The yellow clade (see Figure 18) can be
split into two sub-clades, one without an octamerisation
loop and one with a very short octamerisation loop (5 in-
stead of 16 residues). It is doubtful whether this loop has
the same function as the octamerisation loop in PsVAO
[39].
Cellular localisation All identified fungal proteins ap-
pear to be intracellularly located since no N-terminal sig-
nal peptides have been found in any sequence using the
SignalP 4.1 Server. A proposed C-terminal peroxisomal
targeting signal (WKL-COOH instead of the SKL-COOH
peroxisomal targeting signal-1 [29]) was only present in
some of the sequences in the VAO clade, or further
changed to YKL-COOH in eurotiomycetes and absent in
all other sequences. In the same study, it was found
that VAO localises in the cytoplasm as well as peroxi-
somes in P. simplicissimum [29]. The predictions of the
DeepLoc server [208] reflect the experimental data, espe-
cially the bimodal distribution observed experimentally
for VAO: cytoplasmic or peroxisomal localisation is often
predicted to be equally likely. With only two exceptions
(WP_056693180.1 and Calvi1_515549 (Calocera viscosa)),
all sequences are predicted to be peroxisomal or cytoplas-
mic.
In P. simplicissimum, VAO is expressed together with
a catalase-peroxidase [29]. At the time of that study, no
sequence for this catalase-peroxidase was available, but
in the meantime several sequences and crystal structures
from related organisms have been solved, e.g. [209, 210,
211, 212]. Using sequence Q96VT4 from Aspergillus nidu-
lans, we searched the genomes of fungi in the red clade for
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Figure 18: Analysis of the molecular phylogeny of VAO by Maximum Likelihood method. The evolutionary his-
tory was inferred by using the Maximum Likelihood method based on the JTT matrix-based model [206]. The
tree with the highest log likelihood (-36578.6019) is shown. Initial tree(s) for the heuristic search were obtained
automatically as follows. When the number of common sites was < 100 or less than one fourth of the total num-
ber of sites, themaximumparsimonymethodwas used; otherwise BIONJmethodwithMCL distancematrix was
used. The tree is drawn to scale, with branch lengthsmeasured in the number of substitutions per site. The anal-
ysis involved 97 amino acid sequences. All positions containing gaps and missing data were eliminated. There
were a total of 429 positions in the final dataset. Evolutionary analyses were conducted in MEGA5 [207]. Minor
manual modifications were made to the obtained tree.
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homologs of this catalase-peroxidase. In total, 87 puta-
tive catalase-peroxidases were found, including isoforms
in several fungi. Ninety percent of these sequences were
predicted by the DeepLoc webserver to be localised in the
cytoplasm or peroxisome.
Genomic Environment of putative VAOs We analysed
the genomic environment of sequences in the VAO clade
(red clade, marked in red in Figure 18). There is some syn-
teny between closely related species, but a notable lack
thereof in a broader view across the fungal kingdom. The
fact that VAO is not located in a region of high synteny
could indicate that horizontal gene transfer played a role
in the origin of fungal VAOs.
Conservation of critical amino acid residues All fungal
sequences identified contain the Tyr108-Tyr503-Arg504
triad and His422 with the exception of Diaam1_2 (7551,
from Diaporthe ampelina), which has phenylalanine
residues at positions 503 and 422. His61, which has been
found to be involved in the autocatalytic formation of the
covalent His422-flavin bond [213] is not conserved in the
sequences, but often replaced by a tyrosine,methionine or
phenylalanine. No sequence has a tyrosine residue at po-
sition 414, but two carry a cysteine (Bauco1 (78266, from
Baudoinia compniacensis) and Aciri1_meta (49642, from
Acidomyces richmondensis)).
The catalytic base, Asp170 is present in all sequences
in the VAO clade, with the exception of Diaam1_2 (7551,
from D. ampelina), which carries a glutamate at that po-
sition. Sequences in other clades carry mainly serine
or alanine at position 170. Thr457 is not strictly con-
served in either of the three clades, but the majority of
sequences carry Thr457 or Asp457. These two facts com-
bined are a good predictor for changed or absent enan-
tioselectivity [46]. Especially in the blue clade, inverted
enantioselectivity can be expected, likely producing (S)-
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1-(4-hydroxyphenyl)ethanol from 4-ethylphenol [46].
The loop between residues 220 and 237 in PsVAO is
present in all sequences in the VAO clade, and absent in all
other sequences. Interestingly a much shorter loop (five
residues) is present in some sequences of the yellow clade.
This indicates that not all of the sequences identified here
will produce octameric VAOs. Considerable variation in
the loop itself occurs, but prolines appear to bemore con-
served than other residues in the loop.
Sequences in the blue clade aremore similar to the bac-
terial 4POs in the sense that they do not share Asp170 with
PsVAO, but contain a serine or alanine instead. However,
they all share His422 with PsVAO. Like the bacterial se-
quences, sequences in the blue clade lack residue Tyr51.
See also Supplementary Figure 1 for sequence logos of the
three fungal clades (yellow, red and blue). Tyr51 was sug-
gested to be involved in dioxygen migration to the active
site (together with Tyr408, which is not conserved). These
two tyrosines are located in a loop in PsVAO, where the cy-
tochrome c subunit binds to the FAD-subunit in PpPCMH
[199].
Motifs for VAOs PsVAO and the other members of the
4PO subgroup, as well as members of the VAO/PCMH
family all share the same FAD-binding fold, for which a
motif has been proposed [203]. Their specific mode of
FAD binding however differs: they bind their FAD cofactor
non-covalently, mono-covalently, or bi-covalently [196].
Members that bind their FAD cofactor via the C8α posi-
tion of the isoalloxazine ring do not always use the same
residue or even the same domain [214]. This fact can be
used to distinguish between the different members at the
sequence level [204]. Expanding on this idea of function-
related patterns or motifs, it should also be possible to
distinguish between 4PO enzymes with different activities
based on patterns or motifs of active site residues.
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Table 3.2: Motifs for 4POs and their starting position in
PsVAO, defined based on Figure 19 (in PROSITE format).
Bold letters indicate a critical amino acid residue.
4PO-motif-1; start 96 P-x-x-x-x-S-x-G-[RK]-N-x-G-Y-G-[GS]
4PO-motif-2; start 143 E-P-G-V-[TS]-[FY]
4PO-motif-3; start 178 G-N-x-x-x-x-G
4PO-motif-4; start 252 G-x-F-x-Q-x-x-x-G-x-x-x-K-x-G-x-x-L
4PO-motif-5; start 503 Y-R-x-x-(x)-x-x-x-D
VAO-motif-1; start 169 P-x-x-G-x-(x)-G-S-x-x-G-N-x-x-x-x-G
VAO-motif-2; start 422 H-x-x-x-x-P-x-x-x-x-x-G
To define a motif specific to VAOs, we expanded the se-
quencemotifs proposed by Dym and Eisenberg [203] with
the present knowledge of critical amino acid residues (see
Figure 19). The well-known dinucleotide-binding motif
[215] is absent in VAO, as these enzymes do not contain
a Rossmann fold, but have their own, distinct fold, which
is shared by all members of this family. We defined motifs
based on Figure 19, as summarised in Table 3.2. Some of
these motifs are specific to VAO, and others to the known
members of the 4PO subgroup.
Discussion
Fungi and bacteria separated about 4090million years ago
(MYA). This makes it remarkable that RjEUGO still clus-
ters more closely with VAO than with the bacterial 4POs.
To better understand this, we looked at RjEUGO more
closely. This enzyme originates from Rhodoccocus jostii
RHA1 [55, 202], which is an actinobacterium. The other
bacterial members of the 4PO subgroup all come from
Pseudomonas strains, which makes them proteobacterial.
Actinobacteria and Proteobacteria separated 3169 MYA.
It is interesting to note that these speciation events all
took place before the great oxidation event, so before at-
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Figure 19: Sequence logos of fungal VAOs and their location in the structure (PDBID 2VAO). Top: coloured boxes
indicate the differentmotifs. Cyan highlights the 4PO-motif-1, purple the 4PO-motif-2, turquoise the 4PO-motif-
3, orange the 4PO-motif-4 and yellow the 4PO-motif-5. Turquoise also highlights the VAO-motif-1, which over-
laps with the 4PO-motif-3 and grey the VAO-motif-2. Gaps are introduced by the removed bacterial outgroup.
Bottom: Stereoview of the structure of VAOwith the same colours as above indicating the location of the different
motifs defined in this study (see Table 2 for details). The FAD cofactor is shown as sticks and coloured in yellow.
The cap domain (residues 270-500, interrupting the FADbinding domain) is shown inwhite and the FADbinding
domain in grey.
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mospheric oxygen levels increased permanently (2400 to
2100 MYA, [3]). The absence of atmospheric oxygen at the
time of this separation makes it likely that the common
ancestor of all 4POs was not a true oxidase.
Candidate fungal VAOs are present in a variety of fungi,
but predominantly in the class of Pezizomycotina and
Agaricomycotina. None of the earlier lineages appear to
contain any copies of this gene, suggesting that it origi-
nated after the dikarya evolved as a separate group from
those earlier lineages. However, in those groups of fungi
that contain species with a VAO (e.g. Sordariomycetes,
Dothidiomycetes, Eurotiomycetes, Leotiomycetes, Agari-
comycotina), the presence of vao genes is restricted to a
small number of species, often not closely related. The
broad diversity of species that contains vao genes could
indicate that VAO is an old enzyme that was frequently lost
in fungal species, likely due to it no longer being essential.
However, the phylogenetic analysis of fungal VAOs also
points to an alternative explanation. As the VAO tree only
partially follows the taxonomic relationships between the
species, this suggests the possibility that several of these
species obtained the vao gene through horizontal trans-
fer, possibly from bacteria. This would explain the low fre-
quency of presence of VAO in fungal genomes, as well as
the phylogenetic diversity of the fungal VAO candidates.
Interestingly, among the species that contain candidate
vao genes, the number varies from one to seven copies,
suggesting that those species with multiple copies have
really capitalized on this enzymatic function and there-
fore likely require it for life in their biotope. An inter-
esting example of this is Aspergillus sydowii that has the
highest number of vao genes detected (seven) and has
both a terrestrial and a marine life style, in which it has
been implicated as a major causal agent of coral bleach
[216]. Another factor speaking in favour of horizontal
transfer as the origin of fungal VAOs is the non-conserved
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genomic region in which the genes have been detected.
This would be consistent with introduction by horizontal
transfer, while an ancient fungal origin would more likely
result in some conservation/synteny of the neighbouring
genes of the vao genes, which we could not detect.
Based on the conservation of critical amino acid
residues, we are confident that the sequences we have
identified will produce enzymes with VAO-like activity,
with the exception of the putative VAO from D. ampelina.
This sequence might be a pseudogene. Sequences in the
blue clade are likely to have modified activities, especially
changed enantioselectivity. We argue that it is more re-
liable to use critical amino acid residues than overall se-
quence identity to predict the enzymatic function of a
sequence. Sequence identities between PsVAO and the
novel VAOs in the blue clade are only between 30 and 40
%, but most critical amino acid residues are strictly con-
served. It is therefore crucial to use these critical amino
acid residues when annotating novel VAO sequences. We
have also included the critical amino acid residues into the
motifs we defined.
The functional role of the identified motifs is likely
structural: the residues in the 4PO-motif-1 form a loop,
which is in close contact with the FAD cofactor. It is im-
portant to note that one of the tyrosines crucially involved
in substrate deprotonation (Tyr108) is located in this loop.
This motif is therefore likely linked to proper orientation
and stabilisation of the position of Tyr108. The 4PO-motif-
5 also forms a loop containing the other two residues
involved in substrate deprotonation, Tyr503 and Arg504.
Proper orientation of these residues is also the likely rea-
son for the conservation of this motif.
Searching the Swiss-Prot database with the defined
motifs shows that, as could be expected, the shorter
motifs are not specific enough to identify 4POs from
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the database. However, 4PO-motif-1 is highly selec-
tive and only yields sequences of PsVAO and PpPCMH.
The sequence of RjEUGO is not a reviewed sequence
entry in the Swiss-Prot database and therefore not a
hit. We then expanded our search to GenBank, UniProt,
RefSeq and PDBSTR. Only the 4PO-motif-1 was suffi-
ciently selective, giving 848 hits. These sequences are
(automatically) annotated as VAOs, PCMHs, glycolate
oxidases, alcohol oxidases, aryl alcohol oxidases, hy-
pothetical proteins, FAD-binding oxidoreductases, FAD
binding domain-containing proteins and uncharacterised
proteins. It is highly likely that the annotations of
these sequences are erroneous and that they are actu-
ally all VAOs. For example, one sequence annotated
only as FAD-binding oxidoreductase is actually RjEUGO
(WP_011595933.1). PsVAO is also annotated as an aryl-
alcohol oxidase in many organisms, including Y15627
from P. simplicissimum. This annotated aryl-alcohol ox-
idase is identical to P56216, the original sequence of VAO.
Calling VAO an aryl-alcohol oxdiase is not technically
wrong, but leads to confusion because the enzymes with
EC number 1.1.3.7 that are defined as aryl-alcohol oxi-
dases are part of the glucose-methanol-choline oxidore-
ductase family [217].
We recommend using the 4PO-motif-1 for a
knowledge-based search of novel 4POs or to improve
the annotation of these sequences. The additional use of
the other motifs will help to further narrow down putative
functions. In addition to these motifs, several fingerprint
residues can be used to identify VAOs in a given set of
sequences (see Table 1). Including the original PsVAO
sequence (P56216.1) is highly recommended for ease of
finding these fingerprints.
Cellular localisation of the putative VAOs and a co-
expressed catalase-peroxidase was predicted to be perox-
isomal or cytoplasmic. This is in agreement with exper-
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imental data available on both enzymes from P. simpli-
cissimum [29, 218]. It is likely that fungi that intracellu-
larly express highly active VAO also co-express a catalase-
peroxidase to prevent accumulation of toxic levels of hy-
drogen peroxide. However, the catalase-peroxidase genes
we identified in the genomes of the red clade are not lo-
cated in the immediate environment of the vao gene.
VAO and the other members of the 4PO subgroup are
the only known members of the VAO/PCMH family that
covalently bind their FAD cofactor via a residue in the
cap domain. The other family members bind FAD either
mono-covalently or bi-covalently via (a) residue(s) in the
FAD-binding domain, or non-covalently. Tyrosines, cys-
teines and histidines are involved in the covalent binding
modes [40, 56, 219]. Histidines can bind FADvia an 8α-N1-
histidyl (to the FAD-binding domain) or 8α-N3-histidyl
bond. PsVAO uses His422 of the cap domain to install the
8α-N3-histidylflavin bond [40]. Interestingly, many puta-
tive VAOs do not contain His61 which is involved in the
autocatalytic incorporation of FAD [41], but all contain
His422 and none contain Tyr414. For putative VAOs with
Tyr61 this residue may be able to have the same function.
But for other putative VAOs, the autocatalytic incorpora-
tion of FAD, as observed for PsVAO, is unlikely, or another
mechanism is in place to activate His422. The absence
of Tyr414 also negates the option of a 8α-O-tyrosyl-FAD,
although two sequences with a cysteine at position 414
might have a 8α-S-cysteinyl-FAD. Some of these putative
VAOs might bind their FAD cofactor non-covalently.
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Conclusion
In conclusion, we have identified sequences, which repre-
sent with a high likelihood novel, fungal VAOs. Genomic
analysis revealed presence of VAO in only a small sub-
set of fungal species that are present in several fungal or-
ders. Based on phylogeny and synteny analysis, it seems
more likely that fungi that possess VAOs obtained these
through horizontal transfer, possibly from bacteria, rather
than that many fungi have lost this gene through evolu-
tion. We have defined a specific sequence motif (P-x-x-
x-x-S-x-G-[RK]-N-x-G-Y-G-[GS]) that recognizes 4PO en-
zymes, that can be used in combination with several fin-
gerprint residues to identify novel VAOs. Several proper-
ties of the members of the 4PO subgroup remain confus-
ing. Their substrate specificities overlap, but RjEUGO is
unable to convert alkylphenols. PpPCMH and other bac-
terial 4POs as well as the fungal PsVAO are able to convert
these molecules enantioselectively. Their fungal or bacte-
rial origin cannot be used to functionally separate them as
the bacterial RjEUGO is a true oxidase like PsVAO, but the
other bacterial 4POs are not. Also, these enzymes are in-
duced by different molecules [35, 197, 220], and no com-
mon inducer or physiological substrate has been identi-
fied (yet). Biochemical characterisation of the identified
fungal sequences will help to shed light on whether there
are “fungal EUGOs” or “fungal PCMHs” and additional
work to identify and characterise bacterialmembers of the
4PO subgroup will also help to illuminate whether there
are “bacterial VAOs”. More work is certainly needed to dis-
entangle these enzymes from each other.
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Manual gene model correction
can be done like this:
1. download the entire genome
of the organism.
2. locate the gene of interest in
the gene list.
3. select the DNA of the gene of
interest and add at least 1000
nucleotides upstream and
downstream.
4. use blastx to search databases
using your full gene sequence
- this will help to better judge
which introns need to be re-
moved.
5. locate introns - in
fungi, introns start with
G[T/C/A]NNG[TCA] and end
with [C/T/A/G]AG and are
typically 40-60 nucleotides
long.
6. remove introns.
7. use blastx to search databases
using your new, manually
edited gene.
8. judge if you trust your edited
gene or go back to step 4.
Methods
VAO is currently the only member of the Auxiliary Activity Family 4 (AA4)
of the CAZy database. In CAZy, there are 21 eukaryotic and 131 bacte-
rial sequences classified as AA4, presenting a clear bias against fungal
sequences. A manual search of the Mycocosm database (April 2017) re-
vealed 89 putative VAOs. Gene models of enzymes annotated as CAZy-
AA4 in the Mycocosm database were analysed. Sequences from non-
published genomes were removed, greatly reducing the amount of se-
quences. Protein sequences and genomes were downloaded and gene
models were manually corrected where necessary. Sequences with obvi-
ous internal STOP codons were removed. If unresolvable problems were
presentwith one sequence froman organism, all sequences from that or-
ganismwere removed. Sequences were aligned using clustal omega. The
verified alignmentwas used to build a phylogenetic treewithMEGA (ver-
sion 5.2). Sequences originating from Ascomycota and Basidiomycota
were identified, with the majority of sequences in the Ascomycota phy-
lum (78, vs 11 in Basidiomycota). Genemodels for 15 of these 89 unchar-
acterised fungal sequences were manually corrected. Organisms from
different classes in the two phyla contained putative VAOs. The original
sequence of PsVAO was added to the 89 putative VAOs, as were the bac-
terial sequences of characterized 4POs, giving a total of 97 sequences,
for which an alignment, and subsequently a phylogenetic tree, was built
using the clustal omega webserver ( https://www.ebi.ac.uk/Tools/
msa/clustalo/) and the MEGA5 program [206, 207]. Sequencelogos
were created using the weblogo webserver ([221], http://weblogo.
berkeley.edu/) and edited with inkscape (https://inkscape.org/
en/). The genomic environment was manually extracted from the My-
cocosm database, only selecting ORFs on the same strand as the puta-
tive VAO. Visualisation was performed with inkscape. The DeepLoc web-
server was used to analyse the probable localisation of putative VAOs
([208], http://www.cbs.dtu.dk/services/DeepLoc-1.0/). Esti-
mated times of speciation events of the last common ancestor of organ-
isms containing 4POs were median times given by http://timetree.
org/. The proposedmotifs were tested using http://www.genome.jp/
tools/motif/MOTIF2.html, on 14.11.2017. Catalase-peroxidases were
identified in fungi in the red clade by blasting with Q96VT4. Cellular lo-
calisation of sequences of the best hits was analysed using the DeepLoc
server ([208], http://www.cbs.dtu.dk/services/DeepLoc-1.0/).
CHAPTER 3 97
Bibliography follows at the end of the thesis
Supplementary figures
Supplementary Figure 1: Sequence logos of fungal VAOs from different clades (yellow, red and blue
clade in Figure 18). The figure follows on page 98.
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Chapter 4:
Vanillyl alcohol oxidases produced in Ko-
magataella phaffii contain a highly sta-
ble non-covalently bound anionic FAD
semiquinone
This chapter is based on:
G. Gygli andW. J. H. van Berkel. Biocatalysis, 3(1): 17-26, 2017.
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CHAPTER 4 101
Enzyme yields: as a rule of
thumb for research, an excellent
expression and purification sys-
tem yields more than 100 mg of
protein per litre (of culture of the
organism producing the enzyme).
Because purification can be time-
consuming, it is more practical
if more enzyme is produced per
litre of culture. For activity ex-
periments, only a few μg of en-
zyme are needed. For other exper-
iments, e.g. crystallisation, larger
amounts of enzyme are needed.
Often, many (more than 24) differ-
ent crystallisation conditions need
to be tested before enzymes crys-
tallise, each condition requiring
between 0.5-2 μl of enzyme so-
lution at concentrations of 2-50
mg/ml. For mechanistic studies
of enzymes, even more protein is
needed.
Abstract
Vanillyl alcohol oxidase (VAO) from Penicillium simplicis-
simum is a covalent flavoprotein that has emerged as a
promising biocatalyst for the production of aromatic fine
chemicals such as vanillin, coniferyl alcohol and enan-
tiopure 1-(4’-hydroxyphenyl) alcohols. The large-scale
production of this eukaryotic enzyme in Escherichia coli
has remained challenging thus far. For that reason an
alternative, eukaryotic expression system, Komagataella
phaffii, was tested. Additionally, to produce novel VAO
biocatalysts, we screened genomes for VAO homologues.
One bacterial and five fungal sequences were selected for
expression, using key active site residues as criteria for
their selection. Expression of the putative vao genes in
K. phaffii was successful, however expression levels were
low (1 mg per litre of culture). Surprisingly, all puri-
fied enzymes were found to contain a highly stable, non-
covalently bound anionic FAD semiquinone that could
not be reduced by dithionite or cyanoborohydride. Ac-
tivity experiments revealed that VAO produced in K. phaf-
fii does not produce vanillin because the enzyme suffers
from oxidative stress.
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Introduction
Vanillyl alcohol oxidase (VAO) is an homo-octameric
flavoenzyme, which covalently binds its FAD cofactor
[31]. FAD cofactors can attain three different redox
states: (i) the oxidised form, which is bright yellow
in colour, (ii) the one-electron reduced semiquinone,
a radical species which can be blue or red depend-
ing on whether it is in the neutral or anionic state,
and (iii) the two-electron reduced form which is al-
Figure 20: Visible absorption
properties of FAD redox states:
yellow: oxidised; red: anionic
semiquinone; blue: neutral
semiquinone; black: anionic
hydroquinone (modified from
[222]).
most colourless (Figure 20). VAO is active with a wide
range of 4-hydroxybenzylic compounds (Figures 21, 21)
and has emerged as a promising biocatalyst for the pro-
duction of aromatic fine chemicals, such as vanillin (4-
hydroxy-3-methoxybenzaldehyde), coniferyl alcohol (4-
hydroxy-3-methoxycinnamyl alcohol) and enantiopure 1-
(4’-hydroxyphenyl) alcohols [31, 36, 37]. During catalysis,
the FAD cofactor initially becomes reduced through hy-
dride transfer from the phenolic substrate, generating a
quinone methide product intermediate [36]. The fate of
this intermediate depends on the type of substrate [223].
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Figure 21: The different reactions
VAO catalyses are: the oxidation of
vanillyl alcohol to vanillin (I) and
the enantio-selective conversion
of 4-ethyl-phenol to (R)-1-(4’-
hydroxyphenyl)ethanol (II) and
the oxidative demethylation of
4-(methoxymethyl)phenol to
4-hydroxybenzaldehyde (III).
With vanillyl alcohol (4-hydroxy-3-methoxybenzyl alco-
hol), the aldehyde product (vanillin) is formedwithout the
intermediate hydration of the quinone methide (Figures
21, 22). In the reactions with 4-(methoxymethyl)phenol
and eugenol (2-methoxy-4-allylphenol), the quinone me-
thide intermediate is hydrated at the Cα- or Cγ-atom, gen-
erating 4-hydroxybenzaldehyde and coniferyl alcohol as
final products, respectively (Figures 21,22). VAOalso catal-
yses the enantioselective hydroxylation of 4-alkylphenols
to the corresponding (R)-1-(4’-hydroxyphenyl) alcohols
with an e.e. of 94% [37]. In the final step of the VAO reac-
tion, the reduced flavin gets oxidised bymolecular oxygen,
regenerating the oxidised enzyme [31].
VAO covalently binds its FAD cofactor via His422 [14,
41, 42]. The proposed sequence of events of this post-
translational modification of VAO is as follows: Before
any incorporation of FAD can occur, the VAO-polypeptide
folds and oligomerises to the dimer. The produced
apoprotein then encapsulates FAD in its highly pre-
organised binding cavity. Non-covalent FAD binding pro-
motes the octamerisation of the enzyme. Next, the flavin
becomes covalently bound via an autocatalytic process,
involving the fully reduced formof FAD. Covalent incorpo-
ration increases the redox potential of the flavin cofactor
and stimulates efficient redox catalysis. The full process
takes approximately 30-60 minutes [14, 41, 42].
Active site residues which have been found to be es-
sential for the reactions andmechanisms described above
are: (i) Asp170: essential for efficient redox catalysis and
involved in the autocatalytic flavinylation [43] (ii) His422:
covalently binds the FAD cofactor and thus enables ef-
ficient redox catalysis [44] (iii) His61: enables His422
to covalently bind FAD [41], (iv) Thr457: together with
Asp170 directs the enantioselective hydroxylation of 4-
alkylphenols of VAO to the R isomers [46] and (v) Tyr108,
Tyr503 and Arg504: form an anion-binding subsite which
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Figure 22: The different reactions
VAO catalyses are: the oxidation of
eugenol to coniferyl alcohol (IV),
and the oxidative deamination of
vanillylamine to vanillin (V).
is hypothesised to stabilise the phenolate form of VAO’s
substrates [40]. Residues remote from the active site
that have been found through directed evolution to influ-
ence the enzyme reactivity are Ile238, Phe454, Glu502 and
Thr505 [45]. Also, a loop ranging from residue 220 to 235
has been shown to be essential for octamerisation of VAO
[39].
Over the past three decades, studies with VAO have led
to different experiences producing this enzyme in differ-
ent expression systems [31, 224]. VAO as it was first de-
scribed in 1992 was purified from Penicillium simplicissi-
mum [31]. Absence of a gene sequence until 1998 [224]
necessitated that the production of the enzyme relied on
its natural host. Yields for VAO from P. simplicissimum
were around 5% of total protein produced, leading to ap-
proximately 50 mg of protein per litre of culture. VAO
was then heterologously produced in E. coli (using pBC11
[43]) and Aspergillus niger to yields of about 5-10 mg and
greater than 50 mg of enzyme per litre of culture, respec-
tively [224]. Because the protein produced extracellularly
in A. niger was prone to proteolysis, E. coli was selected as
host for subsequent protein engineering studies. The dis-
advantage of the relatively low yield of the E. coli system
compared to production in P. simplicissimum was out-
weighed by the ease of site-directedmutagenesis in E. coli
systems.
Microbial systems previously used to produce other
VAOs are E. coli, to express VAO from Fusarium verti-
cillioides strains, as well as Byssochlamys fulva V107 to
produce VAO from B. fulva V107 [34, 205]. The amino
acid sequence and crystal structure of VAO from P. sim-
plicissimum are available in sequence databases and the
PDB under the accession codes P56216 and 2VAO, respec-
tively. Amino acid sequences for VAO from F. verticillioides
strains are annotated as EWG41284.1 and AFJ11909.11, of
which the second corresponds to the VAO described in
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Before the age of genome se-
quencing, detailed characterisa-
tions of enzymes were common-
place. Now, sequencing data is ex-
ceeding enzyme characterisations
by far. The dilemma is that of-
ten either enzyme kinetic data
without an associated enzyme se-
quence is available or, more of-
ten, sequence data without an as-
sociated characterisation. Only by
having enzyme kinetic data and
sequence data available for many
enzymes can one hope to estab-
lish reliable sequence-function re-
lationships.
[205]. No amino acid sequence is available for the VAO
from B. fulva V107.
It is difficult to conclusively establish sequence-
function relationships based on only two known charac-
terised and sequenced VAOs. One can attempt to uncover
such relationships through site-directed mutagenesis or
directed evolution, as has been performed previously in
our group [41, 43, 44, 45]. Another approach is to tap natu-
ral evolution and screen genomes for VAO-like sequences.
We have chosen a combined approach, using the knowl-
edge gained from mutagenesis experiments to define a
set of key VAO residues which are known to be essential
for function of VAO from P. simplicissimum and then use
this criterion to select VAO-like sequences for expression
in Komagataella phaffii (formerly known as Pichia pas-
toris or Komagataella pastoris [190]). This methylotrophic
yeast was chosen for its ability to express eukaryotic pro-
teins to high yields as well as its use as an industrial sys-
tem for protein expression [225]. All the selected putative
VAOs as well as VAO from P. simplicissimum produced in
this way were found to be catalytically incompetent and
to contain a highly stable, non-covalently bound anionic
FAD semiquinone (anionic FADSQ).
Results
Bioinformatics Nowadays, a vast amount of sequence
data is available in sequence databases, and when screen-
ing these databases for homologues of a known pro-
tein one usually finds many more putative proteins than
can be produced under non-automated conditions. This
is also the case for the genome screening of the non-
redundant sequence database for VAO-like sequences,
where one finds more than three thousand hits when
blasting with the sequence of VAO from P. simplicissi-
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Figure 23: Visualisation of key
residues of VAO. (A) Functionally
important residues are coloured
according to (B). Also shown is the
cova- lently bound FAD cofactor
(in yellow). This figure was cre-
ated using PyMOL (The PyMOL
Molecular Graphics System, Ver-
sion 1.7 Schrödinger, LLC.). (B)
Summary of key residues in the se-
lected sequences, as numbered in
VAO. Data was extracted from the
alignment in Supplementary Fig-
ure 2 and processed in R [226].
mum. For practical reasons, a maximum of six novel vao
geneswas selected for expression. Selection of these genes
was based on the presence of residues that are impor-
tant for the functioning of VAO. These key residues are
His61, Tyr108, Asp170, Ile238, His422, Thr457, Glu502,
Tyr503, Arg504 and Thr505 as well as a loop from residues
220 to 235 (see Figure 23). The alignment of the VAO-
like sequences thus identified and their relationships to
VAO from P. simplicissimum are depicted in Supplemen-
tary Figure 1. The only bacterial sequence selected
originates from Cycloclasticus, a proteobacterium, while
the other sequences are of fungal origin, with the se-
quence from Dacryopinax being the only one from a ba-
sidiomycete. Sequence identities to VAO from P. sim-
plicissimum were 49%, 45%, 62%, 63%, 88% and 42%
for CRG90285, M5FTW7, C7Z853, W9CKB3, V5FPK0 and
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Figure 24: Elution profile of VAO
from P. simplicissimum as ex-
pressed in K. phaffii during purifi-
cation on a Superdex 200HR 10/30
column. An SDS-PAGE gel of col-
lected fractions is shownbelow the
curves. The big-framed box shows
the subunit molecular masses of
the marker proteins and the sam-
ple before purification on the Su-
perdex 200 column. The small-
framed box indicates which frac-
tions were pooled and used for
subsequent analysis.
You can already see that some-
thing is wrong with the FAD cofac-
tor from this figure: the absorp-
tion at 450 nm is very low. Usu-
ally, a more distinctive peak indi-
cating elution of a FAD-containing
protein can be detected. If you
compare the absorpions of FADOX
and FADSQ in Figures 20 and 25,
you see a considerably higher ab-
sorption at 450nm of the oxidised
FAD compared to the anionic FAD
semiquinone.
M5FTW7 is also present in Chap-
ter 3, but under a different acces-
sion code. It is from the fungus
Dacryopinax primogenitus, which
is abbreviated as Dacsp, and the
sequence number there is 56472.
K0C1W8, respectively. As can be seen from Figure 23B, all
these sequences contain the key residues Tyr108, His422,
Tyr503 andArg504, and only K0C1W8does not contain the
critical Asp170.
Production of VAO-like enzymes in K. phaffii VAO from
P. simplicissimum as well as the VAO-like enzymes were
successfully expressed extracellularly under the control
of an α-factor signal sequence in K. phaffii and puri-
fied as described in Methods. During production and
purification procedures, activity was tracked using the
horseradish peroxidase coupled activity assay (HRP assay)
described inMethods. After purification, rather low yields
were observed, ranging between 1 and 2 mg of pure en-
zyme from 2 L of culture. During the third purification
step, enzymes eluted at the volume of octameric VAO on
a Superdex 200 column, see Figure 24 [227]. SDS-PAGE
showed a subunit molecular mass of about 70 kDa for all
enzymes, corresponding to the calculatedmass of 74 kDa,
as can be seen in Figure 24.
Absorption spectra revealed the presence of an anionic
FADSQ in all the enzymes expressed in K. phaffii, com-
pared to the oxidized FAD observed in VAO expressed
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Catalase is an enzyme that catal-
yses the decomposition of hydro-
gen peroxide to water and dioxy-
gen. Superoxide dismutase catal-
yses the dismutation of the su-
peroxide radical into dioxygen or
hydrogen peroxide. We only see
dioxygen recovery if we add cata-
lase to the reaction (and not su-
peroxide mutase), and therefore
conclude that no superoxide is
formed. Catalase therefore con-
verts the hydrogen peroxide pro-
duced by VAO back to dioxygen
and this dioxygen is available for
further reaction cycles of VAO. In
the case of PsVAOE, recovery of hy-
drogen peroxide to dioxygen does
not lead to more reaction cycles of
the enzyme. We can see this be-
cause the dioxygen produced by
catalase is not used up by the re-
action anymore. In the case of
PsVAOK, we do see continuous de-
pletion of the dioxygen produced
by catalase. This shows that the
substrate is not limiting the reac-
tion of this enzyme, but the pres-
ence of dioxygen is.
in E. coli (see Figure 25A compared to Figure 25B). VAO
from P. simplicissimum expressed in K. phaffii also con-
tained anionic flavin semiquinone (VAOSQ). The use of
different growth media (see Methods) did not change the
semiquinone redox state of the purified enzymes. Chang-
ing the construct by removal of the c-terminal c-myc epi-
tope andHis-tag (6x) also lead to the production of VAOSQ.
Growth of K. phaffii and subsequent enzyme purification
under dark conditions also resulted in VAOSQ.
Stability of the anionic FAD semiquinone Attempts to
oxidise or reduce the flavin cofactor of VAO with ferri-
cyanide or dithionite or cyanoborohydride failed. VAOSQ
persisted also against the addition of the substrates
vanillyl alcohol and eugenol, as well as the inhibitors
isoeugenol and cinnamyl alcohol. Dialysis to remove
eventually boundmolecules, either in the absence or pres-
ence of excess FAD, did not change the flavin redox state.
Reoxidation of VAOSQ was only possible through denatu-
ration of the protein through TCAprecipitation or heating.
This revealed that the VAOSQ cofactor was non-covalently
bound, and the thus freed flavin was confirmed to be FAD
through TLC and HPLC/MS.
Of note is that due to the low amounts of protein avail-
able, absorption spectra were recorded using a nanodrop
2000c machine, which gave reliable and quick results (see
Figure 25). The fact that only 2 μL at most are needed for
ameasurement reduced greatly the volume needed to test
different conditions when trying to oxidise or reduce the
anionic FADSQ in VAO. Catalytic properties Tracking prod-
uct formation by following absorption changes at 340 nm
and 296 nm with the common VAO substrates vanillyl al-
cohol and eugenol indicated that all enzymes expressed in
K. phaffii did not produce the expected products vanillin
and coniferyl alcohol, respectively. This is surprising as
activity was detected using the HRP assay with purified
enzymes.
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Figure 25: Illustration of the dif-
ferent spectra recorded for (A)
VAOSQ with non-covalently bound
FAD and (B) VAOOX with cova-
lently bound FAD with Hewlett-
Packard HP 8453 diode array spec-
trophotometer (HP) or Thermo
Scientific NanoDrop 2000c UV-Vis
spectrophotometer (nanodrop).
To explain the discrepancy between the absorbance
measurements of vanillin production (at 340 nm) and
hydrogen peroxide formation (followed indirectly at 510
nm), wemonitored oxygen consumption with VAO from P.
simplicissimum as expressed in K. phaffii (PsVAOK) or E.
coli (PsVAOE). Measurements for both enzymes with lim-
iting amounts of vanillyl alcohol (0.2 mM), as described
in Methods, revealed consumption of oxygen for both en-
zymes. However, the rate of oxygen consumption with
PsVAOE was 10 times faster than with PsVAOK. More-
over, PsVAOE consumed 0.2 mM oxygen while PsVAOK
used up all oxygen present in the reaction mixture. Ab-
sorbancemeasurements and olfactory analysis confirmed
that vanillin was only formed with PsVAOE and not with
PsVAOK These observations hint at non-productive redox
cycling in the case of PsVAOK. Addition of catalase or su-
peroxide dismutase at the end or beginning of the reac-
tion showed the production of hydrogen peroxide dur-
ing this redox cycling, but not superoxide. In the case of
PsVAOK, the oxygen produced from the reaction of hydro-
gen peroxide with catalase was completely used up again.
In the case of PsVAOE, this oxygen exhaustion did not oc-
110 VAOSWITH A NON-COVALENTLY BOUND ANIONIC FAD SEMIQUINONE
In this methanol oxidase from K.
phaffii, about 30% of the flavin is
also a catalytically inactive, modi-
fied flavin, and only about 35% of
the flavin is functional.
The lifetime of the FADSQ in
choline oxidase is pH dependent.
We therefore tested if expression
of VAOat pH6.0 and 7.0 (seeMeth-
ods), as well as incubating purified
PsVAOK at different pH would also
change the lifetime of our FADSQ.
Unfortunately, the stability of VAO
at pH 6.0 is low, and we observed
comparable rates of denaturation
to PsVAOE.
cur because no more vanillyl alcohol was present. We can
therefore conclude that with PsVAOK, the substrate acts as
an effector uncoupling oxygen consumption fromproduct
formation.
Discussion
Many flavoprotein oxidases that form an anionic FADSQ
are known: A transient anionic FADSQ is observed in D-
amino acid oxidase upon titration with methyl viologen
at pH 8.5 and in sarcosine oxidase upon titration with L-
proline or sarcosine at pH 7.0 [228, 229]. Glycine oxidase
was found to form a transient anionic FADSQ upon pho-
toreduction [230]. Lactate oxidase forms a slowly decaying
anionic FADSQ, which is induced by reaction with pyru-
vate or photoirradiation, and reoxidised bymolecular oxy-
gen within 24 h [231]. In methanol oxidase from K. phaffii
anionic FADSQ was found to make up approximately 30-
35% of the flavin after purification [232]. The anionic
FADSQ ofmethanol oxidase was not reduced bymethanol.
A positively charged residue near N(1) is present in many
of these enzymes, mostly histidine or arginine, which
could stabilise the (transient) anionic FADSQ. In choline
oxidase, the anionic FADSQ is stabilised upon reduction in
the wild-type enzyme and the H466A mutant but not in
the H466Dmutant. The interaction of the negative charge
of the N(1) of anionic FAD SQ with the introduced nega-
tive charge of Asp466 of the H466Dmutant is suggested to
be unfavourable for the formation of the anionic FADSQ.
The absence of a positive charge near flavin N(1) in the
H466A mutant is not enough to prevent formation of the
anionic FADSQ in this enzyme [233]. Interestingly, the an-
ionic FADSQ in choline oxidase is unusually insensitive to
oxygen or ferricyanide at pH 8, but can be transformed
into oxidised FAD by incubating the enzyme at pH 6 for
several hours [234].
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Thermodynamic vs kinetic sta-
bility: every system can be rep-
resented by a free energy surface.
On this surface, local and global
minima and maxima exist. A local
maximum in Wageningen would
be the "Wageningse berg", which
undoubtedly is not a global max-
ima when compared to the Swiss
alps. And comparing the elevation
of the city of Basel to the elevation
of Amsterdam, the latter is more
likely to be a globalminimum than
the first. If a molecule is trapped
in a global minimum, it is ther-
modynamically stable, while if it is
trapped in a local minimum, it is
kinetically stable. The flavin radi-
cal is thermodynamically unstable
in most cases described here, and
thus easily "falls down" from the
global maximum.
For VAO produced in its natural host, P. simplicissi-
mum, the semiquinone state is not observed in rapid
reaction kinetic experiments. This indicates that the
semiquinone is not kinetically stabilised during flavin re-
duction, in agreement with the hydride transfer mecha-
nism [40]. A transient anionic FADSQ is observed upon
anaerobic reduction with dithionite, but it is easily reox-
idised upon mixing with air. Photoreduction of VAO also
leads to the transient formation of anionic FADSQ, while
photoreduction in the presence of cinnamyl alcohol yields
irreversibly bleached FAD [34]. In VAOH422A , a VAO vari-
ant that binds the FAD cofactor non-covalently, a large
portion of transient neutral (blue) FADSQ is observed dur-
ing xanthine oxidase mediated reduction [44]. In VAO,
Arg504 is located near the N(1) locus of FAD.
The above examples highlight that, independent of
whether they bind their FAD cofactor covalently or not,
many flavoprotein oxidases are able to stabilise anionic
FADSQ, andmost do form a transient anionic FADSQ upon
anaerobic reduction with dithionite. However, in all of
these enzymes, the flavin radical is thermodynamically
unstable and can be easily transformed to FADOX or
FADRED. Here we found that expression of six novel VAO
variants as well as VAO fromP. simplicissimum inK. phaffii
results in the production of octameric enzymes that bind
the anionic semiquinone form of FAD in a non-covalent
mode. Remarkably, the VAO-bound anionic FADSQ ap-
peared to be extremely stable and could only be trans-
formed to the oxidized state upon protein denaturation.
Neither could it be reduced with the strongest reducing
agents dithionite or cyanoborohydride. Surprisingly, even
VAO from P. simplicissimum (P56216), which has been
functionally expressed in E. coli, A. niger and P. simpliciss-
mum, presents as catalytically incompetent VAOSQ. Given
the presence of His422 and Arg504 in all sequences as well
as His61 in P56216, M5FTW7 and V5FPK0, these three en-
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zymes are expected to covalently bind FAD. Another un-
expected finding is that all novel VAO variants present as
octamers. Based on the absence of a loop that has been
shown to be essential for octamerisation in VAO, K0C1W8,
CRG90285 and M5FTW7 are expected to be dimeric pro-
teins [39].
The low yields of these enzymes as well as their unex-
pected behaviourwhen expressed inK. phaffii leaves open
the questionwhether low yields are due to the unexpected
behaviour or the use of an unsuited expression system. In
E. coli and P. simplicissimum, VAO is produced intracel-
luarly, and in A. niger and K. phaffii it is secreted. It ap-
pears that the formation of VAOSQ is specific to K. phaffii,
although the mechanism behind the formation of VAOSQ
is still unclear. Because the flavin semiquinone is non-
covalently bound, we hypothesise that stabilisation of the
semiquinone state prevents the covalent flavinylation of
VAO by excluding the formation of the reduced flavin and
flavin iminoquinone methide that have been proposed to
act as intermediates in the covalent flavinylation process
[214, 235]. It is remarkable that the semiquinone state
of FAD persists despite the apparent oxygen consump-
tion and hydrogen peroxide formation in reaction exper-
iments. It appears that PsVAOK suffers from oxidative
stress because substrate binding stimulates single elec-
tron flavin redox cycling, which uncouples oxygen reduc-
tion from aromatic product formation.
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Extracellular expression using
the α-factor signal sequence: this
sequence is N-terminal andmarks
the produced enzyme as a target
for secretion to the outside of the
cell.
Methods
Chemicals. Vanillyl alcohol, eugenol and horseradish peroxidase (type
II) were from Sigma-Aldrich. Peptone was from Sigma-Aldrich (pep-
tone from casein, pancreatic digest; for microbiology) and tryptone
was from Duchefa Biochemie. Catalase from beef liver and superoxide
dismutase from bovine erythrocytes were from Boehringer Mannheim
GmbH. All other chemicals were from commercial sources and of the
purest grade available. Growth media used were: Yeast Extract Pep-
tone Dextrose Medium (YPD) (1% yeast extract, 2% peptone, 2% glu-
cose, 100 μg/mL Zeocin), Buffered Glycerol-complex Medium (BMGY)
and BufferedMethanol-complex Medium (BMMY) (1% yeast extract, 2%
peptone, 100 mM potassium phosphate, pH 6.0 or pH 7.0, 1.34% Yeast
Nitrogen Base, 4 x 10–5 % biotin, 1% glycerol or 0.5respectively). In
BMMY, 2% peptone was replaced with 2% tryptone or 0.1 mM FAD was
added when testing different growth conditions.
Strains, expression of synthetic genes and protein purification. Ko-
magataella phaffii, NRRL Y-48124 X33 strain, as obtained from the
EasySelectTM Pichia Expression Kit (Invitrogen) was used for extracel-
lular expression of CRG90285, M5FTW7, C7Z853, W9CKB3, V5FPK0,
K0C1W8 and P56216 (VAO from P. simplicissimum). Sequences with a
longer N-terminus than in VAO from P. simplicissimum were shortened
andmade to contain the sameN-terminal part as VAO fromP. simplicissi-
mum. Codon optimised synthetic genes for these sequences in pPICZαA
vector were ordered from Life Technologies. Transformation of K. phaf-
fii NRRL Y-48124 X33 strain was performed following the EasySelectTM
Pichia Expression Kit instructions.
Growth of K. phaffii X33 and expression of VAO-like enzymes was as
follows: a pre-pre culture of transformed X33 cells in 5 mL YPDmedium
was grown overnight in a 50mL tube, then transferred into a 125mL baf-
fled flask with 20mL BMGYmedium (pre-culture), and grown overnight.
The pre-culture was then transferred into a 1 L baffled flask with 200 mL
BMMY medium and grown for four days, with methanol being added to
a final concentration of 0.5% twice a day. 50 mL of cultures that showed
VAO- activity with the horseradish peroxidase-coupled activity assay
(HRP assay) described below were transferred into 2 L baffled flasks with
500 mL BMMY medium and grown for another 5-6 days, with methanol
being added to a final concentration of 0.5% twice a day. A negative con-
trol of non-transformed cells (X33 as present in the EasySelectTM Pichia
Expression Kit from Invitrogen) was included and found to show no ac-
tivity with the HRP assay described below. Also, no intracellular expres-
sion of VAOs was observed in samples where extracellular expression of
VAOs occurred.
Purification of enzymes produced in K. phaffii was performed as fol-
lows (after [224]): The culture supernatants were harvested by centrifu-
gation (30 min, 4400 g, 4 °C). Subsequently, ammonium sulphate was
added to 65% saturation at 4 °C and then the precipitate was removed
by centrifugation (30 min, 4400 g, 4 °C). The pellet was dissolved in 50
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mM potassium phosphate buffer, 0.5 M ammonium sulphate, pH 7.0
and loaded onto a phenyl-Sepharose column pre-equilibrated with the
same buffer. The enzymes were eluted with a linear descending gradient
from 0.5 M to 0 M ammonium sulphate in 50 mM potassium phosphate
buffer, pH 7.0 using a Pharmacia BiotechÄkta system. Active fractions, as
determined using the HRP assay described below, were pooled, dialysed
against 50 mM potassium phosphate buffer pH 7.0, containing 150 mM
KCl and concentrated using Amicon 10kDa spin-filters. Samples were
then applied to a Superdex 200 10/30 GL column (GE Healthcare) run-
ning in 50 mM potassium phosphate buffer pH 7.0, containing 150 mM
KCl, at a flow rate of 1.0 mL/min. Fractions containing pure enzymes, as
determined by SDS-PAGE, were pooled, concentrated and dialysed to a
50 mM potassium phosphate buffer pH 7.5 with 10% glycerol and stored
at -80 °C.
Analytical gel filtration was performed at room temperature using a
Superdex 200 10/30GL column (GEHealthcare) running in 50mMpotas-
sium phosphate buffer pH 7.0, containing 150 mM KCl, at a flow rate of
1.0 mL/min. Analysis of the oligomeric state of the VAO-like enzymes
was done as described elsewhere [227].
Biochemical characterisation and spectral properties. A horseradish
peroxidase-coupled activity assay (HRP assay) was used to screen for
presence of VAO-like enzymes during production and purification. Re-
action mixtures containing 3 U/mL horseradish peroxidase, 0.1 mM 4-
aminoantipyrine, 1 mM dichlorohydroxybenzenesulfonic acid, 0.2 mM
vanillyl alcohol and an appropriate amount of enzyme sample in 50 mM
potassium phosphate buffer, pH 7.5, were incubated at room tempera-
ture for at least 15 min. The appearance of the typical pink colour upon
occurrence of a reaction was observed by eye. All activity measurements
with the purified enzymes were performed with previously frozen en-
zymes. Without the addition of glycerol to 10% before freezing the en-
zymes, it was found that the activity detected in the HRP assay was lost.
Specific activity wasmeasured by following the conversion of vanillyl
alcohol to vanillin or the conversion of eugenol to coniferyl alcohol by
monitoring the absorption of the products at 340 nm (ε340 = 14 mM –1
cm –1 at pH 7.5) and 296 nm (ε296 = 6.8 mM –1 cm –1 at pH 7.5) respec-
tively. Reactionmixtures containing 0.26 μMof VAO-like enzyme and 0.5
mM vanillyl alcohol or 0.05mM eugenol in 50mMpotassium phosphate
buffer, pH 7.5 were incubated at 25 °C in quartz cuvettes. Production of
vanillin or coniferyl alcohol was observed using a Hewlett- Packard HP
8453 diode array spectrophotometer.
Oxygen consumption was monitored using a Hansatech Oxytherm
system (Hansatech Instruments, King’s Lynn, UK). Reactions were con-
ducted at 25 °C with 0.2 mM vanillyl alcohol in 50 mM potassium phos-
phate buffer pH 7.5, and enzyme added to a final concentration of 0.4 μM
VAO or 1.2 μMVAOSQ. Catalytic amounts of catalase, superoxide dismu-
tase or horseradish peroxidase were added immediately after addition of
VAO or VAOSQ to the reactionmixture or towards the end of the reaction.
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Sequence identifiers (often ab-
breviated as SeqID) such as
P56216 are unique and assigned
to any sequence deposited in one
of the many available sequence
databases. Different databases as-
sign different formats of sequence
identifiers: P56216 is a sequence
found in the UniProt database.
P56216.1 would indicate that this
is version one of this sequence.
This becomes especially impor-
tant if more than one version of
the sequence is available. Cor-
rections of a sequence will lead
to it becoming version 2 of the
same sequence, resulting in a
hypothetical "P56216.2" sequence
identifier.
Flavin absorption spectra of the enzymes were recorded using a
Hewlett-Packard HP 8453 diode array spectrophotometer and quartz cu-
vettes, or with a Thermo Scientific NanoDrop 2000c UV-Vis spectropho-
tomer. Protein concentrations of the purified enzymes in a potassium
phosphate buffer pH 7.5 were determined using absorption values at 439
nm and ε439 =12.5 mM –1 cm –1 for VAOOX and assuming ε439 =7.8 mM
–1 cm –1 for VAOSQ, respectively.
Reduction of the flavin cofactor was attempted by incubating 27 μM
of enzyme with 10mMdithionite or 30mM cyanoborohydride in 50mM
potassium phosphate buffer, pH 7.5 at room temperature for at least 1 h.
After the incubations, the redox state of the flavin cofactors was deter-
mined from their absorption spectra. To force the release of their flavin
cofactor, enzymes were denatured using trichloroacetic acid (TCA) pre-
cipitation. For the TCA precipitation, cold 40% TCA was added to the
enzyme sample to a final concentration of 5% on ice. Samples were cen-
trifuged at 4 °C, 18,000 g for 10 min to separate the denatured protein
from the released flavin cofactor. Absorption spectra of neutralised (pH
7.0, using NaOH) supernatants were recorded as described above.
Identification and quantification of FAD using HPLC/MS. To deter-
mine the identity of the flavin cofactor, it was separated from the en-
zymes by heat denaturation. Samples were incubated for 10min at 95 °C,
followedby removal of the protein by centrifugation (18,000 g for 10min).
FAD was identified and quantified using a Shimadzu UPLC-triple quad
mass spectrometer (LCMS-8040) using the following procedure: The pu-
rified flavin cofactor from VAOSQ was freeze-dried and dissolved in 120
μl H2O. 2 μL of this cofactor solution were injected onto a Discovery HS
F5-3 (2.1 mm I.D. x 150mm, 3 μmparticles) from Sigma Aldrich. Separa-
tion was performed at 40 °C with a gradient from 100% H2O (with 0.1%
formic acid) to 35rate of 250 μL/min. The triple quad mass spectrome-
ter was operating with 3 L/min nebulizing gas flow and 15 L/min drying
gas flow. The inlet temperature was set to 250 °C and the heat block tem-
perature to 400 °C. Electrospray ionisation was used. FAD was detected
in positive mode for the transition from 786.15 to 136.10 m/z and from
786.15 to 348.10 m/z at 8.53 min.
Bioinformatics. Novel, putative vao genes were identified through
pblast using P56216 as query sequence in the non-redundant sequence
database. Sequences were aligned using clustal omega (http://www.
ebi.ac.uk/Tools/msa/clustalo/) and the obtained alignment was
visualised with Jalview [236]. Six novel sequences were selected based on
presence or absence of residues corresponding to positions 61, 108, 170,
220-235, 238, 422, 457 and 502-505 in P56216. Visualisation of these posi-
tions out of context of the alignment was performed using R version 3.2.2
(2015-08-14) [226]. A phylogenetic tree was created with the Neighbour
Joining Clustering method using percentage of sequence identity option
in Jalview and visualised using Dendroscope [236, 237]. All final graphics
were created using Inkscape (https://inkscape.org/en/).
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SupplementaryFigure 2: Bioinformatic analysis of selected sequences: (A)Multiple sequence align-
ment, showing consensus sequence. Note that a proposed variant of the PTS1 sequence, WKL-
COOH instead of SKL-COOH (as described in [29]), is only present in P56216 but not in the other,
novel vao genes. (B) Phylogenetic tree of sequences. Branch length is proportional to the number of
substitutions, as indicated by the bar (10 substitutions per sequence position).
The figure follows on page 117.
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Chapter 5:
The ins and outs of vanillyl alcohol oxidase:
identification of ligand migration paths
This chapter is based on:
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Abstract
Vanillyl alcohol oxidase (VAO) is a homo-octameric
flavoenzyme belonging to the VAO/PCMH family.
Each VAO subunit consists of two domains, the FAD-
binding and the cap domain. VAO catalyses, among
other reactions, the two-step conversion of p-creosol
(2-methoxy-4-methylphenol) to vanillin (4-hydroxy-
3-methoxybenzaldehyde). To elucidate how different
ligands enter and exit the secluded active site, Monte
Carlo based simulations have been performed.
One entry/exit path via the subunit interface and two
additional exit paths have been identified for phenolic
ligands, all leading to the si side of FAD. We argue that
the entry/exit path is the most probable route for these
ligands. A fourth path leading to the re side of FAD has
been found for the co-ligands dioxygen and hydrogen
peroxide. Based on binding energies and on the behaviour
of ligands in these four paths, we propose a sequence
of events for ligand and co-ligand migration during
catalysis. We have also identified two residues, His466
and Tyr503, which could act as concierges of the active
site for phenolic ligands, as well as two other residues,
Tyr51 and Tyr408, which could act as a gateway to the re
side of FAD for dioxygen.
Most of the residues in the four paths are also present
in VAO’s closest relatives, eugenol oxidase and p-cresol
methylhydroxylase. Key path residues show movements
in our simulations that correspond well to conformations
observed in crystal structures of these enzymes. Preserva-
tion of other path residues can be linked to the electron
acceptor specificity and oligomerisation state of the three
enzymes. This study is the first comprehensive overview
of ligand and co-ligand migration in a member of the
VAO/PCMH family, and provides a proof of concept for
the use of an unbiased method to sample this process.
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Introduction
Vanillyl alcohol oxidase (VAO) is a flavoenzyme involved
in the mineralisation of aromatic compounds in the soil
fungus Penicillium simplicissimum. VAO is active with
a wide range of para-substituted phenolic compounds,
but received its name because the enzyme initially was
found to catalyse the oxidation of vanillyl alcohol (4-
hydroxy-3-methoxybenzyl alcohol) to vanillin (4-hydroxy-
3-methoxybenzaldehyde) [31]. The natural substrate of
the enzyme could be 4-(methoxymethyl)phenol, as it is
the only substrate known to induce VAO expression [35].
VAO is one of the designatingmembers of the VAO/PCMH
family of oxidoreductases that share a conserved FAD-
binding domain [179, 196, 198]. Members of this family
often bind their flavin cofactor in a covalent mode. The
closest known and characterised relatives of VAO in the
VAO/PCMH family are the bacterial enzymes eugenol ox-
idase (EUGO) and p-cresol methyl-hydroxylase (PCMH).
While substrate specificities of these three enzymes dif-
fer, they all require their substrates to be para-substituted
phenols [36, 40, 55, 56, 238]. The amino acid sequence of
VAO ismost similar to EUGO, sharing 47% sequence iden-
tity, while VAO and PCMH share 40% sequence identity.
Interestingly, the sequence identity between the two bac-
terial enzymes is only 33%. All three enzymes bind their
FAD cofactor covalently. In VAO, this bond is formed via
an autocatalytic process, resulting in a covalent link be-
tween His422 and FAD [41]. In EUGO, the flavin is linked
to His390 [202], while in PCMH, the flavin is covalently
bound to Tyr384 [239].
VAO is a homo-octamer composed of a tetramer of
dimers, where each subunit consists of 560 amino acids.
Each subunit is organised into two domains, the FAD-
binding domain and the cap domain [40], finding the
active site at their interface (Figure 26). In vitro, VAO
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Figure 26: Three-dimensional
structure of vanillyl alcohol oxi-
dase (PDB ID: 1VAO). The dimer
is shown as cartoon with the cap
domain coloured in red and FAD-
binding domain in green. A zoom
into the active site at the interface
of the two domains is shown with
selected residues shown as blue
sticks and the isoalloxazine ring
of the covalently bound flavin
cofactor in yellow.
forms a mixture of dimers and octamers, with the oc-
tamers prevailing at physiological ionic strength [38, 227].
EUGO and PCMH have different quaternary structures.
EUGO is exclusively homodimeric, while PCMH consists
of a heterotetramer. This heterotetramer consists of two
FAD-binding subunits forming a homodimer and two cy-
tochrome c subunits. The homodimeric structure of the
FAD-binding subunits is the same in all three enzymes.
See also Supplementary Figure 3 for an overview of the
quaternary structures of these three enzymes.
Important active site residues of VAO are Tyr108,
Asp170, His422, Tyr503 and Arg504 (see the zoom into the
active site in Figure 26). Tyr108, Tyr503 and Arg504 are
proposed to be crucially involved in the deprotonation
of substrates upon their arrival in the active site [40, 49].
Asp170 has a multifunctional role. It is involved in the au-
tocatalytic incorporation of the flavin cofactor and assists
in increasing the redox potential of VAO (making it less
negative) [43]. Asp170 can also act as active site base [43],
and is involved in the enantioselective hydroxylation of 4-
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"Catalytic" bottlenecks may not
be the best choice of words here,
as ligand binding normally does
not affect catalysis: most en-
zymes are not diffusion limited
and therefore ligand migration
to the active site happens much
faster than catalysis itself. To
speak of catalytic bottlenecks im-
plies that the overall enzyme reac-
tion is limited by ligandmigration,
which of course can be the case.
A bottleneck can have steric
and/or electrochemical prop-
erties. A steric bottleneck is
created if a large amino acid
blocks a passage by its presence.
An electrochemical bottleneck is
created if a charged amino acid
blocks a passage through the
action of its charge. For example,
positively charged amino acids
would present a bottleneck for
positively (or negatively) charged
ligands by repelling (attracting)
them and thus making passage
difficult.
alkylphenols [46]. His422 increases the oxidation power of
the FAD cofactor by increasing its redox potential (making
it less negative) through covalent flavin binding [41, 44].
The catalytic mechanism of VAO involves two half-
reactions. In the reductive half-reaction, the enzyme-
bound flavin is reduced by the phenolic substrate to
generate a quinone methide intermediate [36, 223]. In
the oxidative half-reaction, the reduced flavin is oxi-
dised by dioxygen, generating hydrogen peroxide. De-
pending on the substrate, there are differences in the
reaction mechanism. With 4-(methoxymethyl)phenol,
water addition to the quinone methide intermediate
gives an unstable hemiacetal, which decomposes to 4-
hydroxybenzaldehyde. VAO can produce vanillin in a
one-step reaction from vanillyl alcohol as well as in a
two-step reaction from p-creosol, where vanillyl alcohol
is the decomposition product of the initially formed air-
stable flavin-creosol adduct [178]. The reaction with p-
creosol (Figure 27, plates 1 to 5) is rate-limited by the
extremely slow decomposition of the flavin-N5 substrate
adduct (Figure 27, plate 4) [40]. In the reaction of vanil-
lyl alcohol to vanillin, there is no addition of water to the
vanillyl alcohol quinone methide (Figure 27, plates 6 to 8)
[223].
Although many details of the catalytic mechanism of
VAO have been uncovered, it is unknown how the reaction
participants enter and exit the active site. No path for sol-
vent or ligand access to the active site is visible from the
crystal structure of VAO. It is of fundamental interest to
understand how reaction participants enter an enzyme’s
active site to be able to identify catalytic bottlenecks.
Such bottlenecks can then be used to guide substrate or
enzyme redesign to eliminate them. This work provides
a proof of concept for the use of an unbiased method to
sample entry and exit pathways of a complex enzyme sys-
tem. We aim to discover the migration path(s) of reaction
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Figure 27: Overview of the reaction cycle from p-creosol to vanillyl alcohol and vanillin catalysed by VAO. Reac-
tion rates at pH 7.5, 25 °C are shown in the centre of the reaction cycle (data obtained from [45]). The rate-limiting
step for the conversion of p-creosol to vanillyl alcohol is the decomposition of the air-stable flavin N5 substrate
adduct (panel 4, marked in red). For the conversion of vanillyl alcohol to vanillin the rate-limiting step is the
reduction of the flavin by the substrate (panel 7). In both reactions, the yellow flavin cofactor is rendered color-
less through reduction by the substrate (occurring between panels 2 and 3 as well as 6 and 7). Molecular oxygen
driven oxidation of reduced flavin (colourless) to oxidized flavin (yellow) occurs between panels 5 and 6 as well
as panels 8 and 1, in the presence or absence of either vanillyl alcohol or vanillin.
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Allostery is normally defined as
the regulation of protein function
through a change in its quartenary
structure, most often through its
interaction with a ligand or an ad-
ditional protein subunit. Recently,
it has been suggested that all pro-
teins are allosteric [245] and that
allostery and catalysis are evolu-
tionary linked [246].
partners of VAO for the reaction from p-creosol to vanillin.
Recent studies, with other enzymes, have pointed to the
importance of remote residues for catalysis or the pres-
ence of multiple paths for ligands [240, 241, 242, 243, 244].
It is also worthy to note that during enzyme catalysis, the
entry and exit of reaction partners may result in traffic
jams in migration paths. We try to address these issues
by modelling migration paths of reaction partners of VAO.
Given the large size of VAO and the involvement of multi-
ple ligands, it is conceivable that substrates and products
use different paths.
In this study, we used Protein Energy Landscape Explo-
ration (PELE), aMonte Carlo based program [67], to inves-
tigate the entry and exit paths of three phenolic ligands in
VAO. Protonated and deprotonated phenolic ligands were
used to be able to observe possible differences in binding
energies during the simulations and thus establish when
substrate deprotonation and product re-protonation hap-
pen in the reaction pathway of VAO.
An entry and exit path for phenolic ligands at the sub-
unit interface, along with two additional exits paths, lead-
ing through the cap domain or the FAD-binding domain,
were identified. It was found that protonated p-creosol
freely migrated to the active site, while deprotonated p-
creosol did not. In addition, the behaviour of dioxygen
and hydrogen peroxide was modelled. Migration via the
flavin re side turned out to be the shortest path for these
molecules.
Results
Ligandmigration simulations using PELE were run on the
dimer of VAO with phenolic ligands COP, COD, VAP, VAD,
VNP and VND, as well as with dioxygen and hydrogen per-
oxide. Figure 28 illustrates the location in VAO of all the
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Figure 28: Three-dimensional
structure of vanillyl alcohol oxi-
dase and the four paths identified
in this study. Vanillyl alcohol
oxidase is shown as cartoon
and coloured in grey, with FAD
shown as sticks and coloured in
yellow (PDB ID: 1VAO). The paths
identified in this work are shown
through sphere representation of
ligand positions in the trajecto-
ries. The cap path is coloured in
orange, the FAD path in blue, the
subunit interface path in magenta
and the re path in cyan.
A: Octameric VAO, seen from the
front.
B: Octameric VAO seen from the
side.
C: Dimeric VAO as seen in Figure
26.
paths identified through the approaches described inMa-
terials andMethods.
Due to the stochastic nature of the PELE method, it is
not possible to correlate the observed movements to bi-
ological timescales. Instead, the calculated binding ener-
gies (presented as interaction internal energies, see Meth-
ods), at different distances of the ligand from the FAD as
well as the number of contacts between ligands and pro-
tein residues, were used to estimate theirmost likely paths
as they move through the protein. Furthermore, we com-
puted the flexibility of each protein residue during the
simulations through RMSFs. This data can also be used to
estimate if a path involves bottlenecks where the ligands
tend to get stuck.
Description of the entry path used by phenolic ligands
Using the adaptive PELE simulations, the surface of the
VAO dimer was explored for COP entry, see Figure 29A.
As stated, the ligand was placed in the bulk solvent and
allowed to freely explore the surface and any possible en-
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try path(s). It was found that using this approach, the lig-
and moved into the active site exclusively via the subunit
interface. In order to refine the energy landscape along
the entry path, we started additional simulations from the
surface of the subunit interface with a reduced translation
range (maximum ligand translation of 1.5 Å). These refine-
ment simulations confirmed the entry for COP, but indi-
cated that COD was unable to enter the protein via this
path. Binding energies calculated showed that it was en-
ergetically favourable for COP to reach the active site via
the subunit interface, but energetically unfavourable for
COD to do the same (Figure 29C). The COP entry path,
which is identical to the third exit path described below,
involves mainly residues Arg183, Val185, Asp192, His193,
Met195,Met303, Ile428,Met462, His466 Ile468, Tyr503 and
Arg504. Residues His466 and Tyr503 are easily changing
conformation to grant the ligand access to the active site.
This path is symmetrical, leading from the starting point
at the subunit interface to either of the two active sites of
the dimer, as can be seen in Fig 4C. The most contacted
residues were His193, Met195 and Ile428 and the most
flexible residues were Asp192, Gly462, His466 and Tyr503,
as can be seen in Fig 4B.
Overview of the three exit paths used by phenolic lig-
ands (cap, FAD and subunit interface path) To identify exit
paths, simulationswere performed for the dimeric protein
and the ligands were placed into one of the two subunits
and both subunits were used as starting points in equal
amounts. We observed symmetry in our data (see Fig-
ure 28): some paths were fully symmetrical in simulations
starting from either subunit and other paths were partly
symmetrical, most likely due to incomplete sampling as
can be seen from Figures 28 and 29A. The fact that we ob-
served identical results independent of the starting point
is a good indication that all potential paths have been
sampled. Extrapolating data from each of the two sub-
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Figure 29: Overview of the en-
trance path identified with COP
(A) as well as RMSF and atom con-
tacts (B, for COP) and binding en-
ergy data (C, for COP and COD).
A: The VAO dimer is shown as
cartoon in grey and its FAD co-
factor is shown as sticks in yel-
low. The entrance path is shown
through sphere representation of
ligand positions in the trajectories
and coloured inmagenta. For clar-
ity, we only show data for an en-
trance simulation where COP mi-
grates to the left-hand subunit.
B: Highest RMSF values (black
boxplot boxes) and atom contact
counts with the ligand (grey box-
plot boxes) of residues in VAO.Ma-
genta filling of the boxplots in-
dicates that the residue belongs
to the entrance path. Residues
that do not have atom contacts
with the ligand but are highly flex-
ible only have a black boxplot
(for RMSF). Because data was ob-
tained from only one simulation,
the atom contacts do not have any
variation.
C: Scatterplot of binding energies
as a function of the distance be-
tween the ligand and FAD. Nega-
tive x-values indicate the distance
to the FAD in the other subunit.
This graph shows that the path
is symmetrical for COP (in ma-
genta).
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RMSF stands for Root-Mean-
Square Fluctuations of atomic
positions and measures the dis-
tance between atoms of a protein
relative to an average structure.
units to the other subunit gave fully symmetrical paths,
which were continuously connected.
Three independent exit paths were observed for simu-
lations with phenolic ligands, as shown in Figure 28 and
parts A of Figures 29, 30 and Supplementary Figures 4 and
5. The paths shown in different colours correspond to i)
the cap path (in orange) where ligands exit the protein
through the cap-domain, ii) the FAD path (in blue) where
ligands traverse the protein through the FAD-binding do-
main, and iii) the subunit interface path (in magenta),
which corresponds to a path connecting the subunits (and
agreeing with the entry path described above).
Not all simulations led to the ligand leaving VAO. Some
simulations showed that the ligand also moved from one
path to the other, resulting in mixed paths. Only one of
the three paths, the cap path, is exclusively connecting the
active site to the solvent. The other two paths identified,
the FADpath and subunit interface path, lead to interfaces
between subunits or dimers of VAO. Paths leading to the
interface of subunits or dimers allow the enzyme on one
hand to connect the different active sites of the subunits
(Figure 28 and parts A of Figures 29, 30 and of Supplemen-
tary Figures 4 and 5). On the other hand, these paths also
allowed the ligands to exit via the interface of the dimer
or the subunit, as there is sufficient space for the ligands
available there. Because these paths can be expected to
work into both directions, in and out, they could also act
as another access point for the ligands to the active site.
However, analysis of residue flexibility represented by
RMSF data as well as atom contact counts has to be taken
into account to discover possible bottlenecks in these
paths. The RMSF values and atom contacts calculated
per simulation were combined and plotted in boxplots
(parts B and C of Figures 29, 30, and of Supplementary
Figures 4 and 5). The more flexible residues, mostly lo-
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Figure 30: Overview of the exit
paths identified with COP and
COD (A), RMSF and atom contacts
(B for COP and C for COD) and
binding energies (D).
A: The VAO dimer is shown as car-
toon in grey and its FAD cofactor
is shown as sticks in yellow. The
paths identified in this work are
shown through sphere representa-
tion of ligand positions in the tra-
jectories. The cap path is coloured
in orange, the FAD path in blue
and the subunit interface path in
magenta.
B: Plot of simulations with COP,
highest RMSF values (black box-
plot boxes) and atom contact
counts with the ligand (grey box-
plot boxes) of residues in VAO.
Coloured filling of the boxplots in-
dicates that the residue belongs to
the path of that colour.
C: Plot of simulations with COD,
highest RMSF values (black box-
plot boxes) and atom contact
counts with the ligand (grey box-
plot boxes) of residues in VAO.
Coloured filling of the boxplots in-
dicates that the residue belongs to
the path of that colour.
D: Scatterplot of binding energies
as a function of the distance be-
tween the COP and COD (in green
and black) to FAD.
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cated at the surface, were often also the most contacted
ones. Those most flexible surface residues were Arg274
and Arg325, while the buried ones showing larger flexi-
bility were Arg398, Tyr503 and Arg504. Residue Lys545
was the most contacted residue for all ligands except VNP.
Other flexible and/or highly contacted residues in sim-
ulations with most ligands were Trp98 (not with VNP),
Ile100 and Asn105 (not with VAD and VNP) Val185 (not
with VAP), Arg312 (notwithVADandVNP), surface residue
Ser329 (not with COD) and Leu507 (not with VNP).
The binding energies of all the phenolic ligandswere on
comparable scales, but the range of the calculated binding
energies varied between ligands, as can be seen in Supple-
mentary Figure 4C. The binding energies plotted against
the distance of the ligand from the FAD spread least to-
wards higher energy values for COP and VAP compared to
COD and VAD. When comparing the data from the entry
path and the exit paths, COP showed very little spreading
of the data and presents lower binding energies than COD
in both cases. Combining this information suggests that it
is energetically more favourable for protonated substrates
tomigrate into and out of VAO than for deprotonated sub-
strates or products.
In the following sections, each path and the behaviour
of path residues will be described individually.
Detailed description of the cap path In this path, lig-
ands migrated to the “upper-part” of the active site (or-
ange in Figures 28, 30 and Supplementary Figures 4 and
5), passing Glu410, Trp413, Arg312 and Arg398 to exit the
protein in the cap domain. Arg398 and Trp413 have been
proposed to be involved in a size-exclusion mechanism
that could limit the size of the substrate-binding pocket
[40]. The cap path requires the ligands to pass Arg312 and
Arg398, which are among the most frequently contacted
and most flexible residues for most ligands. Arg398 inter-
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acts with Glu410 and Trp413 and it is this interaction that
the ligands need to disrupt to exit the active site via this
route. Simulations often showed ligands to be trapped be-
tween the two arginines as they tried to pass this portal.
This path was the shortest of the three identified for the
phenolic ligands, but contained a bottleneck composed
of residues Arg312, Arg398, Glu410 and Trp413 (as can be
seen in Figures 28, 29 and Supplementary Figures 4 and
5). Combining the data for all the ligands, residues be-
longing to the cap path that are among themost flexible or
contacted residues were Leu171, Arg312, Leu316, Tyr354,
Pro390, Glu391, Asn392, Val394, Arg398 and Thr401.
Detailed description of the FAD path In this path (blue
in Figures 28, 30 and Supplementary Figures 4 and 5), lig-
andsmigrated through Tyr503 and Arg504 tomove closely
along the FADphosphate-ribityl chain towards the adeno-
sine monophosphate part of the cofactor and to exit the
protein between Trp98, Leu507 and Lys545. Trp98 is re-
quired to move aside, which is reflected in the RMSF and
contact data (as can be seen in Figure 28B and 28C in the
middle panel and Supplementary Figures 4A and 5B). This
path led to the dimer-dimer interface in octameric VAO,
where we find sufficient space for the ligand to exit VAO or
migrate to the neighbouring dimer in the octameric sym-
metry unit. However, Trp98, Leu507 and Lys545 consti-
tuted a bottleneck in this path. Combining the data for all
the ligands, residues belonging to the FAD path that were
among themost flexible or contacted residues were Trp98,
Pro99, Asn105, Arg114, Val115, Ser118, Phe424, Thr505,
Leu507, Met510, Lys545 and Ser546.
Detailed description of the subunit interface path In this
path, ligands moved towards the subunit interface of the
VAO dimer (magenta in Figures 28, 30 and Supplementary
Figures 4 and 5). The behaviour of different ligands mod-
elled varied slightly in this path and they followeddifferent
minor variations of it, however all theseminor paths led to
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the subunit interface. Simulations that were started with a
ligand in one subunit sometimes showed the ligand com-
pletely entering the active site of the other subunit. Lig-
ands were frequently found in the upper part of the sub-
unit interface, where they were already surrounded with
solvent. As stated, simulations mapping the entry path
also showed the ligand passing through the same area.
Three residues clearly involved in the subunit inter-
face path, but not showing up as frequently contacted
or highly flexible residues in the analysis, were Asp192,
Met195 and Glu464. Ligands passed quickly through a
portal formed by Glu464, Asp192 and Met195, and from
there directly into the subunit interface (for an illustration
see Supplementary Figure 6). The portal formed by these
three residues appeared to be the easiest for the ligands
to pass through, not requiring significant movements of
large residues and not involving a high frequency of con-
tacts. The portal in this path connects the two active sites
in the VAO dimer to each other.
Additional residues involved in this path areHis466 and
Tyr503, which weremoving aside to grant access to the ac-
tive site in the entry simulations and were also allowing
ligands to exit. See Figure 31A for details on themovement
of His466 and Ty503 as well as Met195 in our simulations.
Residues that were in contact with ligands and that line
the subunit interface were Arg463, Arg300 and Met303.
Combining the data for all the ligands, residues belonging
to the subunit interface path that were among the most
flexible or contacted residues were Arg183, Val185, Tyr187,
Trp194, His197, Tyr244, Tyr249, Ser255, Arg274, Arg300,
Met303, Asn307, Thr310, Ala356, Met402, Met462, Ile468
(see also parts B and C of Figures 31 and Supplementary
Figures 4 and 5).
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Figure 31: Details of the ligandmigration paths identified in this study (A) and illustration of the surface at the re
path in VAO, EUGO and PCMH (B).
A: Crystal structures of VAO, EUGOand PCMHaswell as selected frames fromour simulationswere aligned using
PyMOL. Selected crystal structure residues (labelledwith VAOnumbering) are shown as sticks. Residues involved
in the subunit interface path and their conformations in VAO are coloured inmagenta. The conformations of the
corresponding residues in EUGO and PCMH, are coloured in lighter or darker shades of magenta, respectively.
Residues involved in the re path and their conformations in VAO are coloured in cyan. The conformations of
the corresponding residues in EUGO and PCMH, are coloured in lighter or darker shade of cyan, respectively.
Note that the loop carrying Tyr51 is completely absent in EUGO and PCMH and that Tyr408 present in VAO is
a leucine in EUGO and PCMH. Selected residues from selected frames of our simulations are shown as lines,
in grey. Frames showing the movement of Tyr51 and Tyr408 were taken from simulations with dioxygen, those
showing movement of His466, Tyr503 and Met195 from simulations with phenolic ligands that were migrating
through the subunit interface path. The respective othermonomer of the three crystal structures is visible on the
right of the figure as cartoon in red (cap domain) and green (FAD-binding domain). On the left, the cytochrome
c subunit from PCMH is visible as cartoon, coloured in blue.
B: Surface representation of the surface of the re path to illustrate the size of the channel leading to the re side
of FAD in VAO, EUGO and PCMH. The proteins are shown as surfaces and the FAD cofactors as sticks, coloured
in yellow. Note the different size of the channel in VAO and EUGO, as well as the blockage by the cytochrome c
subunit in PCMH (blue mesh).
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Detailed description of the paths used by dioxygen and
hydrogen peroxide The co-substrate dioxygen and co-
product hydrogen peroxidewere placed on the si or re side
of the isoalloxazine ring of the FAD cofactor and left to
explore the VAO dimer. On the re side of FAD, a possible
oxygen binding pocket is located as indicated by a bound
chloride ion in PDB ID: 1VAO and by a water molecule in
the same position in PDB ID: 2VAO [40, 247].
When placed on the si side of FAD, dioxygen and hydro-
gen peroxide behaved similarly to the phenolic ligands,
but did not leave the enzyme after 200–250 simulation
steps, probably due to under sampling. There is a differ-
ence in the behaviour of the co-ligands though: they both
rarely used the FAD path and hydrogen peroxide had a
clear preference for the cap path, almost exiting the pro-
tein when migrating through that path. When placing the
co-ligands on the re side of FAD, theywere able to leave the
enzyme after 50 to 250 simulation steps via a path through
the interface of the cap and FAD domain. This path will be
referred to as re path for the remainder of this text and is
illustrated in cyan in Figures 28 and 32. Contrary to the
paths identified for phenolic ligands, this path is visible as
an access channel to the active site from the crystal struc-
ture of VAO (see Figure 31B).
Binding energies for dioxygen and hydrogen peroxide
were found to be on a different scale from those of the
phenolic ligands, which is to be expected due to the dif-
ference in size of these molecules (computed binding en-
ergies are extensive properties), for comparison see parts
Dof Figures 29, 30 and 32. However, binding energieswere
comparable for these co-ligands when placed at the si or
re side of FAD. In both cases, variations in binding ener-
gies for hydrogen peroxide were larger than for dioxygen,
but overall binding energiesweremore negative for hydro-
gen peroxide (Figure 32D). This might suggest that hydro-
gen peroxide more likely gets stuck in local energy min-
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Figure 32: Overview of the re path
identified with dioxygen (OXO)
and hydrogen peroxide (PER) (A),
RMSF and atom contacts (B for
dioxygen and C for hydrogen per-
oxide) and binding energies (D).
A: The VAO dimer is shown as car-
toon in grey and its FAD cofactor
is shown as sticks in yellow. The
paths identified in this work are
shown through sphere representa-
tion of ligand positions in the tra-
jectories. The re path is coloured
in cyan.
B: Plot of simulations with dioxy-
gen, highest RMSF values (black
boxplot boxes) and atom contact
counts with the ligand (grey box-
plot boxes) of residues in VAO.
Cyan filling of the boxplots indi-
cates that the residue belongs to
the re path.
C: Plot of simulations with hydro-
gen peroxide, highest RMSF values
(black boxplot boxes) and atom
contact counts with the ligand
(grey boxplot boxes) of residues in
VAO. Coloured filling of the box-
plots indicates that the residue be-
longs to the path of that colour.
D: Scatterplot of binding energies
as a function of the distance be-
tween dioxygen (cyan) or hydro-
gen peroxide (black) to FAD.
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ima, which could mean that dioxygen reaches the active
site in a faster and more directed manner than hydrogen
peroxide leaves it.
Surface residues found in the analysis of RMSF and
atom contacts were residues Lys43, Asp44, Ile46 and
Arg482. Residues of the re path among the most flexible
or contacted residues were Tyr51, Met52, Thr55, Pro60,
His61, Gly103, Arg104, Ser106, Tyr148, Leu171 Gly174,
Leu411 and Lys475 (as illustrated by Figure 32 parts B and
C). Tyr51 and Tyr408 needed to move aside to allow dioxy-
gen and hydrogen peroxide to leave the active site, a be-
haviour likely determining access to the flavin re side for
these molecules. Tyr51 is also positioned close enough to
the proposed oxygen binding pocket that it could be in-
volved in FAD re-oxidation. See also Figure 31A for details
of the movement of Tyr51 and Tyr408 in our simulations.
Amovie illustrating all the paths is available in the sup-
plementary data (S1 Movie).
Structural conservation of the identified migration
paths in VAO, EUGO and PCMH We analysed the struc-
tural conservation of path residues in three crystal struc-
tures of VAO, EUGO and PCMH. Figure 33 shows the
obtained structure-based sequence alignment and illus-
trates the conservation of residues in the different paths
through coloured symbols. We also compared the confor-
mations of the most conserved residues involved in the
paths in the three aligned structures (indicated by star
symbols in Figure 33). With the exception of Met195,
Gly420, His466 and Tyr503 the conformations of all con-
served residues in the crystal structures were identical.
The different conformations of these four residues will
be described below. Met195 was found to have differ-
ent conformations in the crystal structures of VAO, EUGO
and PCMH. These conformations correspond well to the
movement by Met195 observed in our simulations (see
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Figure 33: Structure-based sequence alignment of VAO, EUGO and PCMH. Numbering of residues at the be-
ginning and end of each line correspond to the numbering used in the crystal structures. Numbers on top of
the alignment correspond to the numbering of VAO sequence P56216.1 and is the same as used throughout this
study. Coloured symbols indicate the path the residue underneath it is involved in. Orange, blue, magenta and
cyan was used for the cap, the FAD, the subunit interface and the re path respectively. Red indicates functionally
important residues. Bi-coloured symbols indicate the residue is involved in two paths. The shape of the symbol
indicates preservation of the residue, stars (present in all three structures), circles (present in two of the three
structures) and squares (present in only one of the three structures).
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If enough high-resolution crys-
tal structures of an enzyme are
available with and without ligands
bound, comparing the conforma-
tions of these structures can also
enable the identification of puta-
tive "path residues". However, if
the ligand is not visible in these
crystal structures the interpreta-
tion of the different conforma-
tions of amino acid residues in the
structures becomes more difficult.
Figure 31A for an illustration). Gly420 is located in a sur-
face loop, which is in close proximity to the cytochrome
c subunit in PCMH. This loop adopts a different confor-
mation in PCMH than in VAO and EUGO. This could be in
part due to the presence of the cytochrome c subunit in
PCMH, which is absent in EUGO and VAO, and in part due
to the covalent histidyl linkage to the FAD cofactor in VAO
and EUGObut not PCMH.His466 and Tyr503 have already
been observed to have two conformations in the high res-
olution crystal structure of PCMH (PDB ID: 1DII [56]). The
conformational freedom of these residues is not observed
in the other crystal structures but is in agreement with the
movements of His466 and Tyr503 observed in our simu-
lations (see Figure 31 for an illustration). It is notewor-
thy that the re path identified in VAO leads to where the
cytochrome c subunit is located in PCMH. We compared
this channel in VAO, EUGO and PCMH and found that it is
non-existent in PCMH and narrower in EUGO compared
to VAO (see Figure 31B for an illustration).
Several residues involved in the paths we identified in
VAO are structurally conserved in EUGO and PCMH. If the
paths we identified are also present in so far uncharac-
terised VAO-, EUGO- and PCMH-like enzymes, conserva-
tion of path residues should also be observed. This would
further support the existence of the paths we have identi-
fied. We therefore performed an analysis of sequence con-
servation.
Sequence conservation of the identified migration paths
in VAO, EUGO and PCMH We analysed sequence conser-
vation in MSAVAO, MSAEUGO and MSAPCMH to establish
if the paths identified in this study are also conserved in
so far uncharacterised VAO-, EUGO- and PCMH-like en-
zymes. To this purpose, we used MSAVAO, MSAEUGO and
MSAPCMH, as described in Materials and Methods. We
also defined nine groups of residues to be analysed in de-
tail: the residues in the four paths (cap, FAD, subunit inter-
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face and re path), surface or interface residues, a random
selection of residues, residues in the cap domain and the
entire protein.
We found that within these three alignments, all se-
quences weremore similar than dissimilar (see Figure 34A
for all data). Residues in the cap path and at the surface
were least similar and conserved in all three alignments.
Residues in the FADpath and at the subunit interfacewere
most similar and conserved in all three alignments. Note
that if similarity or conservation is higher than in the en-
tire protein or the random selection, this indicates higher
selective pressure on this group of residues, and lower se-
lective pressure if the opposite is the case.
Preservation of the groups of residues analysed in this
manner should not be used as an indication of similarity
or conservation within all three sets of sequences (Figure
34A). At one position in MSAVAO, a residue can be con-
served or similar, but a different residue can be conserved
or similar in the MSAEUGO or MSAPCMH. To be able to de-
termine overall preservation of residues in all three sets
of sequences (MSAall), we continued our analysis as de-
scribed in Materials andMethods.
The results of this analysis are summarised in Figure
34B. We found that when analysing the full length MSAall,
29% of all positions were more than 90% conserved, and
25% of all positions were similar in VAO and EUGO, but
varied in PCMH (were PCMH-unlike). Residues in the
cap path were most dissimilar, and also the most PCMH-
unlike. Residues in the subunit interface path and at the
subunit interface were most similar and residues in the
FAD path and at the subunit interface were most con-
served. It is noteworthy that all dissimilar residues in the
re path are only dissimilar due to PCMH-like sequences.
It is conspicuous that the percentages of similarity and
conservation in the two analyses differ significantly due to
142 THE INS AND OUTS OF VANILLYL ALCOHOL OXIDASE
Figure 34: Sequence preservation of ligand migration paths. Preservation of residues in the entire protein, a
random selection (random), the cap domain, the subunit interface, on the surface of the protein (surface), in the
cap path, the FAD path, the subunit interface path and the re path.
A: Sequence preservation of ligand migration paths within MSAVAO, MSAEUGO andMSAPCMH.
B: Sequence preservation of ligand migration paths within MSAall.
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the preservation of different residues in VAO-, EUGO- and
PCMH-like sequences. This is reflected in the percentages
of dissimilarity and PCMH-unlikeness. Note the differ-
ence in preservation between residues in the cap domain
and the cap path, which indicates that there is less selec-
tive pressure (or selective pressure for different residues)
on residues in the cap path and the entire cap domain.
Discussion
In this study, we have identified, for the first time, lig-
and and co-ligand migration paths in a member of the
VAO/PCMH family. The process of ligand migration to
the active site is often neglected when discussing enzyme
mechanisms. The advances of computational methods
have made it feasible to study this process in more de-
tail, allowing better fundamental understanding of how
enzymes work. Here, we will first address the impli-
cations our findings have for our understanding of the
mechanism of VAO, and then expand further to cover the
close relatives PCMH and EUGO, to finally discuss what
is known about (co-)ligand migration paths in the entire
VAO/PCMH family.
The residues discussed below are possible targets for
site-directed mutagenesis to attempt to block or open a
path. The effect of such modifications on enzyme activ-
ity can then be determined experimentally. Flavoenzymes
are well suited to study enzyme kinetics using stopped
flow instruments due to their reaction mechanisms in-
volving a reductive and oxidative half-reaction.
Ligand migration paths in VAO We have identified
threemigration paths in VAO for phenolic ligands (see Fig-
ure 35 for an overview). We do not observe any prefer-
ence for a specific path for any of the three phenolic lig-
ands analysed (p-creosol, vanillyl alcohol and vanillin).
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Figure 35: Overview of the iden-
tified paths and the ligands pro-
posed to migrate through them
(uni-or bi- directional). The VAO
dimer is shown in surface repre-
sentation, with the cap domain
coloured in red and the FAD-
binding domain coloured in green
and the FAD cofactor shown as
sticks in yellow. Coloured arrows
indicate the paths for phenolic lig-
ands (cap path in orange, FAD
path in blue and subunit inter-
face path in magenta). Filled in
arrowheads indicate paths to the
si side of FAD and empty arrow-
heads paths to the re side of FAD.
Drawn out lines indicate the path
is on the side of VAO facing the
viewer, and dotted lines indicate
the path is on the back side of VAO.
Note that the two subunits are ro-
tated 180 degrees relative to each
other in the VAO dimer and that a
path pointing towards the viewer
in the right monomer is pointing
away from the viewer in the left
monomer and vice versa. The lo-
cation of the concierge residues,
His466 and Tyr503, is represented
by a black line. The portal formed
by Met192, Met195 and Glu464
is indicated by an ellipse. The
bottlenecks formed by Arg312 and
Arg398 in the cap path and Trp89
and Lys5454 in the FAD path are
represented by pentagrams and
heptagrams, respectively.
Two of these migration paths, the cap and FAD paths,
are less likely paths for these ligands. They require large
movements of amino acid side chains (namely Arg312 and
Arg398 or Trp89 and Lys545, respectively) to allow the phe-
nolic ligand to pass, which make themmore difficult pas-
sages to the active site. This can be seen in the simu-
lations, where the ligands often got stuck next to these
residues. It is also evident from the high number of atom
contacts ligands experienced with these residues. VAO
also accepts phenolic substrates with larger hydropho-
bic side chains than the ligands studied here [40]. These
larger ligands would be prone to have even more diffi-
culties passing the bottlenecks in the cap and FAD path.
Therefore, and because it represents the only entry and
exit path identified, we argue that the VAO subunit inter-
face path is the most probable route for phenolic ligands
to enter or leave the active site.
In the subunit interface path, two residues are observed
to change conformation to allow ligands to leave the ac-
tive site. These two residues, His466 and Tyr503, do not
present obstacles for the migration of the ligands but are
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Dioxygen and hydrogen peroxide
have very different electrochemi-
cal properties, but use the same
path. This indicates that no elec-
trochemical bottleneck exists in
the re path, making the size of the
ligands the most important crite-
rion. Given that dioxygen and hy-
drogen peroxide are similar in size
and the channel through which
they pass is comparably big, both
use the same path.
in a closed conformation once a ligand is bound. Our re-
sults suggest a dual role for Tyr503, which is known to be
involved in substrate deprotonation [49], and which we
can show here to be also involved in substrate migration.
His466 and Tyr503 can be regarded as concierges, limit-
ing access to the active site. Interestingly, in the crystal
structure of PCMH (PDB ID: 1DII [56]), two possible con-
formations are observed forHis436 andTyr473, which cor-
respond to His466 and Tyr503 in VAO (see Figure 31A for
an illustration). We would also like to highlight Met195
as the most flexible of the three portal residues to com-
plete the list of flexible and probably functionally impor-
tant residues in this path. It is of interest to keep in mind
that this path shows that the two active sites of the VAO
dimer are connected via this portal.
We were also able to demonstrate that protonated phe-
nolic substrates enter the enzyme but deprotonated ones
do not. Energy profiles of exit simulations also indicate
more favourable binding of the protonated substrates and
indifference towards the protonation state of the product.
We have also identified an additional migration path, the
re path for the co-ligands dioxygen and hydrogen perox-
ide. This path leads co-ligands to and from the re side of
FAD. The co-ligands were also able to migrate through the
paths identified for the phenolic ligands. The re path is the
shortest connection to the solvent, compared to the paths
on the si side of FAD. On the re side of FAD, a chloride
ion present in the VAO crystal structure (PDB ID: 1VAO)
is indicative of a possible oxygen binding site [27, 247].
There is no evidence from binding energies calculated in
our simulations that the si path is preferred. Our simula-
tions were performed with oxidised FAD, and while dioxy-
gen reacts with reduced FAD, there are no indications of
significant conformational changes in VAO crystal struc-
tures linked to the changed oxidation state of FAD (PDB
ID: 1VAO vs PDB ID: 1AHU). All these observations make
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the re path the most probable migration path for dioxy-
gen and hydrogen peroxide. In this path, it is possible that
Tyr51 is involved in directing dioxygen to the FAD, as it
is one of the most contacted and flexible residues in this
path. It is also located in the probable oxygen-binding
pocket on the re side of FAD, making it a candidate for as-
sisting in reduced flavin oxidation.
From our results of the co-ligand simulations on the si
side of FAD, we can see that co-ligands tend to migrate
into the cap path. Crystallographic data (PDB ID: 1VAO)
show that within the cap path, water molecules are lo-
cated close to Arg312 and Arg398 as well as at the paths
exit/entry on the surface of VAO. Water is able to access
the active site and to participate in the reaction on the si
side of FAD, reacting with the quinone methide of certain
substrates [223]. The cap path is the only path at the si
side of FAD directly connected to the solvent. In the case
of binding of alkylphenolswith hydrophobic aliphatic side
chains, already boundwatermolecules would likely be ex-
pulsed from the active site via the cap path. This would
explain why these substrates are dehydrogenated and not
hydroxylated by VAO [37].
Structure and sequence conservation in VAO, EUGO and
PCMH We will now discuss our findings in VAO in the
context of the close bacterial relatives EUGO and PCMH.
All three enzymes require their substrates to be para-
substituted phenols [36, 40, 55, 56, 238].
In PCMH and EUGO, a possible route for substrate ac-
cess to the active site via the subunit interface has been
suggested purely on crystallographic evidence [56, 202].
In this route, three residues (Glu177, Met180 and Asp434
in PCMH) have been proposed to be involved. These
residues are Asp192, Met195 and Glu464 in VAO, with
Asp192 being in the position of Glu177 and Glu464 in the
position of Asp434. EUGO has recently had its crystal
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structure solved [202]. In EUGO, all the above-mentioned
residues involved in the subunit interface path of VAO are
also present (Figure 31).
We could show that residues at the subunit interface
and in the subunit interface path are themost similar in all
three of these closely related members of the VAO/PCMH
family, an indication that increased selective pressure is in
place for these residues. Additionally, the combination of
this increased selective pressure and the presence of the
entrance/exit migration path at the subunit interface (and
absence of evidence of allosteric regulation in VAO) could
indicate that dimerisation of VAO is functionally linked to
ligand migration. Residues in the cap path are most di-
verse in all three enzymes. This lends support to the pro-
posal that all three enzymes prefer the subunit interface
path for ligand migration. The small amount of PCMH-
like sequences remaining in the analysis after applying our
selection criteria makes interpretation of the data with re-
spect to PCMH less reliable.
VAO and EUGO re-oxidise their FAD cofactor using
molecular oxygen, while PCMH requires a cytochrome c
subunit for this. This functional difference is reflected
in the preservation of the re path in these enzymes (see
specifically the PCMH-unlike category in Figure 34B). In-
terestingly, dissimilarity in the residues of this path is only
due to PCMH-like sequences and not due to differences
between the two oxidases. It is noteworthy that the re
path we identify here is located in a visible channel in VAO
and EUGO. In PCMH, the channel is absent and the cy-
tochrome c subunit in PCMH is located where dioxygen
would exit the protein (see Figure 31B). Evolution of the re
path in these oxidases may thus have coincided with loss
of the cytochrome c subunit.
The strong conservation of residues in the FAD path
could indicate that these residues are essential to the func-
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tion of all three enzymes. It has been established thatmat-
uration of the VAO holoenzyme involves the initial non-
covalent binding of the FAD cofactor to the already folded
dimeric apoenzyme [14, 41]. It could be that FAD binds to
the apoenzyme via this path. A possible scenario is that
FAD enters the enzyme with the isoalloxazine moiety first
and then binds to the enzyme in the correct orientation
already. The alternative scenario, in which FAD binds with
its ADP moiety first, would require reorientation of the
FAD inside the enzyme to fit the isoalloxazine moiety into
the active site. From the crystal structure, it is not evident
how this would happen as the free space around bound
FAD is rather limited. Initial binding of FAD to the en-
zyme surface andmigration of FAD into its binding pocket
is likely guided by pi stacking interactions with the three
tryptophans located in the FAD path (Trp98, Trp549 and
Trp558).
What is known about (co-)ligand migration in the en-
tire VAO/PCMH family? Very little is known about sub-
strate access to the active site for the other members of
this flavoprotein family. Dioxygen migration has been
studied in alditol oxidase, berberine bridge enzyme (also
called (S)-reticuline oxidase) and L-galactono-1,4-lactone
dehydrogenase. Ala113 in L-galactono-1,4-lactone dehy-
drogenase was identified as a gatekeeper residue that pre-
vents the enzyme from functioning as an oxidase [248].
Berberine bridge enzyme also contains such a gate-keeper
residue. The variant G164A showed 800-fold decreased
oxygen reactivity [249]. In alditol oxidase funnel shaped
paths have been identified through molecular dynamics
simulations, leading dioxygen to the “gatekeeper” Ala105
in alditol oxidase and from there to N1/N3 of the flavin
ring [240]. This path leads to the re side of FAD, as does
the re path we identified in this study. Our path, however,
leads to its destination via the dimethylbenzene part of the
flavin ring. We have therefore identified for the first time
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a substrate migration channel, the subunit interface path,
and a novel co-substrate migration path.
In summary, we have carried out an exhaustive compu-
tational analysis of ligandmigration pathways in VAO (see
Figure 35 for an overview). We have identified a gated en-
try and exit path at the subunit interface of VAO for small
phenolic ligands. The residues forming a portal in this
path (Met192, Met195 and Glu464 in VAO) are conserved
in PCMH and EUGO. Two residues, His466 and Tyr503 in
VAO, act as concierges, obstructing the path to the active
site for phenolic substrates once substrate is bound, as has
been postulated before for PCMH [56]. An additional, dif-
ferent entry and exit path for dioxygen and hydrogen per-
oxide at the interface of the two domains of VAO has been
identified (re path). Tyr51 in this path could assist reduced
flavin oxidation in VAO. The only path identified directly
connecting the si side of FAD to the solvent (the cap path)
could be facilitatingwater access to the active site. Overall,
our study illustrates the ability of ligand simulation tech-
niques to advance the mechanistic understanding of en-
zyme function.
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Materials and methods
System set-up The initial coordinates for the VAO protein were taken
from the 1VAO entry in the protein data bank (PDB) [40]. Although the
protein is assembled as an octamer, due to computational limitations
only the dimer, the smallest functional unit of VAO, was modelled. No
allosteric regulation has been observed for VAO in its dimeric or oc-
tameric oligomerisation state. Loop deletion mutagenesis has revealed
that the VAO dimer has similar catalytic properties as the octamer [39].
The protein structure was prepared assisted by the protein preparation
wizard available in the Schrödinger software package [250]. All crys-
tal water molecules were removed and missing hydrogen atoms were
added to protein residues. Residues such as histidines, glutamates and
aspartates were inspected for appropriate protonation states at pH 7.5
to match experimental conditions. PROPKA [251] and H++ web server
(http://biophysics.cs.vt.edu/H++) [252] were employed to deter-
mine the pK a of each residue. His56, His61, His313, His506 and His555
were modelled as ε protonated while all other His residues were δ pro-
tonated. Furthermore, the NE2 atom in the imidazole ring of His422 has
no hydrogen atom since it is covalently bound to the C8M atom of the
FAD cofactor and considered to be neutral. Missing residues from posi-
tion 41 to 47, forming a loop at the surface of the protein, were added and
minimised using PRIME [253].
The final system was composed of a total of 17’674 atoms. Six phe-
nolic and two small ligands were used including: COP, COD (p-creosol,
where the P and D refer to the protonated and deprotonated state of
the ligand; this notation is identical for all molecules), VAP, VAD (vanillyl
alcohol) VNP, VND (vanillin) and dioxygen and hydrogen peroxide. All
charges for the FAD cofactors were obtained through quantummechan-
ics/molecular mechanics (QM/ MM) calculations inside the protein en-
vironment with an 8 Å layer of explicit waters. The QM region included
all the isoalloxazine ring atoms and the QM/MM cut was made between
the C1 and C2 atoms of the FADmolecule. All the ligands were optimized
through QM calculations in an implicit solvent. QM/MM calculations
used the all atom OPLS2005 force field [254], M06 functional [255] with
the 6-31G∗∗ basis set [256] and Poisson Boltzmann Finite element (PBF)
implicit solvent [257] (same functional and basis set used in QM). The
parameter files for all ligands and the FAD cofactor are supplied as sup-
plementary information S1.
Ligandmigration PELE [67] was used to map the migration (exit and
entry) path of different ligands between the VAO active site and the sol-
vent. PELE is a Monte Carlo based algorithm that produces putative
new configurations through a sequential ligand andprotein perturbation
scheme, side chain prediction and minimisation steps. A detailed de-
scription of the PELE methodology can be found elsewhere [67]. Ligand
perturbation involves a random translation and rotation, while protein
perturbation involves a displacement on the alpha carbon following one
go the six lowest Anisotropic Normal Modes (ANM) [258]. These steps
compose a move that is accepted (defining a new minimum) or rejected
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based on a Metropolis criterion for a given temperature. The combina-
tion of ligand and protein backbone perturbations results in an effec-
tive exploration of the protein energy landscape. This approach is ca-
pable of reproducing large conformational changes associated with lig-
and migration and has already been shown to produce reliable results
[259, 260, 261].
For the entry simulations, the ligand was placed in six different po-
sitions at the bulk solvent. Similar parameters to the exit simulations
were used, but with larger translations (from 1.25 and 2.5 Å) during sub-
strate perturbations. The direction of such perturbations was kept for
three consecutive steps. Moreover, for the entry simulations an adaptive
scheme was used (using the new C++ version of PELE [68] plus an OBC
solvent [262]). After a short simulation of 12Monte Carlo steps, the adap-
tive scheme clustered the ligand position and new initial conditionswere
chosen, prioritizing those clusters with less population. Due to the use of
different versions of PELE, the binding energies differ by a level ofmagni-
tude for ligandsmigrating in and out of VAO (see Results). In this context,
it is important to note that the binding energies calculated by PELE are
indicative of favourable or unfavourable positions for the ligand. While
we refer to them as binding energies, they are interaction internal ener-
gies between the protein and the ligand, with a significant larger value
than experimental ones, and should be analysed in a qualitativemanner.
The exit simulation protocol was identical for all substrates and be-
gan by manually docking the phenolic molecule (COP, COD, VAP, VAD,
VND,VNP) to the si side of the isoalloxazine ring of the flavin in the ac-
tive site based on crystallographic evidence from the VAO structure with
isoeugenol (PDB ID: 2VAO) [40]. Simulations were performed in equal
number starting from both protein subunits. The phenolic ligand was
then perturbed with random translations (from 0.75 and 1.75 Å) and ro-
tations (0.05 and 0.25 rad) and requested to move away from the active
site using PELE’s spawning procedure. This procedure selects a reaction
coordinate (e.g. an atom-atom distance, ligand RMSD) and abandons
the trajectories with worst values in the reaction coordinate to restart
the simulation at the best value (which is constantly updated). Trajec-
tories are abandoned only if they fall behind a user-defined range (from
the best value). In our case, the spawning coordinate was the distance
of the ligand center of mass to a point in the void volume of the active
site (X, Y, Z coordinates 92, 25, 41 or 108, 47, 70 for simulations starting
in the active site of chain A or B, respectively), with the distance range
from the spawning coordinate being 4 Å. Protein perturbation was based
on the six lowest normal modes [263] and side chain sampling including
all residues within 8 Å from the ligand. Finally, after global minimisation
had optimised the new configuration, this configurationwas filteredwith
aMetropolis acceptance test. In this test, the energy is described with an
all atom OPLS 2005 force field [254] with a surface generalized Born sol-
vent model [264]. Simulations were stopped when the wall clock limit
time (48h) was reached or the phenolic ligand exited the protein com-
pletely. A total of 800 independent trajectories were produced for each
ligand.
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Simulations exploring exit paths from the active site of the small
ligands dioxygen and hydrogen peroxide were performed using a non-
biased approach as described previously [260], using random transla-
tions and rotations appropriate to achieve continuous paths (between
0.5 and 1.5 Å and 0.1 to 0.3 rad, respectively).
Data analysis was performed using VMD (Version 1.9.1, [265]), Py-
MOL (The PyMOL Molecular Graphics System, Version 1.7 Schrödinger,
LLC.), and R (Version 3.3.1 [226]). Figures were created using the afore-
mentioned programs, with the addition of GnuPlot (Version 4.4 [266])
and ChemDraw (Version 15.1.0.144, PerkinElmer Informatics).
Atom contacts between the ligands and the protein were calculated
using a python script. A contact was defined as a distance smaller than
2.7 Å between an atom from any given residue and an atom belonging to
the ligand. Root mean square fluctuation (RMSF) values of residues in
the simulations were calculated using VMD (Version 1.9.1, [265]). Only
RMSF values from residues in the chain of the dimer where the ligand
was placed were used for the analysis.
Protein structure comparison To compare the structural conservation
of path residues, the crystal structures of VAO, EUGO and PCMH (1VAO,
5FXE and 1DII respectively) were aligned using the PROMALS3D multi-
ple sequence and structure alignment server [267]. The crystal structures
were also compared using PyMOL (The PyMOLMolecular Graphics Sys-
tem, Version 1.7 Schrödinger, LLC.) and the built in alignment function.
Protein sequence comparison To compare the sequence conserva-
tion of path residues, a set of VAO-, EUGO- and PCMH-like sequences
was identified. The protein sequences from crystal structures 1VAO,
1DII and 5FXE were used as queries for similarity searches with Con-
surf [268], searching the uniref90 database using default settings for the
search of homologs. This approach resulted in three alignments (one
each for VAO-, EUGO- and PCMH-like sequences). The obtained align-
ments were manually checked and VAO- and EUGO-like sequences that
did not contain a histidine residue corresponding to His422 and His390
respectively were removed. PCMH-like sequences not containing a tyro-
sine residue corresponding to Tyr384 were removed as well. This selec-
tion was made because the named residues covalently bind the FAD co-
factor, which has a significant impact on enzyme function [238, 41, 202].
The homology search resulted in 121, 117 and 30 VAO-, EUGO- and
PCMH-like sequences remaining in the respective alignments (named
MSA VAO , MSA EUGO and MSA PCMH, respectively). These align-
ments where then merged using the MAFFT webserver (mafft.cbrc.
jp/alignment/software/merge.html) tomatch the residue positions
(resulting in MSAall). The alignments were then uploaded to Consurf
[267] to calculate the residue variety in percentages, always using the pdb
structure 1VAO as query. This approach ensures that the same alignment
positions are compared when the preservation of different residues in
the three alignments is compared as described below; e.g. that residue
number 422 in VAO is always compared to the residue present in the
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other sequences at the corresponding position in the three alignments.
All alignments (MSAVAO, MSAEUGO, MSAPCMH and MSAall ) can be
found as supplementary information S1 Alignment.fa, S2 Alignment.fa,
S3 Alignment.fa and S4 Alignment.fa, respectively.
An R script was used to analyse the preservation of different groups
of residues in these alignments, amongst which residues involved in
the paths identified in this study. We defined nine different groups of
residues: the entire protein (560 amino acids), residues forming the cap
domain (from residue 270 to 500), the re path residues (22 residues),
the FAD path residues (36 residues), the cap path residues (25 residues),
the subunit interface path residues (53 residues), a selection of random
residues (58), surface residues of VAO (90 residues) and residues at the
subunit interface (86 residues). Surface residues were defined using the
built in tool of the SwissPDBviewer, with default settings (30% accessibil-
ity of residues by solvent in dimeric VAO) [269]. Interface residues,mean-
ing residues at the subunit interface, were defined as residues within 4 Å
of either subunit.
Preservation of these residues was analysed based on similar or dis-
similar residues. Similar residues were defined according to the BLO-
SUM62 similarity parameters [270], resulting in six sets of residues (Trp,
Tyr and Phe; Met, Ile, Leu and Val; His, Arg and Lys; Asn, Asp, Gln and
Glu; Ser, Thr, Pro Ala and Gly; and Cys).
The preservation of residues was analysed per position in the align-
ments and a cutoff of 50% preservation was used to categorise them as
similar in the alignment. If preservation of the similar residueswas above
90%, they were categorised as conserved in the alignment. This analysis
was performed for MSAVAO, MSAEUGO and MSA PCMH, for each of the
nine groups of residues. This resulted in a percentage of similarity and a
percentage of conservation for each group of residues for each sequence
alignment of VAO-, EUGO- and PCMH-like sequences.
This analysis did not yet allowus to compare the conservation or sim-
ilarity of these three alignments to each other. Different residues can be
preserved in each of the three alignments, but wewere interested in find-
ing out howmany residues are preserved in all three alignments (MSAall).
We therefore performed the following analysis: we used the same defini-
tions for similarity and conservation as above, but this time analysed the
preservation of the nine groups of residues in MSAall. We added addi-
tional categories to this analysis: dissimilar and PCMH-unlike. Dissim-
ilar positions were defined as positions less than 50% similar. PCMH-
unlike positions are dissimilar positions for which VAO-like and EUGO-
like sequences share a similar residue, but differ from PCMH. This re-
sulted in percentages of similarity and conservation as well as percent-
ages of dissimilarity and PCMH-unlikeness.
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Supplementary Figures
Supplementary Figure 3: Three-
dimensional structures of VAO,
EUGO and PCMH. Proteins (PDB
IDs: 1VAO, 5FXE, 1DII) are shown
as cartoons. The cap domain is
coloured in red, the FAD-binding
domain in green and FAD is shown
as yellow sticks.
A: Octameric VAO, seen from the
front.
B: Dimeric VAO as seen in Fig 1.
C: Octameric VAO seen from the
side.
D: Dimeric EUGO, using the same
colouring scheme as for VAO.
E: Tetrameric PCMH, using the
same colouring scheme as for
VAO, with the cytochrome c sub-
unit coloured in blue.
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Supplementary Figure 4:
Overview of the exit paths
identified with VAP and VAD
(A), RMSF and atom contacts (B
for VAP, C for VAD) and binding
energies (D).
A: The VAO dimer is shown as
cartoon in grey and its FAD
cofactor is shown as sticks in
yellow. The paths identified in this
work are shown through sphere
representation of ligand positions
in the trajectories. The cap path is
coloured in orange, the FAD path
in blue and the subunit interface
path in magenta.
B: Plot of simulations with VAP,
highest RMSF values (black box-
plot boxes) and atom contact
counts with the ligand (grey
boxplot boxes) of residues in VAO.
Coloured filling of the boxplots
indicates that the residue belongs
to the path of that colour.
C: Plot of simulations with VAD,
highest RMSF values (black box-
plot boxes) and atom contact
counts with the ligand (grey
boxplot boxes) of residues in VAO.
Coloured filling of the boxplots
indicates that the residue belongs
to the path of that colour.
D: Scatterplot of binding energies
as a function of the distance
between the VAP and VAD (in
green and black) to FAD.
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Supplementary Figure 5:
Overview of the exit paths
identified with VNP and VND
(A), RMSF and atom contacts (B
for VNP, C for VND) and binding
energies (D).
A: The VAO dimer is shown as
cartoon in grey and its FAD
cofactor is shown as sticks in
yellow. The paths identified in this
work are shown through sphere
representation of ligand positions
in the trajectories. The cap path is
coloured in orange, the FAD path
in blue and the subunit interface
path in magenta.
B: Plot of simulations with VNP,
highest RMSF values (black box-
plot boxes) and atom contact
counts with the ligand (grey
boxplot boxes) of residues in VAO.
Coloured filling of the boxplots
indicates that the residue belongs
to the path of that colour.
C: Plot of simulations with VND,
highest RMSF values (black box-
plot boxes) and atom contact
counts with the ligand (grey
boxplot boxes) of residues in VAO.
Coloured filling of the boxplots
indicates that the residue belongs
to the path of that colour.
D: Scatterplot of binding energies
as a function of the distance
between the VNP and VND (in
green and black) to FAD.
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Supplementary Figure 6: Detailed
view of the portal connecting the
subunit interface to the active site
formed by Asp192, Met195 and
Glu464. Asp192, Met195 and
Glu464 are shown as spheres (with
carbons in violet) within dimeric
VAO (in grey) with FAD shown as
sticks (in yellow). A: The dimer
as cartoon from the front. B: The
dimer seen from the top as mesh.

Chapter 6:
Quantum chemicalmodelling of vanillyl al-
cohol oxidase
This chapter is based on:
G. Gygli, X. Sheng, F. Himo andW. J. H. van Berkel. Manuscript in preparation.
Keywords: Adduct, creosote, density functional theory, flavoprotein,
lignin, natural product, quantum chemistry, vanillin

CHAPTER 6 161
Abstract
The flavoenzyme vanillyl alcohol oxidase (VAO) catalyses
the two-step reaction of p-creosol to vanillin. This reac-
tion is of interest for the production of natural vanillin,
but is slowed down by the formation of a covalent flavin-
creosol adduct. We have studied different possible reac-
tion mechanisms, and identified the most energetically
favourable one for each reaction step.
In both reaction steps, the transfer of a hydride from the
substrate to the flavin initiates the reaction, yielding a p-
quinone methide intermediate. The experimentally ob-
served lifetimes of these two intermediates are however
different, and are in agreement with the energy barriers
we have calculated.
The relative energy barriers of the productive reaction
(leading to vanillyl alcohol) are higher than those of the
non-productive reaction (leading to the covalent adduct).
The relative energies of the vanillyl alcohol product and
the adduct are however comparable. Adduct formation is
therefore kinetically favoured. The short side chain of p-
creosol enables Asp170 to initiate adduct formation. With
bulkier substrates, e.g. vanillyl alcohol, Asp170 is unable
to attack and no adduct is formed.
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Scheme 1: Two-step enzymatic
conversion of p-creosol to vanillin.
Introduction
Vanillyl alcohol oxidase (VAO) is a flavoenzyme capa-
ble of catalysing the conversion of p-creosol to vanillin,
see Scheme 1 [271, 272]. The intermediate of this re-
action, vanillyl alcohol, is also a substrate of the en-
zyme. It is therefore possible to synthesise natural vanillin
from natural p-creosol with VAO [272]. p-Creosol (4-
methylguaiacol) is the secondmost abundant component
in beechwood creosote [273], and a product of lignin py-
rolysis [274, 275]. Vanillin production from lignin or wood
[276, 277] could therefore profit from using VAO. Unfortu-
nately, the reaction of VAOwith p-creosol is severely ham-
pered by the formation of a covalent adduct between p-
creosol and VAO’s FAD cofactor [45]. The mechanism of
adduct formation is poorly understood, opening the door
for this computational study.
VAO is a fungal enzyme, which has structural and cat-
alytic properties in common with several bacterial ho-
mologs, e.g. p-cresol methylhydroxylase (PCMH) and
eugenol oxidase (EUGO) [56, 55, 202]. VAO is a mem-
ber of the VAO/PCMH family, a highly diverse family of
flavoenzymes [196]. VAO, PCMH, and EUGO are part of
the 4-phenol oxidising subgroupof this family [196]. Upon
binding of the phenolic substrates to VAO, the pheno-
late is formed through the action of two tyrosine residues
(Tyr108 and Tyr503) [49]. See Figure 36 for an illustration
of these and other active site residues. Two tyrosines are
also involved in binding the phenolic substrates of pheno-
lic acid decarboxylases [278, 279] and hydroxycinnamoyl-
CoA hydratase-lyase [280].
The catalytic mechanism of VAO has been demon-
strated to operate via a p-quinone methide interme-
diate [36, 223]. Phenolic acid decarboxylases and
hydroxycinnamoyl-CoA hydratase-lyase have also been
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Figure 36: Cofactor interaction di-
agram of VAO. The covalent bond
between His422 and the flavin co-
factor is drawn and the atoms
of the flavin isoalloxazine ring
and the ribityl chain are num-
bered. The ribityl chain is cut
off at C5, and the remainder of
the flavin (FAD) molecule is ab-
breviated as R. Cyan indicates po-
lar, green hydrophobic, red nega-
tively charged and violet positively
charged amino acid residues.
shown and suggested to operate via a p-quinone methide
intermediate [278, 279, 280]. In VAO, the first step of the
reaction of p-creosol to vanillin (Scheme 1), i.e. the con-
version of p-creosol to vanillyl alcohol, is extremely slow
because of the formation of a covalent adduct between
enzyme-bound flavin and p-creosol [45]. For the second
reaction step, the conversion of vanillyl alcohol to vanillin,
reduction of the flavin is rate-limiting [223]. Note that only
the first reaction step requires water as a reactant, and that
the overall reaction is rate limited by the decomposition of
the covalent adduct.
Interestingly, residues remote to the active site appear
to influence the life-time of the adduct [45]. While in-
sight has been gained in the mechanism for the conver-
sion of vanillyl alcohol to vanillin [223], the enzymatic
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conversion of p-creosol to vanillyl alcohol remains puz-
zling. The substrate analogue p-cresol is an excellent sub-
strate for PCMH, but also gives rise to a covalent adduct
in VAO [45]. The active sites of VAO and PCMH vary sig-
nificantly and are likely the source of this different reactiv-
ity. However, the influence of remote residues on VAO ac-
tivity remains cryptic. The lifetime of the p-quinone me-
thide intermediate is different for different substrates. The
intermediates of 4-(methoxymethyl)phenol and vanil-
lyl alcohol can be observed experimentally in stopped-
flow kinetic experiments. The p-quinone methide of 4-
(methoxymethyl)phenol is rather stable in the reduced
enzyme, while the p-quinone methide of vanillyl alcohol
rapidly decomposes to form vanillin [223].
We have studied the reaction mechanism of the VAO-
mediated two-step reaction of p-creosol to vanillin in de-
tail with density functional theory (DFT) calculations em-
ploying the cluster approach [69, 281, 282, 283, 284]. Based
on the optimised structures of the species along the reac-
tion coordinate and the calculated relative energies, we
shed more light on this reaction. The possible mecha-
nisms for this reaction are shown in Figure 37 and sum-
marised here. The red pathway labelled with I denotes
the productive reaction from p-creosol to vanillyl alco-
hol (Figure 37A), the black pathway labelled with Add-
I denotes the non-productive reaction leading to the p-
creosol-flavin-adduct (Figure 37B), and the blue pathway
labelled with II denotes the second reaction step leading
to vanillin (Figure 37C).
In the active site, the phenolate of p-creosol is formed
immediately upon binding (React-I, in red in Figure 37A).
We can therefore neglect the protonated substrate in
our calculations. p-Creosol reduces the flavin cofactor
throughhydride transfer to theN5 of the isoalloxazine ring
of oxidised flavin, yielding the p-quinone methide inter-
mediate (InterI-I in Figure 37A). The productive reaction
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Figure 37: Proposed mechanis-
tic steps of the reaction of p-
creosol to vanillin via vanillyl alco-
hol, based on experimental work
[43, 223, 271] and the calculations
in the present study.
A) Productive reaction of p-creosol
to vanillyl alcohol.
B) Adduct formation from the cre-
osol p-quinone methide interme-
diate.
C) Reaction of vanillyl alcohol to
vanillin. See text for details.
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(in red or grey in Figure 37A) proceeds without adduct
formation, directly forming vanillyl alcohol by water ad-
dition to the p-quinone methide of p-creosol (Prod-I in
Figure 37A). This water addition could be facilitated by
Asp170 acting as proton acceptor (in gray in Figure 37A).
Alternatively, as shown in the mechanism coloured in red
in Figure 37A, the O4H of FAD could be deprotonated by
transferring a proton back to the product, while Asp170
simultaneously attacks the proton of the substrate. This
terminates the reductive half-reaction of the first reac-
tion step. Dioxygen then oxidises the reduced flavin and
releasing hydrogen peroxide completes this first reaction
step (Asp170 also needs to be deprotonated, not shown).
The non-productive reaction to the adduct is coloured in
black in Figure 37B (Inter1-I to Inter2Add-I and ProdAdd-
I). This can happen through the action of Asp170, which
attacks the proton at flavin N5H (yielding protonated
Asp170) and the addition of flavin N5 to the substrate
p-quinone methide intermediate (yielding the adduct,
ProdAdd-I). In theory, this could happen in a concerted
fashion or stepwise (with either of the two steps first or
second). Once the adduct is formed, water addition to
the adduct hypothetically could yield vanillyl alcohol (not
shown in Figure 37B).
To begin the second reaction step, the produced vanil-
lyl alcohol is bound to the active site in its phenolate form
(React-II, in blue or grey in Figure 37C). Vanillyl alcohol
bound to the enzyme then reduces oxidised flavin through
hydride transfer to flavin N5 (Inter-II, in blue in Figure
37C). The p-quinone methide of vanillyl alcohol then de-
composes to the aldehyde (vanillin) through proton trans-
fer to Asp170 (yielding protonated Asp170, Prod-II in blue
in Figure 37C). In theory, these two transfers (hydride
and proton) could happen in a concerted fashion or step-
wise (with either of the two transfers first or second, see
blue and grey alternatives in Figure 37C). To complete the
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redox-cycle, dioxygen again oxidises reduced flavin and
Asp170 is deprotonated (not show in Figure 37C).
Results
We have studied the reductive half-reactions of the two-
step conversion of p-creosol to vanillin by using quantum
mechanical calculations. For this, we have built active site
models for the reaction of p-creosol to vanillyl alcohol and
for the reaction of vanillyl alcohol to vanillin (see Figure 38
for an overviewof these active sitemodels). On the basis of
these models, we optimised the structures of the interme-
diates and transition states along the reaction coordinates
and calculated the energy barriers. We will first describe
the results for the reaction of p-creosol to vanillyl alcohol,
and then the results for the reaction of vanillyl alcohol to
vanillin.
Active site models The crystal structure of VAOwith the
inhibitor isoeugenol bound was chosen to build the ac-
tive site model (PDB ID: 2VAO, [40]). The model consists
of the substrate p-creosol or vanillyl alcohol in place of
the isoeugenol inhibitor, the FAD cofactor and the follow-
ing residues that make up the active site: Tyr108, Asp170,
Arg398, His422, Tyr503 and Arg504. These residues were
included in the model because of their (proposed) in-
volvement in the reaction mechanism. The FAD cofactor
is oxidised, with the ribityl chain cut off at the C3, thus
containing one hydroxyl group at C2 andC3, and an added
hydrogen atom to saturate C3. The model therefore con-
sists of 165 atoms and has a total charge of +1, see also
Figure 38. Non side-chain atoms were removed, except al-
pha carbons, and hydrogen atoms were added to saturate
these alpha carbons. The positions of these hydrogens as
well as the alpha carbons were kept fixed to their crystal-
lographic positions during all the geometry optimisations.
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Figure 38: Optimised structures of
the active site models used in this
study. His422 is located behind the
FAD cofactor and is not labelled
for clarity. The ribityl side chain of
the FAD cofactor is also shown as
lines for clarity. Selected hydrogen
bonds are shown as thin, dashed
lines.
React-I: Active site model with p-
creosol (in red).
React-II: Active site model with
vanillyl alcohol (in cyan) without a
water molecule.
React-II’: Active site model with
vanillyl alcohol (in cyan) and awa-
ter molecule.
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Two of the hydroxyl groups of the ribityl chainwere kept in
the model because of their interaction with the isoallox-
azine ring observed in the crystal structure. The substrate
was positioned in analogy to the binding mode of the in-
hibitor isoeugenol. The hydroxyl group of the phenol (ori-
ented towards Tyr108 and Tyr503) was assumed to lose its
proton upon binding to the active site, based on experi-
mental evidence [49]. The substrate is therefore modelled
in the deprotonated state. Tyr108, Arg398, His422, Ty503
and Arg504 were modelled in their respective protonated
state. A water molecule was included in active site model
React-I (see Figure 38), since it is required for the hydrox-
ylation of p-creosol. The reaction from vanillyl alcohol to
vanillin does not directly involve the water molecule, but
its presence influences the protonation state of Asp170, as
well as the calculated relative energy barriers (see Figures
38 and 41, React-II and React-II’). During geometry opti-
misation of the models for React-I and React-II, Asp170
always abstracts a proton from Arg398. This is possibly an
artefact caused by lacking interactions with residuesmiss-
ing in our active site model.
The reaction of p-creosol to vanillyl alcohol The en-
ergy profile and the optimised structures of all the species
along the reaction are given in Figures 39 and 40, respec-
tively. To our surprise, after the hydride transfer, only the
O4 of FAD can act as the general base to abstract the pro-
ton of water molecule during the hydroxylation. We could
not locate a transition state of the Asp170 as proton accep-
tor. All attempts converged to structures of the interme-
diate. Even more interestingly, a proton transfer can take
place from FAD-O4H to Asp170 with an extremely low en-
ergy barrier, resulting in the formation of the final product
of this half reaction (more discussion below). This reac-
tion mechanism has feasible energy barriers on the basis
of our calculations.
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Figure 39: Energy profiles of the
reaction of p-creosol to vanillyl al-
cohol. Labels are the same as used
in Figure 37. Energies are given in
kcal/mol. Starting from active site
model React-I, the red solid lines
indicate the stationary points of
this reaction. The black solid lines
indicate the stationary points of
the adduct formation (to ProdAdd-
I, described later in the text).
The first mechanistic step of the reaction from p-
creosol to vanillyl alcohol proceeded via a p-quinone me-
thide intermediate (React-I to Inter1-I, via TS1-I in Figures
39 and 40). During the initial step of the hydride trans-
fer from the substrate to the FAD, the isoalloxazine ring
twisted slightly to allow transfer of the hydride. The isoal-
loxazine ring did not become fully planar again with in-
termediate formation. The energy barrier of the hydride
transfer from p-creosol to FAD was calculated to be 16.0
kcal/mol compared to React-I (Figure 39). In the corre-
sponding transition state (TS1-I), the distance of the form-
ing N-H bond is 1.3 Å, and that of the breaking C-H bond
is 1.4 Å. The calculated energy of the resulting intermedi-
ate is 0.8 kcal/mol higher than the React-I, and the Asp170
residue is in its deprotonated state as a result of the proton
transfer back to Arg398.
The second mechanistic step of this reaction, the hy-
droxylation of the p-creosol quinone intermediate (Inter1-
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Figure 40: Optimised structures of
the species involved in the sug-
gested mechanism of the reaction
of p-creosol to vanillyl alcohol.
Distances are given in angstrom,
with the thick dashed lines provid-
ing context for the transition state.
Thin dashed lines show selected
hydrogen bonds. Otherwise, the
representation is the same as in
Figure 38.
I in Figures 37B, 39 and 40), proceededwith an energy bar-
rier of 13.1 kcal/mol compared to React-I. The formed in-
termediate (Inter2-I) is 1.0 kcal/mol lower in energy than
React-I. The hydroxylation was assisted by the O4 of FAD,
see mechanism in Figure 37B (in red). In the correspond-
ing transition state (TS2-I), the distance of the forming O-
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C bond is 1.9 Å, and that of the breaking O-H bond of the
watermolecule is still 1.0 Å. After the formation of the sec-
ond intermediate (Inter2-I), this reaction proceeds via a
proton transfer from the FAD-O4H to Asp170. In the cor-
responding transition state (TS3-I), the distance between
the breaking O-H bond from FAD(H) to the substrate(O)
is 1.5 Å, and that of the breaking O-H bond from sub-
strate(O) to the substrate(H) is 1.2 Å (see Figure 40 for de-
tails). This step is calculated to be barrier-less, and the en-
ergy of the thus obtained product Prod-I is -3.9 kcal/mol
lower in energy than React-I (Figure 39). It is should be
noted here that for Inter1-I and Inter2-I we have also op-
timised the structures with protonated Asp170 residue.
However, they are higher in energy compared to Inter1-I
and Inter2-I, and thus are not reported here.
Alternative mechanisms For the substrate, different
conformations have been optimised. One of them worth
mentioning here is the one with the water molecule more
“remote” from the substrate compared to React-I. We con-
sidered these conformations because different locations
of this water molecule are observed in different crystal
structures. This “remote” structure has a similar energy
to the structure described above, and the calculated bar-
rier of the hydride transfer starting from this substrate is
also very similar to the one above. After the formation of
the quinone intermediate, the “remote” conformation re-
quired the rearrangement of the water molecule to reach
a conformation enabling hydroxylation of the substrate.
This rearrangement resulted in identical conformations
and energies as the reaction path described above. We
have indications that a concerted mechanism for the pro-
ductive reaction is energetically infeasible, with optimi-
sations of the corresponding transition state always con-
verging to the intermediate.
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Figure 41: Optimised structures of
the stationary points of the reac-
tion of p-creosol to the covalent
FAD-adduct. Labels are the same
as used in Figure 39. Distances
are given in angstrom, with the
thick dashed lines providing con-
text for the transition states. Thin
dashed lines show selected hydro-
gen bonds. The p-creosol quinone
intermediate is coloured in black.
Otherwise, the representation is
the same as in Figure 38 (React-I).
The reaction of p-creosol to the covalent adduct Wenow
look at the pathway leading to adduct formation (see Fig-
ures 37A, 39 and 41, in black). The adduct can only be
formed after the p-creosol quinone methide intermedi-
ate (in red) has been produced. Then, a proton transfer
from the N5H to Asp170 takes place, followed by the co-
valent bond formation between the quinone intermediate
and the cofactor. Two transition states are thus involved in
adduct formation. The energy barrier of the proton trans-
fer from N5H to Asp170 was calculated to be 6.8 kcal/mol
relative to React-I. In the corresponding transition state
(TS2Add-I), the distance of the forming O-H bond is 1.2
Å, and that of the breaking N-H bond is 1.4 Å. The energy
barrier of the formation of the C-N bondwas calculated to
be 7.0 kcal/mol relative to React-I. In the corresponding
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transition state (TS3Add-I), the distance of the forming C-
N bond is 2.0 Å. The optimised structures of all the species
along the reaction are given in Figure 41. It is very interest-
ing that the calculated energy barriers of the adduct for-
mation are lower than those of the productive reaction,
and the formed adduct product ProdAdd-I is higher in en-
ergy by 3.7 kcal/mol, compared to Prod-I (see also Figure
39).
Alternative mechanisms We have indications that a
concerted mechanism for adduct formation is energet-
ically infeasible: all optimisations of the corresponding
transition states converged to the intermediate. Water ad-
dition to the adduct was found to be energetically infea-
sible as well. We have also considered the attack of the
substrate on FAD-N5-H as the first step, followed by a pro-
ton transfer to Asp170. However, this pathway was found
to be not energetically viable. The mechanism where the
substrate first attacks N5was also found to be not energet-
ically viable.
The reaction of vanillyl alcohol to vanillin For the re-
action of vanillyl alcohol to vanillin we suggest the follow-
ing reaction mechanism with feasible energy barriers on
the basis of our calculations. In the first mechanistic step
of this reaction the hydride transfer from the substrate
to the FAD cofactor yielded reduced FAD and a quinone
methide intermediate (blue reaction mechanism in Fig-
ure 37B, React-II to Inter-II). The energy barrier of the hy-
dride transfer from vanillyl alcohol to FAD was calculated
to be 10.8 kcal/mol relative to React-II (Figure 42, TS1-II).
In the corresponding transition state (TS1-II), the distance
of the forming N-H bond is 1.3 Å, and the breaking C-H
bond is 1.3 Å (Figure 43). Note that the same twisting of
the FAD cofactor during the hydride transfer as for the re-
action from p-creosol to vanillyl alcohol is observed.
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Figure 42: Energy profile of the
stationary points of the reaction
of vanillyl alcohol to vanillin. La-
bels are the same as used in Fig-
ure 37. Starting from the active
site model, React-II, the light blue
solid lines indicate the stationary
points of the reaction without a
water molecule present. The dark
blue solid lines indicate the sta-
tionary points of the reaction with
a water molecule present (React-
II’, described later in the text). The
energies of TS2 are only indicative,
and therefore shown as dashed
lines. Note that the relative ener-
gies given for the pathways with-
out and with water are only plot-
ted in the same figure for easier
comparison of the energy barri-
ers. The energies of React-II and
React-II’ are not identical due to
the additional water molecule in
the pathway with water (II’).
The second mechanistic step of this reaction, where a
proton from the substrate is abstracted by Asp170, yielded
the product vanillin (blue reaction mechanism in Figure
37B, Inter-II to Prod-II). The optimisation of the transition
state for proton transfer from the quinone methide inter-
mediate to Asp170 always failed. Therefore, the geome-
tries shown in Figures 42 and 43 correspond to the highest
point on the energy profile from the scan (TS2-II). The cal-
culated energy of TS2-II is only 1.0 kcal/mol higher than
Inter-III. The formed vanillin (Prod-II) is -22.7 kcal/mol
lower in energy than React-II. This very low energy may
indicate a limitation of themodel, e.gmissing interactions
with other, second-shell residues.
Alternative mechanisms Asp170 could be optimised to
be in its deprotonated form (without abstracting a proton
from Arg398) if a water molecule is included in the model
for this reaction (see React-II’ in Figure 38). The calcu-
lated energy barrier of the hydride transfer was slightly in-
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Figure 43: Optimised structures of
the species involved in the sug-
gested mechanism of the reaction
of vanillyl alcohol to vanillin. Dis-
tances are given in angstrom, with
the thick dashed lines providing
context for the transition state.
Thin dashed lines show selected
hydrogen bonds. Otherwise, the
representation is the same as in
Figure 38 (React-II). Labels are the
same as used in Figure 42.
creased in this model (12.1 kcal/mol). The intermediate
(Inter-II’) is lower in energy (-8.5 kcal/mol) compared to
the calculationswithout thewatermolecule. Similar to the
case starting with React-II, the transition state for the step
of proton transfer could not be located, and we use also
the structure from the scan here. The barrier of this step
is higher than for the pathway without water, 8.1 kcal/mol
higher than Inter-II’. The formed vanillin is -17.8 kcal/mol
lower in energy than React-II’. The presence or absence
of water has no major impact on the conformation of the
residues in this model (see React-II vs React-II’ in Figure
38 and Figures 43 vs 44).
Calculations with Asp170 protonated by abstracting a
proton from Arg398 and a water molecule were also per-
formed and resulted in an energy barrier of 12.9 kcal/mol
CHAPTER 6 177
Figure 44: Optimised structures of
the stationary points of the reac-
tion of vanillyl alcohol to vanillin
starting from React-II’. Distances
are given in angstrom, with the
thick dashed lines providing con-
text for the transition state. Thin
dashed lines show selected hydro-
gen bonds. Otherwise, the repre-
sentation is the same as in Figure
38 (React-II’). Labels are the same
as used in Figure 42.
for the hydride transfer (data not shown), which is slightly
higher than the ones discussed above. Deprotonation of
Asp170 occurred during formation of the product. The
protonation state of Asp170 has no major impact on the
conformation of the residues in this model. We have
tested alternative reaction mechanisms and found that
the intermediate formed by the proton transfer as a first
mechanistic step cannot be located. We also have indica-
tions that a concerted mechanism is energetically infea-
sible, with optimisations of the corresponding transition
state falling to the intermediate.
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Discussion
We will go stepwise through the reactions we investigated
in the present study. The overall reaction mechanisms for
the conversion ofp-creosol to vanillyl alcohol and the con-
version of vanillyl alcohol to vanillin start out almost iden-
tical, with the hydride transfer from the substrate to the
FAD, yielding reduced FAD. The hydride transfer from the
substrate to FAD is the rate-limiting step for the conver-
sion of p-creosol to vanillyl alcohol, as well as for the con-
version of vanillyl alcohol to vanillin. In agreement with
kinetic data, the energy barrier for this hydride transfer is
higher in the p-creosol to vanillyl alcohol reaction: VAO
converts 0.07 molecules of p-creosol per second, but 1.6
to 5.4 molecules of vanillyl alcohol (depending on the pH)
[45].
Adduct formation vs productive reaction of p-creosol to
vanillyl alcohol In the reaction of p-creosol to vanillyl al-
cohol, after the formation of the quinone methide inter-
mediate, the productive reaction (to Prod-I) is competing
with the reaction leading to the adduct (ProdAdd-I). In the
hydroxylation reaction of the p-creosol quinone methide
intermediate, Asp170 is the final proton acceptor for the
proton of the water molecule. However, during adduct
formation, Asp170 abstracts a proton from flavin N5H.We
propose that in this step, the flexibility of Asp170 required
to initiate adduct formation is crucial: VAO does not form
an adduct with 4-alkylphenols with longer side chains,
such as 4-ethylphenol [271]. Also, the adduct between p-
cresol and FAD is much less affected by the variants men-
tioned above [45]. Bulkier substrates are likely prevent-
ing the flexibility of Asp170 and are therefore not forming
an adduct. The interactions of Asp170 with surrounding
amino acid residues could also further contribute to the
flexibility of Asp170, allowing or forbidding adduct forma-
tion.
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As discussed above, the energy barriers from the
quinone methide intermediate to the adduct product are
very low. The calculated barrier for the adduct forma-
tion is 6 kcal/mol lower than the productive reaction,
and the adduct formation is therefore kinetically favored
(see Figure 39). Also, the vanillyl alcohol product (Prod-I)
has comparable energy to the adduct product (ProdAdd-I):
they only differ by 3 kcal/mol (see Figure 39). Therefore,
both products can be formed in this reaction.
Variants of VAO that show improved activity with p-
creosol have been identified through directed evolution.
All these variants have changed residues remote from the
active site. It is of interest to discover how these variants
influence the reaction of p-creosol to vanillyl alcohol. Do
they slightly change the orientation of Asp170 in the active
site, stabilising it and thus disabling its attack on FAD? Or
do they influence the protonation state of Asp170? Do the
variants influence the energy barriers of product and/or
adduct formation, or do they influence the energies of the
product and/or adduct? To more conclusively establish
the details of adduct formation, we will proceed with a
larger active site model in future work.
The reaction of p-creosol to vanillyl alcohol vs the re-
action of vanillyl alcohol to vanillin The p-quinone me-
thide intermediates formed in these two reactions have
different lifetimes [223]. Our results are consistent with
this experimental data: the intermediate of p-creosol has
a longer lifetime than that of vanillyl alcohol [223]. We
observe a lower energy barrier for Inter-II to Prod-II (1
kcal/mol), compared to the energy barrier of Inter1-I to
Inter2-I (12.3 kcal/mol). Therefore, it is possible that
adduct formation is further facilitated by the longer life-
time of Inter1-I (compared to Inter-II). Also, in crystal
structures, a very similar adduct, the covalent p-cresol-
FAD adduct, can be observed, indicating a long lifetime
of this adduct [40]. We cannot compare the relative ener-
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gies of the two intermediates Inter1-I and Inter-II directly
because they are obtained from different active site mod-
els. However, it would be interesting to design calculations
allowing the direct comparison of the energies of these in-
termediates.
Asp170 The protonation state (and thus the acidity) of
Asp170 is influenced by Arg398 and a water molecule. De-
protonated Asp170 is crucial for the formation of vanillin,
and its protonation state is also possibly influencing the
formation of vanillyl alcohol from p-creosol. Care needs
to be taken not to over-interpret the current results, as the
active site model we have worked with is somewhat unre-
liably representing the acidity of Asp170. This points to
a finely tuned, crucial network of interactions involving
at least Asp170 and Arg398 that determines the acidity of
Asp170. One interesting question remains: does Asp170
activate the water molecule in the p-creosol to vanillyl al-
cohol reaction without the direct involvement of FAD-O4,
like the experimental papers propose? In our calculations
with the current active site models, we see that the O4 of
FAD rather than Asp170 abstracts a proton inwater activa-
tion (see TS2-I in Figure 40), followed by a proton transfer
process from FAD to Asp170. However, this could be due
to the fact that the environment of Asp170-Arg398 pair
was not treated properly. This can be addressed by using
a larger active site model.
VAO vs PCMH A close relative of VAO, PCMH converts
p-cresol without problems (p-creosol was never tested as
a PCMH substrate). As can be seen in Figure 45, the ac-
tive site of PCMH differs from VAO in several important
aspects. Most notably, the active site base in VAO, Asp170,
is replaced by an alanine, Ala154, in PCMH, while Arg398
is conserved in PCMH (Arg368). In PCMH, it is unclear if
Glu427 or Glu380 is the active site base [56]. We will now
discuss in more detail the active site composition of these
two enzymes and their impact on activity based on the re-
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Figure 45: Active site residues in
VAO (A) PDBID:2VAO) and PCMH
(B) PDBD:1DII). Residues in the
active site model for this study are
shown in green or orange (VAO or
the equivalent in PCMH, respec-
tively). The ligands of the crystal
structure are colored in cyan. The
FAD cofactor is colored in yellow,
and other, second shell, active site
residues are colored in grey. Only
amino acid side chains are shown
for clarity.
sults obtained through our calculations.
In our calculations, we observe that the interaction
with Arg398 is crucial for the protonation and therefore
the activity of Asp170 as catalytic base. We also note that
inmost structures, the interactionwith Arg398 alone is not
sufficient to stabilise the deprotonated form of Asp170.
It is likely that there is an entire network of interactions
required to achieve this, possibly including Glu410 and
Arg312 or more residues. It is interesting to note that
Glu410 is conserved in PCMH as Glu380. Also, Tyr187 is
conserved in PCMH as Tyr172, which suggests that the
role of this residue in catalysis has been so far underes-
timated. Tyr187 could interact with Asp170 to stabilise it
in its deprotonated form.
PCMH presents inverted stereoselectivity with 4-
alkylphenols, producing (S)-stereoisomers, while VAO
produces (R)-stereoisomers [195, 285]. The inversion of
Asp170 and Thr457 in PCMH (to Ala170 and Glu457)
is the cause of this changed enantioselectivity: the
D170S/T457E double variant of VAO produces the (S)-
stereoisomers [46]. These results point towards Glu427
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being the catalytic base in PCMH. The reaction mech-
anism of PCMH also involves a p-quinone methide in-
termediate. Our calculations, together with the fact that
PCMHdoes not form an adductwith p-cresol, suggest that
Glu427 is unable to attack flavin N5H in the samemanner
Asp170 does, nor is Glu380. Both Glu380 and Asp170 are
3.6 Å away fromflavinN5. It is therefore likely that the dual
role Asp170 has in VAO [43, 46] is split betweenGlu380 and
Glu427 in PCMH, with Glu380 being involved in the cova-
lent binding of FAD and Glu427 being the catalytic base.
Conclusions and remaining open questions
The current active site model is insufficient for this reac-
tion due to second shell residues that probably influence
Asp170 significantly. It is therefore crucial to perform cal-
culations with a larger active site model. Adduct forma-
tion is easywith p-creosol due to Asp170 flexibility, but not
possible due to a more bulkier side chain of the substrate
for the vanillyl alcohol reaction. The same is true for re-
actions with 4-alkylphenols that have longer side chains
than p-creosol or p-cresol. Asp170 needs to be deproto-
nated after each step to be able to perform its function in
a new reaction step. Can we identify and model the reac-
tions of a H-bond network that releases the proton to the
solvent? Howmany water molecules fit into the active site
next to the substrate? Could additional water molecules
influence the properties of Asp170? Can we somehow
model the two-step reaction with one active site model,
including oxidation of reduced flavin?
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Computational Methods
We performed all calculations using the Gaussian 09 program [286] with
the B3LYP hybrid density functionalmethod [287, 288]. Geometries were
optimised with the 6-31G(d,p) basis set. During the geometry optimisa-
tions, the truncated carbon and also some hydrogen atoms were fixed
to prevent undesirable residue movements. Single-point energies were
calculated with the SMD solvation model, using also the 6-31G(d,p) ba-
sis set [289] to take the effects of the protein environment into account:
the part of the enzyme that is not included in the model is approxi-
mated by a polarisable homogeneousmediumwith a dielectric constant,
here set to = 4. This model does not account for the heterogeneity
of the enzyme surroundings. Systematic studies have shown that the
effect of the solvation decreases quite rapidly with the size of the ac-
tive site model [290, 291, 292, 293]. The optimised structures were then
subjected to single-point energy calculations using the larger basis set
6-311+G(2d,2p) to obtain more accurate energies. All the calculations
in the present study included dispersion corrections by using the DFT-
D3(BJ) method, so using the D3 correction method of [294], with Becke-
Jonson (BJ) damping [295]. Frequency calculations were performed with
the 6-31G(d,p) basis set to obtain zero-point energies (ZPE). The rela-
tive energies shown in this work are therefore the large basis set energies
(including dispersion effects) corrected for ZPE and solvation. The sol-
vation correction was obtained by substracting energies calculated with
the 6-31G(d,p) basis set from the energies calculated using the SMD sol-
vation model.
Bibliography follows at the end of the thesis
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In this thesis, the flavoenzyme vanillyl alcohol oxidase
(VAO) has been studied by computational and experi-
mental techniques. Chapter 2 puts all this work into a
more global and practical context. There, we have identi-
fied, analysed and illustrated in several examples the chal-
lenges enzymes (and specifically oxidative enzymes or ox-
izymes) face, as well as the demands they have to meet
before they can "grow up" to be industrial enzymes.
Enzymes could be the key to a more sustainable chem-
ical industry. Especially oxizymes are of interest due to
their ability to selectively incorporate oxygen atoms into
molecules. In Chapter 2, the industrial usability of ox-
izymes was reviewed. Numerous examples of already ap-
plied oxizymes exist and many oxizymes are on track for
applications. Nevertheless, the promise alone of “poten-
tial industrial applications” in many academic publica-
tions is not enough to make an application immediate re-
ality. Industrial use of oxizymes is undoubtedly promising
and feasible. However, economical costs and the impact
of practical aspects, such as process design, make it diffi-
cult for academic scientists to judge the applicability of an
enzyme.
A growing industrial interest in oxizymes is reflected in
the number of patents filed between 2000 and 2015. A re-
cent review has identified 369 patents related to biocatal-
ysis applications using oxidoreductases that have been
filed in that period [296]. It is unclear how many of
these patents are about oxizymes (as defined in Chap-
ter 2) because the distinction between dehydrogenases
and oxizymes is not made. Most of these patents have
been filed between 2013 and 2015 [296]. The same au-
thors also see miscommunication between academic and
industrial research as an obstacle: "Communication be-
tween academia and industry, however, is often considered
a structural weakness, and a general discrepancy between
industry’s short-term objectives and academia’s long-term
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perspective has been noted"[296].
In the application of oxidases, two issues need special
consideration. Because all oxidases require dioxygen in
their reaction cycle, aeration is a crucial factor to take into
account. Aeration of the reaction mixture on small scale
is usually not a problem, but it becomes a limitation in
large scale reactions. Adding pure dioxygen to the reaction
on large scale includes considerable safety risks due to the
combustibility of oxygen. Some applications use oxidases
specifically for their ability to produce hydrogen peroxide.
However depending on the application, hydrogen perox-
ide can also be a drawback, resulting in enzyme inactiva-
tion. Enzyme cascades using peroxidases or capturing the
hydrogen peroxidewith catalase, could help to resolve this
drawback.
The application of VAO is appealing for different indus-
tries, namely the chemical, food, flavour and fragrance in-
dustry. For the chemical industry, the production of chiral
1-(4’-hydroxyphenyl)alcohols by VAO is of specific interest
[195]. These compounds can be used as chiral building
blocks for more complex chemicals including neuropro-
tective pharmaceuticals. The enantiomeric excess of the
VAO-mediated hydroxylation reactions (94 and 80 % for
the (R)- and (S)-stereoisomer, respectively; [46]) still needs
to be increased to reduce downstream processing. Never-
theless, upscaling experiments in the INDOX project have
already shown that 10 g enantiopure product can easily be
obtained [297]. VAO can use eugenol to produce coniferyl
alcohol, a molecule of interest for the fragrance industry
and a compound which can also be used as a vanillin pre-
cursor [192]. To complete this list, VAO is of interest for
the food industry because it can produce natural vanillin
[178]. We have studied the VAO-catalysed conversion of
para-creosol to vanillin in detail in Chapters 5 and 6.
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Concerning the “greenness” (see
Chapter 2) of the different pro-
duction routes for vanillin, it is un-
clear which one is actually more
environmentally friendly and sus-
tainable. It is essential to keep
in mind that all these vanillin
molecules are chemically identical
and that it does not matter to our
nose how they were produced.
Vanillin, the main constituent of the vanilla flavour, is
produced in the pods of vanilla orchids, e.g. Vanilla plan-
ifolia, V. pompona or V. tahitensis. These orchids all be-
long to the genus Vanilla [298, 299]. In V. planifolia, one
enzyme is converting ferulic acid to vanillin [300]. Only 1
kg of vanillin per 500 kg of vanilla pods is produced [300].
The process is therefore rather inefficient, but due to the
high selling price of the obtained flavour it is nevertheless
economically viable. For an overview of the different con-
ventional production routes of vanilla from pods we refer
the reader to [301], while amore up to date overview of the
bioconversion or biosynthesis routes of natural vanillin
can be found here [302]. Vanillin is currently mainly pro-
duced synthetically, but consumer demand for “natural”
products has lead to the marketing of “natural vanillin”.
Chemically, both molecules are identical, but one is pro-
duced via chemical synthesis (e.g.: Rhovanil®Vanillin),
while the other ismicrobiologically produced from a "nat-
ural" precursor (e.g. Rhovanil®Natural). This difference
in production allows the producers to call it a “natural
flavour”, in agreement with European and US regulation
[303]. This is how Nestlé has been able to claim in 2015
to replace all artificial colours and flavours in its confec-
tionary sold in the US by the end of that year [304].
As the work in this thesis was performed in an aca-
demic setting, the practical aspects of bringing an en-
zyme to industrial application(s) are not discussed be-
yond this point. After all, "in a scientific pursuit there is
continual food for discovery and wonder" [305]. In that
spirit, the remainder of this discussion dealswith themore
mechanistic properties of VAO. More than 20 years after
the discovery of VAO, there is still much to be learned
about the structure-function relationship of this enzyme.
The explosion of sequence data since the beginning of
this century has lead to a data revolution taking place.
Surely, many VAO-like sequences are concealed in the vast
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amounts of sequence data stored in databases. The chal-
lenge is to find the right ones. Most sequences are au-
tomatically annotated, and the thus annotated function
is often suspect. Unfortunately, manual functional an-
notation, preferably by in depth biochemical characteri-
sation, is much more time consuming. For VAO, misan-
notation is a serious problem because of the many VAO-
like sequences that are annotated with ambiguous terms
like hypothetical proteins, FAD-binding oxidoreductases,
FAD binding domain-containing proteins and uncharac-
terized proteins, or they are annotated as glycolate oxi-
dases, alcohol oxidases or aryl alcohol oxidases (seeChap-
ter 3). Overall sequence identity of enzymes with VAO-
like function (e.g. EUGO or PCMH) can be as low as 47
or 40 % sequence identity, or even lower amongst fungal
VAOs, making functional predictions difficult (see Chap-
ter 3). The use of critical amino acid residues to assign
function would be more promising (see Chapter 3). Two
different screening strategies were used inChapters 3 and
4, and they are printed in this thesis in reverse order, with
the work done last in Chapter 3 and the work done first in
Chapter 4.
There is a discrepancy between the amount of se-
quences and the sequences for which a function has been
verified, resulting in more than one hundred million en-
tries in the so-called RefSeq database, and only around
55’000 entries in the manually verified UniProtKB/Swiss-
Prot database [306, 307]. Besides the obvious issue of mis-
annoation, other biases are present in these databases,
which are introduced by biases in high-throughput ex-
perimental data [308]. To resolve misannotations manu-
ally is tedious work. It would be much more effective if
the annotation could be automatically resolved (just as it
has been automatically annotated). This would require
knowledge of where the (mis)annotation originated from
to allow the correction to also use that origin. Another op-
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Platforms like https:
//www.zooniverse.org/
are public, freely available and
host projects ranging from arts to
physics. People-powered research
is a tool that not only helps to re-
solve research questions, but that
can help to increase acceptance of
science in a more sceptical world.
tion would be to allow every user of the database to re-
annotate sequences (manually or automated). This open
access, open editing concept has worked quite well for
wikipedia, with the exception of political topics (which
protein sequences in general are not). Projects like Fold it
(https://fold.it/) have an excellent track recordwhen
it comes to have "the internet-crowd" solve puzzles for
science. Such projects create a different type of high-
throughput experiments, using the interconnectedness of
modern day society to their advantage.
We have analysed the natural variation of fungal en-
zymes that are putative VAOs in Chapter 3 and have at-
tempted to functionally express some of them in Chap-
ter 4. In Chapter 3, an already filtered, high-quality set of
sequences present in the mycocosm database was anal-
ysed. Only one sequence is present in both chapters, a se-
quence fromDacryopinax (SeqIDM5FTW7). Based on the
high-quality set of sequences inChapter 3we also defined
motifs of VAO-like sequences. Hopefully, these motifs will
help to reduce the misannotations that exist for putative
VAOs and inspire the characterisation of novel enzymes.
We are confident that our functional predictions based on
the available knowledge from experimental studies are ac-
curate, but hope that there is still "food for wonder" in this
scientific pursuit.
One important aspect that we hope will be answered
by future studies is the physiological role of VAO in
its host organisms. The only substrate that also in-
duces expression of the vao gene in P. simplicissimum,
4-(methoxymethyl)phenol, is the proposed physiological
substrate. The limited knowledge of the biological occur-
rence of this molecule however forbids any conclusions
about the physiological role of VAO. A very general hy-
pothesis could be that the organisms that produce VAOs
are in symbiotic or parasitic relationships with organisms
that degrade or produce lignin. Organisms that degrade
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lignin often secrete enzymes for this purpose, leaving the
lignin-degradation products available to other organisms
that are themselves unable to degrade lignin. The phe-
nolic compounds thus produced (either during the an-
abolism or catabolism of lignin) are substrates of VAOs.
In catabolism, toxicity of phenolic compounds to fungal
communities of lignin degraders may thus be prevented
by organisms producing VAOs. These VAO-producersmay
have developed a tolerance for phenolic compounds by
producing enzymes such as VAO [309].
In Chapter 3, we propose that fungal VAOs have been
aquired through horizontal gene transfer of at least one
bacterial ancestral VAO.While this explains how fungiwith
diverse lifestyles obtained VAOs, it does not explain why
they kept these enzymes, and why some fungi even have
multiple copies in their genome. More studies are re-
quired to understand the physiological role of VAO bet-
ter. Proteomics studies of P. simplicissimum or other VAO
producers under different growth conditions (using differ-
ent, phenolic carbon sources) should be able to identify
more enzymes that are co-produced with VAO and dis-
cover if VAO belongs to a specific metabolic network. It
would be interesting to know ifP. simplicissimum (or other
fungi producing VAO) show an increased phenol tolerance
due to the presence of VAO. Most putative VAO homo-
logues identified in Chapter 3 are present in the phylum
Ascomycota, which contains brown-rot fungi. Only seven
species of the phylumBasidiomycota contain VAO-like se-
quences, and none of them are white-rot fungi. Typically,
brown-rot fungi, like P. simplicissimum, degrade hemicel-
lulose and cellulose, while white-rot fungi degrade cell-
lulose and lignin. It would be of interest to grow fungal
communities of P. simplicissimum with white-rot fungi to
find out if the addition of P. simplicissimum has a bene-
ficial effect on lignin-degradation. Interestingly, VAO ho-
mologues identified in Chapter 3 in the phylum Ascomy-
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Protein folding is often depicted
with a rugged, funnel-shaped free
energy landscape. Misfolding of
the protein means that the pro-
tein ends up in one of the grooves
of the rugged surface instead of
the global minimum. Misfolded
proteins are a big problem in pro-
tein expression experiments, and
screening efforts to achieve ex-
pression of functional proteins are
considerable. Specialised con-
sortia have been formed to re-
solve these issues, especially for
the determination of crystal struc-
tures. In recent years however,
in silico, de novo structure deter-
mination has become more and
more reliable, as demonstrated in
the Critical Assessment of Pro-
tein Structure Prediction (CASP)
competition. For more informa-
tion see their website and publi-
cations by the consortium: http:
//predictioncenter.org/
cota have diverse lifestyles, with only a fewbeingwoodde-
cayers. We wonder what role VAO has in these organisms.
In Chapter 4, we searched the non-redundant se-
quence database and then selected genes for expres-
sion based on presence or absence of critical amino acid
residues. Alas, expression of these putative vao genes
in the yeast Komagataella phaffii resulted in VAOs con-
taining an unusually stable anionic FAD semiquinone.
VAOs produced in this organism have several other unex-
pected properties: they all bind their FAD cofactor non-
covalently, are exclusively octameric and are unable to
productively convert substrates. It could be that K. phaf-
fii does not allow proper folding of VAOs. In VAO, FAD
binding requires a highly pre-organised binding cavity
[14, 41, 42]. We can safely say that this cavity is formed be-
cause we do observe FAD bound to the enzyme. However,
it is doubtful that the cavity is organised correctly since the
FAD cofactor is only bound non-covalently. In VAO, co-
valent incorporation of FAD happens via an autocatalytic
process [41, 42]. It might be that the precise conformation
to achieve covalent cofactor attachment is not reached in
VAOs produced in K. phaffii, resulting in the observed an-
ionic FAD semiquinone.
It would be of interest to study the autocatalytic mecha-
nism of covalent FAD incorporation using quantum me-
chanical calculations. This would allow to answer sev-
eral questions, namely: (i) what is the precise role of
His61 in this process, and can the tyrosine residue ob-
served at the same position in many VAO-like sequences
perform the same function (see Chapters 3 and 4)? (ii)
can a conformational change result in a "non-productive"
autocatalytic reaction and lead to the formation of an-
ionic FAD semiquinone? (iii) is it possible to change
the covalent binding mode of VAO? For this, quantum
chemical calculations for relatives of VAO with different
FAD binding modes have to be computed (e.g. PCMH,
194 DISCUSSION
Figure 46: An overview of the dif-
ferent computational approaches
that can be used to study enzymes.
For details see text.
6-hydroxynicotine oxidase and glucooligosaccharide oxi-
dase, which bind their FAD cofactor via a 8α-Tyr-bond, 8α-
His-N1-linkage or bi-covalently [56, 219, 310, 311]).
If functional enzyme can be produced, experimental
studies of its reactionmechanism are possible. In the case
of VAO, several types of reactions are observed with differ-
ent substrates (the reader is referred to Figures 16, 21 or
22 in Chapter 3 or 4). However, in the absence of func-
tional enzyme, and if a crystal structure has been solved,
computational calculations can be performed to study the
enzyme in silico (see Figure 46 for an overview of possible
approaches).
From a structure (or homology model) of an enzyme
with unknown properties (top in Figure 46), blind dock-
ing studies can help identify the location of the active
site. This is illustrated by the successful docking of the
cyan molecule in the active site. The active site can also
be identified by studying the migration of substrate(s) or
product(s) in the enzymes, for example using PELE (see
Chapter 5). Once an active site has been identified, the re-
action mechanism can be studied using QCM or QM/MM
(see Chapter 6). If the substrate scope of the enzyme is
unknown, docking studies may help to narrow down the
choices for in depth quantum mechanical calculations. If
the location of the active site is not known, the method-
ology used in Chapter 5 can identify it. Even if the loca-
tion of the active site is known, it is of interest to discover
the path(s) ligand(s) take to enter it. Although substrate
binding is an often neglected and even trivialised [312]
event in an enzymes reaction cycle, bottlenecks or blocked
passages can profoundly change an enzyme’s activity, see
e.g. the gatekeeper residue in galactonolactone dehydro-
genase [248].
In Chapter 5, we have explored the free energy land-
scape of VAO using PELE and studied how participants in
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Figure 47: Interfaces and faces in
VAO. Top: the symmetric tetramer
of dimers, middle: the dimer,
with the two subunits (grey and
coloured) and the two domains
(red and green), bottom: the two
faces of the FAD cofactor, si (with
the substrate coloured in cyan,
down into the plane of the paper)
and re (up towards the viewer in
the plane of the paper).
the reaction of para-creosol to vanillin enter and exit the
enzyme’s active site. We have found that phenolic ligands
use a gated entry and exit path at the subunit interface of
VAO, leading to the si side of the FAD cofactor in the active
site (see Figure 47). The co-substrates dioxygen and hy-
drogen peroxide use a different entry and exit path at the
interface of the two domains, leading to the re-side of the
FAD cofactor in the active site (see Figure 47).
We have seen that protonated p-creosol can enter VAO
without problems and that deprotonated p-creosol does
not enter VAO. From our simulations, it is obvious that it
is energetically unfavourable for deprotonated substrates
to migrate through VAO. Deprotonated p-creosol can be
forced to enter, and under these conditions we see a sig-
nificant increase in energy when it is around 10 Å away
from the FAD cofactor. This coincides with the location of
the two concierge residues, His466 and Tyr503, thus sug-
gesting the conclusion that these residues are part of the
“phenolate-exclusionmechanism” in VAO.Without forcing
deprotonated p-creosol to enter, it is energetically more
favourable for it to leave to the solvent than to migrate to
the FAD. Our results indicate that deprotonated p-creosol
is unable to migrate through VAO efficiently.
VAO has a pH optimumat pH 10, and the phenolic sub-
strates of VAO have a pK a of around 10. Thismeans that at
pH 10, the amount of phenolate in solution is drastically
increased (compared to pH 7). From our computational
studies we know that the phenolate of p-creosol cannot
enter the active site, and that therefore deprotonation of
this substrate must occur in the active site. From previous
work, it is known that the pK a of the competitive inhibitor
isoeugenol is different in solution than in VAO [36]: the
pK a of isoeugenol drops to values around 5 inside VAO,
compared to values around 10 in solution. This suggests
that under experimental conditions at pH 7.5, phenolic
substrates are prevalently bound in the VAO active site in
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Our simulations were performed
at pH 7.5. Therefore, we can-
not exclude that the behaviour of
the phenolate form of substrates is
different at pH 10.
their phenolate form. Additionally, two reduction rates of
FAD by chavicol were observed [49]. The faster of these
rates was suggested to correspond to the reduction of FAD
by the deprotonated substrate, while the slower one was
assigned to the reduction of FAD by protonated substrate.
The contribution of the faster reduction rate to the overall
rate was also shown to increase with increasing pH.
Combining the experimentalmodel with our computa-
tional model, we obtain the following, combined, model:
protonated substrates migrate to the active site of VAO,
where they are deprotontated. When increasing the pH
of the reaction, substrate deprotonation in the active site
is more favourable, leading to a faster overall reduction
rate due to the increased contribution of the deprotonated
substrate to the reaction. To verify this model, the calcu-
lations we have performed in Chapter 6 can be extended
using protonated substrate to check if the energy barriers
of that reaction are in agreementwith the slower reduction
rate observed by Ewing et al. [49].
In Chapter 6, we have explored another part of the free
energy landscape of VAO using quantum mechanical cal-
culations. We have seen that several conformations and
transition states can exist for one reaction, and not all lead
to the formation of the desired product. Small random
movements of active site residues and the substrate al-
low the exploration of different conformations. Forma-
tion of a "suicide" complex is a possibility, such as the
adduct formed by p-creosol and FAD. The height of the
energy barrier that needs to be crossed to lead to prod-
uct formation determines if the reaction happens or not.
One crucial mechanistic step of the reaction of VAO is
the reduction of FAD by hydride transfer from the sub-
strate. Because we work with deprotonated substrate only
in our QM studies, we should observe energy barriers cor-
responding to rates in the order of the faster reduction
rate observed by Ewing et al. [49]. Indeed, the calculated
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energy barrier for the hydride transfer is 10.8 kcal/mol,
and thereforemore in agreement with the faster reduction
rate.
We have observed certain limitations of the active site
model used in Chapter 6. The model we built contains
only some of the amino acid residues forming the active
site, allowing a faster exploration of the free energy pro-
files of a reaction. We built a model containing 165 atoms
to study the reductive half-reactions of the two-step reac-
tion of p-creosol to vanillin. This model is missing several
residues that interact with the catalytic base Asp170 and
might influence its acidity. Specifically the influence of
Arg398, but likely also Arg312, Glu410 and possibly Tyr187
on Asp170 needs to be studied inmore detail. Preliminary
data of VAO variants (R312A, R312H, R312K, R398A and
E410A) indicates that the second shell residues Arg312,
Arg398 and Glu410 do significantly influence enzyme ac-
tivity [313, 314]. Activity of the R398A and E410A variants
is absent with vanillyl alcohol, while eugenol is still con-
verted. Also, the conservation of the positive charge in the
R312H and R312K variants appears to conserve the (low-
ered) activity in these variants. The Michaelis constant
(Km) of vanillyl alcohol is at least doubled in these vari-
ants, whereas the kcat of eugenol is decreased at least 5-
fold.
Such different, changed activities of VAO-variants with
different substrates are often observed, e.g in the VAO-
variants created by directed evolution experiments [45].
Therefore, it is crucial to perform quantum chemical cal-
culations with a larger model to refine the calculated
energy barriers. Based on our results from Chapter 6,
it would be very interesting to test the activity of the
D170S/T457E double variant [46] with p-creosol. Al-
though this variant has a very low activity with ethylphe-
nol, testing its activity with p-creosol could be beneficial
to our understanding of the reactivity of Asp170. We pre-
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dict that this variant does not form an adduct with p-
creosol because of the rearrangement of these two active
site residues: Glu457, unlike Asp170, should be unable to
attack the flavin to initiate adduct formation. In the bioin-
formatics studies of VAO and its closest homologues de-
scribed in Chapters 3 and 4 we see that a direct replace-
ment of Asp170 by a glutamate does not occur without
additional mutations of the enzyme. This is an indication
that this mutation had detrimental effects. The only ho-
mologue with only Glu170 is the very suspicious sequence
from the sordariomycete Diaporthe ampelina. Therefore
it is not recommended to only change Asp170, but to ei-
ther create the T457D variant (as observed in some of the
sequences in Chapter 3) or study the D170S/T457E dou-
ble variant in more detail.
It is essential that further computational and exper-
imental studies use the same substrates to allow better
comparison of results and include appropriate controls.
Calculating properties of already existing variants or ex-
plaining already known properties of VAO by using com-
putational techniques is of course valuable, but it can con-
tain an inherent bias. To allow an unbiased interpreta-
tion of computational and experimental results, the exper-
imental and computational work needs to be kept strictly
apart before publication (similar to the CASP competi-
tion). Publishing the results together would defeat the
purpose of eliminating possible bias (or even invite the
reproach of bias). In the context of a CASP-like compe-
tition, publication in a special issue where all experimen-
tal and computational results are included would be de-
sirable. To study the mechanistics of variants discovered
by van den Heuvel et al. [45], the following approach
would be beneficial: perform detailed studies of reduc-
tion rates as well as calculations of the corresponding en-
ergy barriers, ensuring no results or conclusions are ex-
changed and then publish the results separately. The vari-
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ants discovered by van den Heuvel et al. [45] are espe-
cially challenging because they are remote from the active
site. Therefore, different models and hypotheses will have
to be tested computationally and experimentally. Such
“battles of wits” between the experimental and computa-
tional community would surely benefit the field and im-
prove our understanding of sequence-structure-function
relationships immensely.
A computational outlook
Currently, many different computational tools are avail-
able to study different steps of an enzyme reaction. For
computational studies of ligand migration, online tools
like CAVERor PELE are available, as are free software pack-
ages like GROMACS or CHARMM [67, 315, 316, 317, 318].
For computational studies of enzyme catalysis, quan-
tum chemical modelling (QCM) or quantum mechan-
ics/molecular mechanics (QM/MM) calculations can be
performed using, e.g., GAUSSIAN or PELE [286, 67]. De-
pending on the research question, different tools have to
be chosen. We have used PELE, aMonte Carlo (MC) based
program to study ligand migration in VAO in Chapter 5,
and QCM in Chapter 6. It is important to know that the
quantum chemical cluster approach or all-QM approach
we have used is entirely different from a QM/MM ap-
proach, as explained in Chapter 1.
Enzyme activity is significantly affected by solvent effects.
Several concepts to study the effects of solvents on en-
zyme activity have been developed or are currently un-
der development [319, 320, 321, 322, 323, 324, 322, 325,
326, 327, 328, 329, 330]. Work is ongoing to combine
these concepts into an easy to use tool for experimental-
ists. It is therefore becoming feasible to computationally
model complete enzyme reactions and enzyme mecha-
nisms. However, at least three different tools or software
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packages (one for MD or MC, one for QCM or QM/MM
and one to study solvent effects) need to be used to do
so, presenting a considerable barrier for expert and non-
expert users. Contributing to this barrier is the fact that
different methodologies are behind these tools or soft-
ware packages, and consequently the correct interpreta-
tion of their results requires in depth understanding of
each methodology.
Nevertheless, computational tools are becoming more
and more user-friendly and the times where intense pro-
gramming efforts were required by the user are over. Most
of the tools mentioned above are also freely available (at
least to academic users). Unfortunately, this free availabil-
ity also has a downside: changing availability [331] and
lack of stable technical assistance. The costs of maintain-
ing the code behind these tools is often not covered by
funding schemes, and maintenance of the generated data
is left to the personal preference of the user that created it.
The future of enzymes as the key to a more sustain-
able chemical industry requires not only the better com-
munication between industry and academia, but also the
more integrated use of computational tools. In the last few
decades, biotechnology has revolutionised experimental
work. Kits for cloning of genes, protein expression and
protein characterisation have made biotechnology suc-
cessful by making it accessible and easy to use. The
data revolution triggered by high-throughput genome se-
quencing (which was in turn a consequence of biotech-
nology revolution) has seen equal success with easy to
use, online bioinformatics tools. Examples include BLAST,
Clustalomega, DeepLoc, SWISS-MODEL and EFI-EST as
well as sequences databases like Ensembl and Swiss-Prot.
These services are maintained by the European Bioinfor-
matics Institute (EMBL-EBI), the Enzyme Function Initia-
tive (EFI) or the Swiss Insititute of Bioinformatics (SIB).
Currently, the only databases available for structural in-
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F.A.I.R.: Data has to be Find-
able: data need to be assigned
a unique and persistent identifier,
described with richmetadata, reg-
istered or indexed in a searchable
source and have a data identifier
specified by metadata. Data has
to be Accessible: data need to be
retrievable by their identifier via a
standardised, open, free and uni-
versally implementable commu-
nications protocol and the meta-
data need to be accessible even if
the data are no longer available.
Data has to be Interoperable: data
need to use vocabulary following
F.A.I.R principles in a formal, ac-
cessible, shared andbroadly appli-
cable language and include quali-
fied references to other data. Data
has to be Reusable: data need
to be associated with their prove-
nance and meet domain-relevant
community standards.
formation are the PDB for experimentally determined
structures or smaller databases for homology models (e.g.
ModBase). Several databases or servers building on the
structural information in the PDB exist (e.g. Molecular
Modeling Database or Inferred Biomolecular Interactions
Server). However, no databases for MD, MC, QCM or
QM/MM calculations exist.
Increasing and improving the availability of computa-
tional tools and increasing acceptance by experimental-
ists will lead to an increase of data generated by MD, MC,
QM or QM/MM. It would be highly beneficial to require
that data generated using freely available tools is also
made freely available, e.g. under an ODC Open Database
License. Data should also be Findable, Accessible, Inter-
operable and Reuseable (F.A.I.R.) [332, 333, 334].
202 DISCUSSION
Conclusion
An enzymatic reaction is a multistep process, involving
substrate entrance, substrate diffusion to the active site,
catalysis, product diffusion to the solvent, and product
exit. It is almost impossible to separate these events in
experimental data when studying enzyme mechanisms,
even in stopped flow experiments. Computational stud-
ies boost insight into these events and allow to interpret
experimental data in a more complete way (see Chapters
5 and 6). Healthy sceptisism from experimentalists to-
wards computational data, and vice versa, will ensure that
the most realistic models of enzyme reactions can be de-
fined. It should never be forgotten that enzyme kinetics is
also "only a model" of the complex process that is enzyme
catalysis. A plethora of sequence information is available
and we need to find better ways to annotate it (see Chap-
ters 3 and 4). The challenge we are facing in this century
is not data collection, but data management and analysis.
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